Processing 00000000.tx.1: Identification of Insulin Domains Important for Binding to and Degradation by Endosomal Acidic Insulinase* Franois Authier, Gillian M. 

Phrase: "Identification of Insulin Domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "Important for Binding"

Phrase: "to"

Phrase: "and"

Phrase: "Degradation by Endosomal Acidic Insulinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "* Franois Authier,"

Phrase: "Gillian M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Danielsen, Mostafa Kouach, Gilbert Briand and Genevive Chauvet Institut National de la Sant et de la Recherche Mdicale U510 (F.A.), Facult de Pharmacie Paris XI, 92296 Chtenay-Malabry, France; 

Phrase: "Danielsen,"

Phrase: "Mostafa Kouach,"

Phrase: "Gilbert Briand"

Phrase: "and"

Phrase: "Genevive Chauvet Institut National de la Sant et de la Recherche Mdicale U510"

Phrase: "(F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A."

Phrase: ")"

Phrase: ","

Phrase: "Facult de Pharmacie Paris XI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1720296:Xi [Intellectual Product]

Phrase: "92296 Chtenay-Malabry,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ";"
Processing 00000000.tx.3: Health Care Discovery (G.M.D.), Novo Nordisk A/S, Novo Alle, DK-2880 Bagsvaerd, Denmark; 

Phrase: "Health Care Discovery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1880355:Discovery [Activity]
   734   C0086388:Health Care [Health Care Activity]

Phrase: "(G.M.D."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0439417:g d [Quantitative Concept]
   901   C0456715:g m [Quantitative Concept]
   901   C1512018:M.D. [Intellectual Product]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "Novo Nordisk A/S, Novo Alle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1002199:Alle [Bird]

Phrase: "DK-2880 Bagsvaerd,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ";"
Processing 00000000.tx.4: Laboratoire de Spectromtrie de masse (M.K., G.B.), Facult de Mdecine, 59000 Lille, France; 

Phrase: "Laboratoire de Spectromtrie de masse"

Phrase: "("

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Facult de Mdecine,"

Phrase: "59000 Lille,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ";"
Processing 00000000.tx.5: Institut National de la Sant et de la Recherche Mdicale U30 (G.C.), Hpital Necker Enfants-Malades, 75015 Paris, France Address all correspondence and requests for reprints to: Franois Authier, INSERM U510, Facult de Pharmacie Paris XI, 5 rue Jean-Baptiste Clment, 92296 Chtenay-Malabry, France. 

Phrase: "Institut National de la Sant et de la Recherche Mdicale U30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C1419504:U30 [Gene or Genome]

Phrase: "(G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "C."

Phrase: ")"

Phrase: ","

Phrase: "Hpital Necker Enfants-Malades,"

Phrase: "75015 Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030561:Paris [Geographic Area]
   861   C0331677:Paris [Plant]
   861   C1824032:PARIS [Gene or Genome]
   827 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Franois Authier,"

Phrase: "INSERM U510,"

Phrase: "Facult de Pharmacie Paris XI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1720296:Xi [Intellectual Product]

Phrase: "5 rue Jean-Baptiste Clment,"

Phrase: "92296 Chtenay-Malabry,"

Phrase: "France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]
Processing 00000000.tx.6: E-mail: francois.authier{at}cep.u-psud.fr  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  The endosomal compartment of hepatic parenchymal cells contains an acidic endopeptidase, endosomal acidic insulinase (EAI), which hydrolyzes internalized insulin at a limited number of sites. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "francois.authier{at}cep.u-psud.fr  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The endosomal compartment of hepatic parenchymal cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C2349967:Compartment of cell [Anatomical Structure]
           Cell compartment
   781   C2336292:Compartment of endosome [Body Space or Junction]
   757   C1948049:Cell (compartment) [Spatial Concept]
   748   C1185625:Compartment [Body Space or Junction]
   748   C2986730:Compartment [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an acidic endopeptidase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "endosomal acidic insulinase (EAI),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "which"

Phrase: "hydrolyzes"

Phrase: "internalized insulin at a limited number of sites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.7: Although the positions of these cleavages are partially known, the residues of insulin important in its binding to and proteolysis by EAI have not been defined. 

Phrase: "Although"

Phrase: "the positions of these cleavages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0733755:positions [Spatial Concept]

Phrase: "are"

Phrase: "partially"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "the residues of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "important in its binding"

Phrase: "to"

Phrase: "and"

Phrase: "proteolysis by EAI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597304:Proteolysis [Molecular Function]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.8: To this end, we have studied the degradation over time of native human insulin and three insulin-analog peptides using a soluble endosomal extract from rat liver parenchyma followed by purification of the products by HPLC and determination of their structure by mass spectrometry. 

Phrase: "To this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the degradation over time of native human insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C3547574:insulin degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "three insulin-analog peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a soluble endosomal extract from rat liver parenchyma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0023899:Liver Extract [Organic Chemical,Pharmacologic Substance]
   744   C2828366:Extract [Substance]

Phrase: "followed by purification of the products"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0243114:purification [Functional Concept]
   753   C1514468:Products [Entity]
   753   C1998793:Purification [Functional Concept]
   719 E C1704444:Product [Quantitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "by HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "and"

Phrase: "determination of their structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "by mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.9: We found variable rates of ligand processing, i.e. high ([AspB10]- and [GluA13,GluB10]-insulin), moderate (insulin) and low (the H2-analog). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "variable rates of ligand processing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "i.e. high"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "("

Phrase: "[AspB10"

Phrase: "]-"

Phrase: "and ["

Phrase: "GluA13,"

Phrase: "GluB10"

Phrase: "]-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "(insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "("

Phrase: "the H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.10: On the basis of IC50 values, competition studies revealed that human and mutant insulins display nearly equivalent affinity for the EAI. 

Phrase: "On the basis of IC50 values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "competition studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0679932:competition [Social Behavior]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mutant insulins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0021641:insulins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C3537244:Insulins [Pharmacologic Substance]
   827 E C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827 E C1579433:Insulin [Pharmacologic Substance]
   789 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "nearly equivalent affinity for the EAI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.11: Proteolysis of human and mutant insulins by EAI resulted in eight cleavages in the B-chain which occurred in the central region (GluB13-LeuB17) and at the C-terminus (ArgB22-ThrB27), the latter region comprising the initial cleavages at PheB24-PheB25 (major pathway) and PheB25-TyrB26 (minor pathway) bonds. 

Phrase: "Proteolysis of human"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0597304:Proteolysis [Molecular Function]
   718 E C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "mutant insulins by EAI"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0021641:insulins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C3537244:Insulins [Pharmacologic Substance]
   719 E C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   719 E C1579433:Insulin [Pharmacologic Substance]

Phrase: "resulted in eight cleavages"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205454:Eight [Quantitative Concept]
   737   C0010813:cleavage [Cell Function]
   737   C0596311:Cleavage [Phenomenon or Process]
   737   C1274040:Result [Functional Concept]
   737   C1330957:cleavage [Cell Function]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in the B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "which"

Phrase: "occurred in the central region"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0454907:Central region [Geographic Area]
   760   C0017446:Region [Geographic Area]
   760   C0205099:Central [Spatial Concept]
   760   C0205147:Region [Spatial Concept]
   760   C1709305:Occurred [Activity]
   760   C1879652:Central - [Laboratory Procedure]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "(GluB13-LeuB17"

Phrase: ")"

Phrase: "and at the C-terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515981:And [Idea or Concept]

Phrase: "(ArgB22-ThrB27"

Phrase: ")"

Phrase: ","

Phrase: "the latter region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "comprising"

Phrase: "the initial cleavages at PheB24-PheB25"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0010813:cleavage [Cell Function]
   719   C0596311:Cleavage [Phenomenon or Process]
   719   C1330957:cleavage [Cell Function]

Phrase: "(major pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "PheB25-TyrB26"

Phrase: "(minor pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: ")"

Phrase: "bonds."
Processing 00000000.tx.12: Except for the [GluA13,GluB10]-insulin mutant, only one cleavage on the A-chain was observed at residues GlnA15-LeuA16. 

Phrase: "Except for the [GluA13,"

Phrase: "GluB10"

Phrase: "]-insulin mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "only one cleavage on the A-chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "observed at residues GlnA15-LeuA16."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1441672:Observed [Functional Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.13: Analysis of the nine cleavage sites showed a preference for hydrophobic and aromatic amino acid residues on both the carboxyl and amino sides of a cleaved peptide bond. 

Phrase: "Analysis of the nine cleavage sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a preference for hydrophobic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0558295:preference [Idea or Concept]
   770   C1549513:Preference [Idea or Concept]

Phrase: "and"

Phrase: "aromatic amino acid residues on both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "the carboxyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596260:Carboxyl [Organic Chemical]

Phrase: "and"

Phrase: "amino sides of a cleaved peptide bond."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0441987:Side [Spatial Concept]
Processing 00000000.tx.14: Using the B-chain alone as a substrate resulted in a 30-fold increase in affinity for EAI and a 6-fold increase in the rate of hydrolysis compared with native insulin. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "alone as a substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Alone [Quantitative Concept]
   770   C0439044:alone [Finding]
   770   C0679994:alone [Group Attribute]

Phrase: "resulted in a 30-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C1880834:FOLD [Phenomenon or Process]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "and"

Phrase: "a 6-fold increase in the rate of hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "compared with native insulin."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0302891:Native [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1707455:Compared [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.15: A similar role for the C-terminal region of the B-chain of insulin in the high-affinity recognition of EAI was supported by the use of the corresponding B22-B30 peptide, which displayed an increase in EAI affinity similar to the entire B-chain vs. wild-type insulin. 

Phrase: "A similar role for the C-terminal region of the B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0035820:Role [Social Behavior]
   736   C1705810:Role [Conceptual Entity]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the high-affinity recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0524637:Recognition [Mental Process]

Phrase: "of EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "was"

Phrase: "supported by the use of the corresponding B22-B30 peptide,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C1524063:Use of [Functional Concept]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0042153:use [Functional Concept]
   739   C0457083:Use [Functional Concept]
   739   C1417641:B22 [Gene or Genome]
   739   C1521721:Supported [Conceptual Entity]
   739   C1947944:Use [Intellectual Product]
   706 E C0183683:Support [Medical Device]

Phrase: "which"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "an increase in EAI affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "similar to the entire B-chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "vs. wild-type insulin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.16: Thus, we have identified a highly specific molecular interaction of insulin with EAI at the aromatic locus PheB24-PheB25-TyrB26. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a highly specific molecular interaction of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1167622:Molecular Interaction [Molecular Function]
   748   C1704675:Interaction [Functional Concept]

Phrase: "with EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "at the aromatic locus PheB24-PheB25-TyrB26."
Processing 00000000.tx.17: Analytical subfractionation of a postmitochondrial supernatant fraction showed that a pulse of internalized [125I]TyrA14-H2-analog, a protease-resistant insulin analog, undergoes a greater lysosomal transfer and lesser degradation than [125I]TyrA14-insulin, confirming that endosomal sorting is regulated directly or indirectly by endosomal proteolysis.  

Phrase: "Analytical subfractionation of a postmitochondrial supernatant fraction"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a pulse of internalized"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0232117:PULSE [Clinical Attribute]
   770   C0391850:Pulse [Physiologic Function]
   770   C1947910:Pulse [Phenomenon or Process]

Phrase: "[125I"

Phrase: "]TyrA14-H2-analog,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "a protease-resistant insulin analog,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0243071:Analog [Chemical Viewed Structurally]
   712 E C0679213:analogies [Idea or Concept]

Phrase: "undergoes"

Phrase: "a greater lysosomal transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "lesser degradation than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "[125I"

Phrase: "]TyrA14-insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that endosomal sorting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237886:Sorting [Mental Process]
   861   C0700314:sorting [Cell Function]
   861   C1947906:Sorting [Activity]

Phrase: "is"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "indirectly by endosomal proteolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]
Processing 00000000.tx.18: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  LIVER parenchyma has evolved endosomally located mechanisms to regulate the specificity of receptor tyrosine kinase signal transduction (1). 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "LIVER parenchyma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0736268:Liver parenchyma [Body Part, Organ, or Organ Component]
   861   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "evolved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332253:evolved [Functional Concept]

Phrase: "endosomally located mechanisms to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "regulate"

Phrase: "the specificity of receptor tyrosine kinase signal transduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037791:Specificity [Quantitative Concept]
   744   C1511884:Specificity [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: One of these regulatory mechanisms is at the level of intraendosomal ligand degradation (2, 3, 4). 

Phrase: "One of these regulatory mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "is at the level of intraendosomal ligand degradation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0023688:Ligand [Chemical]
   744   C0243125:degradation [Functional Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C0699900:Degradation [Organism Function]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.20: Liver endosomes contain an acidic insulinase activity, endosomal acidic insulinase (EAI), which is not related to insulin-degrading enzyme (IDE) (5). 

Phrase: "Liver endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an acidic insulinase activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150184:insulinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "endosomal acidic insulinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "(EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to insulin-degrading enzyme (IDE)"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0163712:Relate [Organic Chemical]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: In conjunction with endosome-associated phosphotyrosine phosphatase(s) directed against the tyrosine-phosphorylated insulin receptor (6), EAI limits the temporal window of activation and transduction of insulin receptor internalized into the endosomal compartment (7). 

Phrase: "In conjunction with endosome-associated phosphotyrosine phosphatase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0085536:Phosphotyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "("

Phrase: "s)"

Phrase: "directed against the tyrosine-phosphorylated insulin receptor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   778   C1334133:INSULIN RECEPTOR [Gene or Genome]
   774   C0255618:tyrosine receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "limits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "the temporal window of activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0442043:Temporal [Spatial Concept]
   760   C0557702:Window [Manufactured Object]
   760   C1272706:Window [Temporal Concept]
   760   C1704674:Window [Manufactured Object]
   760   C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "transduction of insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1160185:transduction [Organism Function]

Phrase: "internalized into the endosomal compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.22: EAI showed a low pH optimum (pH 45.5) and was easily extracted from endocytic vesicles by hypotonic shock (5). 

Phrase: "EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a low pH optimum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2698651:Optimum [Qualitative Concept]
   734   C0728725:Low pH [Finding]

Phrase: "(pH 45.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "extracted from endocytic vesicles"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0887883:Endocytic Vesicles [Cell Component]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C3541890:EXTRACTED [Finding]
   737 E C1622418:vesicle [Cell Component]
   737 E C2828366:Extract [Substance]

Phrase: "by hypotonic shock"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   861   C0036974:Shock [Pathologic Function]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.23: However, the nature of the responsible endosomal proteinase remained undefined, and no study has been directed toward the identity of the insulin degradation products and proteolytic cleavage sites using native human insulin. 

Phrase: "However,"

Phrase: "the nature of the responsible endosomal proteinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "remained"

Phrase: "undefined,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750600:undefined [Idea or Concept]

Phrase: "and"

Phrase: "no study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "directed toward the identity of the insulin degradation products"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C3547574:insulin degradation [Molecular Function]
   762   C0021641:insulin products [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   742   C0243125:degradation [Functional Concept]
   742   C0424215:Identity [Mental Process]
   742   C0699900:Degradation [Organism Function]
   742   C1514468:Products [Entity]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C2003939:Identity [Finding]
   708   C0439851:Direct [Qualitative Concept]
   708 E C1704444:Product [Quantitative Concept]
   708   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "proteolytic cleavage sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "native human insulin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.24: However, elucidation of the cleavage sites in the human insulin molecule is essential to provide precise information toward a better understanding of the substrate recognition and cleavage site specificity of EAI. 

Phrase: "However,"

Phrase: "elucidation of the cleavage sites"

Phrase: "in the human insulin molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]
   734   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "is"

Phrase: "essential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205224:Essential [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "precise information toward a better understanding of the substrate recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1533716:Information [Idea or Concept]

Phrase: "and"

Phrase: "cleavage site specificity of EAI."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C2945843:Site of [Qualitative Concept]
   748   C0037791:Specificity [Quantitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1511884:Specificity [Quantitative Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   743   C0449604:site specific [Spatial Concept]
Processing 00000000.tx.25: Previous studies have identified the structural domains of insulin responsible for binding and affinity to its receptor (8). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the structural domains of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "responsible for binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "affinity to its receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.26: These studies have putatively defined the regions A8, B9-B12 and B24-B26 as critical to the high-affinity interaction of insulin with its receptor (8, 9, 10). 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "putatively"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "the regions A8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0933644:A8 [Body Part, Organ, or Organ Component]

Phrase: "B9-B12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1417635:B12 [Gene or Genome]
   861   C1420797:B12 [Gene or Genome]
   861   C3538796:B12 [Gene or Genome]

Phrase: "and"

Phrase: "B24-B26 as critical"

Phrase: "to the high-affinity interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with its receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.27: Thus, substitution of PheB25 by aspartic acid ([AspB25]-HI) caused an almost complete loss of affinity for the insulin receptor in HepG2 cells (11). 

Phrase: "Thus,"

Phrase: "substitution of PheB25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1555721:Substitution [Idea or Concept]
   790   C1706204:Substitution [Activity]

Phrase: "by aspartic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0004015:Aspartic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "("

Phrase: "[AspB25"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an almost"

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "loss of affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "for the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.28: [LeuB25]-pork insulin had only approximately 1% receptor binding affinity relative to pork insulin (12) and D-[PheB25]-HI displayed only approximately 4% potency relative to HI (13). 

Phrase: "[LeuB25"

Phrase: "]-pork insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0770206:Insulin, Pork [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "had"

Phrase: "only approximately 1% receptor binding affinity relative to pork insulin"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   857   C0034818:receptor insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   804   C0770206:Insulin, Pork [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(12"

Phrase: ")"

Phrase: "and"

Phrase: "D-["

Phrase: "PheB25"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "only approximately 4% potency"

Phrase: "relative to HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.29: ValB12 and residues located in close vicinity were also considered as a putative receptor binding region (14) which was in agreement with a 3-fold higher affinity of [AspB10]-HI toward the insulin receptor compared with authentic HI (15). 

Phrase: "ValB12"

Phrase: "and"

Phrase: "residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "located in close vicinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0587267:Close [Functional Concept]

Phrase: "were"

Phrase: "also"

Phrase: "considered as a putative receptor binding region"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0597358:Receptor Binding [Molecular Function]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0750591:considered [Idea or Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "(14"

Phrase: ")"

Phrase: "which"

Phrase: "was in agreement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0680240:Agreement [Social Behavior]
   790   C1421478:WAS [Gene or Genome]

Phrase: "with a 3-fold higher affinity of [AspB10"

Phrase: "]-HI toward the insulin receptor"

Phrase: "compared with authentic HI"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086418:Human [Human]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1707455:Compared [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.30: In addition, ThrA8 interfered with binding to receptors because substitution with HisA8 contributed substantially to the high affinity of chicken insulin (16). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ThrA8"

Phrase: "interfered with binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0243122:binding [Functional Concept]
   790   C0521102:Interfered [Qualitative Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "to receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "because"

Phrase: "substitution with HisA8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1555721:Substitution [Idea or Concept]
   790   C1706204:Substitution [Activity]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "substantially to the high affinity of chicken insulin"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0020459:high insulin [Disease or Syndrome]
   744   C0008051:Chicken [Bird]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0205250:High [Qualitative Concept]
   744   C0677521:Chicken [Food]
   744   C1299351:High [Qualitative Concept]
   744   C1365945:CHICKEN [Food]
   744   C1510827:Affinity [Natural Phenomenon or Process]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.31: In the present study, we have selected two groups of insulin analogs with widely different kinetics of endosomal proteolysis (higher and lower rates of degradation by EAI compared with wild-type HI), to study the molecular mechanisms responsible for altered endosomal clearance. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "groups of insulin analogs"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   816   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0243071:analogs [Chemical Viewed Structurally]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with widely different kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022702:Kinetics [Natural Phenomenon or Process]
   827   C0220865:kinetics [Functional Concept]
   827   C2825046:Kinetics [Occupation or Discipline]

Phrase: "of endosomal proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597304:Proteolysis [Molecular Function]
   789 E C1947941:proteolytic [Enzyme]

Phrase: "(higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "lower rates of degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "by EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "compared with wild-type HI"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086418:Human [Human]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1547052:*Type [Quantitative Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1707455:Compared [Activity]

Phrase: ")"

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for altered endosomal clearance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.32: Because it was essential to preserve receptor-binding capacity while altering protease affinity, low-Kd analogs, such as [HisA8,HisB4, GluB10,HisB27]-HI (H2-analog), [AspB10]-HI and [GluA13,GluB10]-HI, which are considered as superpotent insulins (7, 11, 17) were used in this present study. 

Phrase: "Because"

Phrase: "it"

Phrase: "was"

Phrase: "essential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205224:Essential [Qualitative Concept]

Phrase: "preserve"

Phrase: "receptor-binding capacity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439155:Binding capacity [Quantitative Concept]
   901   C0597358:Receptor Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "while"

Phrase: "altering protease affinity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "low-Kd analogs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:analogs [Chemical Viewed Structurally]
   721 E C0679213:analogies [Idea or Concept]

Phrase: "such as"

Phrase: "[HisA8,"

Phrase: "HisB4,"

Phrase: "GluB10,"

Phrase: "HisB27"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "[AspB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "GluA13,"

Phrase: "GluB10"

Phrase: "]-HI,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "which"

Phrase: "are"

Phrase: "considered as superpotent insulins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0021641:insulins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0750591:considered [Idea or Concept]
   770   C3537244:Insulins [Pharmacologic Substance]
   737 E C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   737 E C1579433:Insulin [Pharmacologic Substance]

Phrase: "(7,"

Phrase: "11,"

Phrase: "17"

Phrase: ")"

Phrase: "were"

Phrase: "used in this present study."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.33: The data presented in this present study have attempted to: 1) study the time sequence degradation of native insulin and three insulin analogs using soluble endosomal extract (ENs) from hepatic endosomes followed by HPLC analysis; 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented in this present study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0449450:Presented [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "have"

Phrase: "attempted to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1516084:Attempt [Event]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the time sequence degradation of native insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "three insulin analogs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0243071:analogs [Chemical Viewed Structurally]
   721 E C0679213:analogies [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: ")"

Phrase: "from hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "followed by HPLC analysis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0008562:HPLC [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.34: 2) elucidate the major sites of cleavage of insulin and insulin mutants by EAI; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "elucidate"

Phrase: "the major sites of cleavage of insulin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "insulin mutants by EAI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.35: 3) determine the structure of the major insulin and insulin-analog intermediates; 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "determine"

Phrase: "the structure of the major insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "insulin-analog intermediates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]
   734   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.36: 4) examine whether the quantitative differences in the degradation state of the insulin analogs were due to an altered affinity of the insulin mutants for EAI and/or qualitative differences in the processing of the ligands; 

Phrase: "4"

Phrase: ")"

Phrase: "examine"

Phrase: "whether"

Phrase: "the quantitative differences in the degradation state of the insulin analogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C1705241:*Difference [Quantitative Concept]
   704   C1705242:Difference [Qualitative Concept]

Phrase: "were due to an altered affinity of the insulin mutants"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0678226:Due to [Functional Concept]
           due
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0392747:Altered [Functional Concept]
   739   C0596988:mutants [Cell or Molecular Dysfunction]
   739   C1510827:Affinity [Natural Phenomenon or Process]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C3146286:Due [Idea or Concept]

Phrase: "for EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "and/or"

Phrase: "qualitative differences in the processing of the ligands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.37: and 5) study the endosomal fate and lysosomal transfer of an insulin analog which displays a reduced rate of proteolysis within endosomes compared with authentic insulin.  

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the endosomal fate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1539479:FATE [Gene or Genome]
   789 E C1302234:Fatal [Qualitative Concept]
   789 E C1705232:Fatal [Finding]

Phrase: "and"

Phrase: "lysosomal transfer of an insulin analog"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "which"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a reduced rate of proteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "within endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "compared with authentic insulin."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1707455:Compared [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.38: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Peptides, ligand radioiodination, protein determination, antibodies and materials Human insulin (used as the reference insulin) and porcine glucagon were purchased from Sigma. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "ligand radioiodination,"

Phrase: "protein determination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "materials Human insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "used as the reference insulin"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   797   C0240016:Insulin used [Finding]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1273517:used [Finding]
   760   C1514811:Reference [Idea or Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1706462:Reference [Conceptual Entity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "porcine glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.39: [HisA8,HisB4, GluB10,HisB27]insulin (H2-analog), [AspB10]insulin and [GluA13,GluB10]insulin were produced and purified as previously described (17). 

Phrase: "[HisA8,"

Phrase: "HisB4,"

Phrase: "GluB10,"

Phrase: "HisB27"

Phrase: "]insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "[AspB10"

Phrase: "]insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "GluA13,"

Phrase: "GluB10"

Phrase: "]insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "produced"

Phrase: "and"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.40: A-chain, B-chain and the B-chain fragment ArgB22-AlaB30 from bovine insulin were purchased from Sigma. 

Phrase: "A-chain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "the B-chain fragment ArgB22-AlaB30 from bovine insulin"

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.41: Human IGF-I was purchased from Intergen. 

Phrase: "Human IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1334089:IGF I [Gene or Genome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "purchased from Intergen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.42: Porcine glucagon was obtained from Sigma. 

Phrase: "Porcine glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "obtained from Sigma."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.43: Mouse EGF was purchased from Collaborative Biomedical Products. 

Phrase: "Mouse EGF"

Phrase: "was"

Phrase: "purchased from Collaborative Biomedical Products."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0282116:collaborative [Social Behavior]
   760   C0869011:purchased [Activity]
   760   C1514468:Products [Entity]
   760   C1879848:Biomedical [Biomedical Occupation or Discipline]
   726 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.44: Human insulin, H2-analog and glucagon were radioiodinated by the lactoperoxidase method and purified by reverse-phase HPLC to specific activities of 80380 Ci/g as described previously (7, 18). 

Phrase: "Human insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "radioiodinated by the lactoperoxidase method"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0022948:LACTOPEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C1416903:LACTOPEROXIDASE [Gene or Genome]

Phrase: "and"

Phrase: "purified by reverse-phase HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1555029:Reverse [Idea or Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "to specific activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0205369:Specific [Qualitative Concept]
   861   C0441655:Activities [Activity]
   861   C1552740:specific [Intellectual Product]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "of 80380 Ci/g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2348019:Ci/g [Quantitative Concept]
   827   C0439267:g% [Quantitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(7,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.45: The protein content of isolated fractions was determined by the method of Lowry et al. 

Phrase: "The protein content of isolated fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "determined by the method of Lowry et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.46: (19). 

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.47: Mouse monoclonal antibody 9B12 directed against the human insulin-degrading enzyme (IDE) (20) was a kind gift from Dr. 

Phrase: "Mouse monoclonal antibody 9B12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the human insulin-degrading enzyme"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   778   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086418:Human [Human]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "(20"

Phrase: ")"

Phrase: "was"

Phrase: "a kind gift from Dr."
Processing 00000000.tx.48: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.49: A. 

Phrase: "A."
Processing 00000000.tx.50: Roth (Stanford University, Stanford, CA). 

Phrase: "Roth"

Phrase: "(Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA)."
Processing 00000000.tx.51: Rabbit antirat procathepsin B 7183 (21, 22) and rabbit antirat cathepsin L R958 (22, 23) were obtained from Dr. 

Phrase: "Rabbit antirat procathepsin B 7183"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0072033:procathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0034493:Rabbit [Mammal]

Phrase: "(21,"

Phrase: "22"

Phrase: ")"

Phrase: "and"

Phrase: "rabbit antirat cathepsin L R958"

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.52: J. 

Phrase: "J."
Processing 00000000.tx.53: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.54: Mort (Shriners Hospital for Crippled Children, Montreal, Qubec, Canada). 

Phrase: "Mort (Shriners Hospital for Crippled Children,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0020017:Children's hospital [Health Care Related Organization]
   753   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   753   C1510665:Hospital [Qualitative Concept]

Phrase: "Montreal,"

Phrase: "Qubec,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.55: Rabbit antirat tripeptidylpeptidase II (TPP II) (24) was a kind gift from Dr. 

Phrase: "Rabbit antirat tripeptidylpeptidase II (TPP II)"

Phrase: "(24"

Phrase: ")"

Phrase: "was"

Phrase: "a kind gift from Dr."
Processing 00000000.tx.56: J.-C. 

Phrase: "J.-C."
Processing 00000000.tx.57: Schwartz (U109 INSERM, Center Paul Broca, Paris, France). 

Phrase: "Schwartz"

Phrase: "(U109 INSERM,"

Phrase: "Center Paul Broca,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.58: Sheep antirat Thimet Oligopeptidase (TOP) (25) was a kind gift from Dr. 

Phrase: "Sheep antirat Thimet Oligopeptidase (TOP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(25"

Phrase: ")"

Phrase: "was"

Phrase: "a kind gift from Dr."
Processing 00000000.tx.59: J.-M. 

Phrase: "J.-M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.60: Chen (The Babraham Institute, Cambridge, UK). 

Phrase: "Chen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "("

Phrase: "The Babraham Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Cambridge,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.61: HPLC grade acetonitrile and trifluoroacetic acid (TFA) were obtained from Baker Chemical Co. 

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441800:Grade [Classification]
  1000   C0919553:Grade [Classification]
  1000   C3244287:grade [Finding]

Phrase: "acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "and"

Phrase: "trifluoroacetic acid (TFA)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040982:Trifluoroacetic Acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained from Baker Chemical Co."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0220806:Chemical [Chemical]
   760   C0238749:Baker [Professional or Occupational Group]
   760   C1301820:Obtained [Functional Concept]
   760   C3272558:Chemical [Intellectual Product]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.62: All other chemicals were obtained from commercial sources and were of reagent grade. 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "obtained from commercial sources"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C1516719:Commercial Sources [Classification]
   770   C0449416:sources [Finding]
   770   C0680536:commercial [Intellectual Product]
   770   C1301820:Obtained [Functional Concept]
   770   C3272563:Commercial [Intellectual Product]
   737 E C1705919:Source [Idea or Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "were of reagent grade."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0441800:Grade [Classification]
   770   C0919553:Grade [Classification]
   770   C3244287:grade [Finding]
Processing 00000000.tx.63: Animals and injections Male Sprague Dawley rats weighing 180200 g were obtained from Charles River Laboratories, Inc. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "injections Male Sprague Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0034715:Rats, Sprague-Dawley [Mammal]
   840   C2699239:Sprague-Dawley [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "weighing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305866:Weighing [Diagnostic Procedure]

Phrase: "180200 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from Charles River Laboratories,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0337050:River [Natural Phenomenon or Process]
   760   C1301820:Obtained [Functional Concept]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C1706701:Obtain [Activity]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."
Processing 00000000.tx.64: (St. Aubin Les Elbeufs, France) and were fasted for 18 h before they were killed. 

Phrase: "(St. Aubin Les Elbeufs,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "fasted for 18 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0015663:Fast [Finding]
   737   C0456962:Fast [Qualitative Concept]

Phrase: "before"

Phrase: "they"

Phrase: "were"

Phrase: "killed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]
Processing 00000000.tx.65: [125I]TyrA14-labeled human insulin and [125I]TyrA14-H2-analog (30 x 106 cpm, 9 pmol) were diluted in 0.3 ml of 0.15 M NaCl and injected within 5 sec into the penis vein under light ether anesthesia. 

Phrase: "[125I"

Phrase: "]TyrA14-labeled human insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]TyrA14-H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "(30 x 106 cpm,"

Phrase: "9 pmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439192:pmol [Quantitative Concept]

Phrase: "were"

Phrase: "diluted in 0.3 ml of 0.15 M NaCl"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C0168944:M 15 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   739   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0439526:/mL [Quantitative Concept]
   739   C0441923:M+ [Intellectual Product]
   739   C1959973:% NaCl [Quantitative Concept]
   706   C1720119:Dilute [Functional Concept]
   706   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "injected within 5 sec"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1720154:Inject [Functional Concept]

Phrase: "into the penis vein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "under light ether anesthesia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0475746:Light anaesthesia [Finding]
   827   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   827   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   711 E C0002932:Anaesthetic [Pharmacologic Substance]
Processing 00000000.tx.66: Isolation of subcellular fractions from rat liver Subcellular fractionation was performed using established procedures (5, 7, 18, 22, 26, 27, 28). 

Phrase: "Isolation of subcellular fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]

Phrase: "from rat liver Subcellular fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1656251:subcellular fractionation [Laboratory Procedure]
   812   C0016640:fractionation [Laboratory Procedure]
   812   C0524811:fractionation [Therapeutic or Preventive Procedure]
   812   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "established procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "18,"

Phrase: "22,"

Phrase: "26,"

Phrase: "27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.67: The endosomal fraction (EN) was isolated by discontinuous sucrose gradient centrifugation and collected at the 0.25 M to 1.0 M sucrose interface (5, 7, 18, 22, 26, 27, 28). 

Phrase: "The endosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(EN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417861:eN [Gene or Genome]
  1000   C2987294:EN [Qualitative Concept]

Phrase: "was"

Phrase: "isolated by discontinuous sucrose gradient centrifugation"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0007703:Centrifugation [Laboratory Procedure]
   753   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0205409:Isolated [Functional Concept]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0439599:Discontinuous [Temporal Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   753   C1444662:Discontinuous [Finding]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "collected at the 0.25 M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]

Phrase: "to 1.0 M sucrose interface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1708533:Interface [Manufactured Object]
   804   C2698172:Interface [Intellectual Product]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "18,"

Phrase: "22,"

Phrase: "26,"

Phrase: "27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.68: The soluble extract from the endosomal fractions was isolated by freeze/thawing in 5 mM Na-phosphate pH 7.4, and disrupted in the same hypotonic medium using a small Dounce homogenizer (15 strokes with the tight Type A pestle) followed by centrifugation at 300,000 x g for 30 min as described previously (5, 7, 22, 28). 

Phrase: "The soluble extract from the endosomal fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "isolated by freeze/thawing"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0016701:Freeze [Natural Phenomenon or Process]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737   C1710378:Thaw [Laboratory Procedure]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in 5 mM Na-phosphate pH 7.4,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   829   C2678549:PH-4 [Gene or Genome]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   795   C0031701:phosphate [Organophosphorus Compound]
   795   C0439084:>5 [Quantitative Concept]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C0728893:+5 [Quantitative Concept]
   795   C1272460:{NA} [Qualitative Concept]
   795   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "disrupted in the same hypotonic medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0241938:Hypotonic [Pathologic Function]
   753   C0332454:Disrupted [Qualitative Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a small Dounce homogenizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0181200:homogenizer [Medical Device]

Phrase: "(15 strokes with the tight Type A pestle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0038454:Strokes [Disease or Syndrome]

Phrase: ")"

Phrase: "followed by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "at 300,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "22,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.69: In vitro endosome-lysosome transfer reaction Animals were killed 10 min after injection of the appropriate radiolabeled ligand and livers rapidly removed and minced in ice-cold isotonic homogenization buffer containing 0.25 M sucrose, 10 mM Tes, pH 7.4, and 7 mM MgCl2. 

Phrase: "In vitro endosome-lysosome transfer reaction Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "10 min after injection of the appropriate radiolabeled ligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0456692:/10 min [Temporal Concept]
   742   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "livers rapidly"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0023884:Livers [Body Part, Organ, or Organ Component]
   827 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   827 E C1278929:Liver [Body Part, Organ, or Organ Component]
   827 E C2346688:LIVER [Food]
   789 E C0205054:Hepatic [Body Location or Region]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "minced in ice-cold isotonic homogenization buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0456963:Ice cold [Qualitative Concept]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0234192:Cold [Physiologic Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.25 M sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "10 mM Tes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0076172:TES [Organic Chemical]
   827   C1422793:TES [Gene or Genome]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "7 mM MgCl2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.70: Intact cells, nuclei, and mitochondria were removed from the homogenate by centrifugation at 3,300 x g for 10 min. 

Phrase: "Intact cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "nuclei,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "removed from the homogenate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0849355:Removed [Qualitative Concept]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 3,300 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.71: A cell-free transfer reaction was carried out as described previously (29, 30). 

Phrase: "A cell-free transfer reaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0678610:transfer reaction [Natural Phenomenon or Process]
   804   C0040671:Transfer [Mental Process]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1705822:Transfer [Activity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.72: The postmitochondrial supernatant (referred to as the LPS fraction) was incubated at 4 C or 37 C with 5 mM ATP, 1 mg/ml creatine kinase and 20 mM phosphocreatine. 

Phrase: "The postmitochondrial supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "("

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "the LPS fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "incubated at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "37 C with 5 mM ATP,"

Phrase: "1 mg/ml creatine kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0010287:Creatine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "20 mM phosphocreatine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031634:Phosphocreatine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.73: After cooling to 4 C, incubation mixtures were layered over 10 ml linear gradients prepared from 35% (mass/vol.) 

Phrase: "After cooling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678568:cooling [Natural Phenomenon or Process]
   966 E C1548792:Cool [Qualitative Concept]

Phrase: "to 4 C,"

Phrase: "incubation mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "layered over 10 ml linear gradients"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0205132:Linear [Spatial Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C0812409:gradients [Quantitative Concept]
   753   C0934502:Layered [Body Part, Organ, or Organ Component]
   719 E C0439182:% gradient [Quantitative Concept]
   719 E C1522408:Layer [Qualitative Concept]
   719 E C1561599:Layer [Intellectual Product]

Phrase: "prepared from 35%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "(mass/vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]

Phrase: ")"
Processing 00000000.tx.74: Nycodenz and 0.25 M sucrose containing 10 mM Tes pH 7.4 and 2 mM EDTA (density range, 1.061.16 g/ml). 

Phrase: "Nycodenz"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0729204:Nycodenz [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "0.25 M sucrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mM Tes pH 7.4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   839   C2678549:PH-4 [Gene or Genome]
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0076172:TES [Organic Chemical]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C1422793:TES [Gene or Genome]

Phrase: "and"

Phrase: "2 mM EDTA (density range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]

Phrase: "1.061.16 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.75: The gradients were centrifuged at 200,000 x g for 60 min in a Beckman Coulter, Inc. 

Phrase: "The gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0812409:gradients [Quantitative Concept]
   966 E C0439182:% gradient [Quantitative Concept]

Phrase: "were"

Phrase: "centrifuged at 200,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in a Beckman Coulter,"

Phrase: "Inc."
Processing 00000000.tx.76: SW 41 rotor, following which 0.5 ml fractions were collected, densities determined and enzyme activity, radioactivity, and immunoblot analyses carried out. 

Phrase: "SW 41 rotor,"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "which 0.5 ml fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "densities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:densities [Quantitative Concept]
   916 E C0439794:Dense [Qualitative Concept]

Phrase: "determined"

Phrase: "and"

Phrase: "enzyme activity,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "radioactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "immunoblot analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.77: Components appearing at densities 1.0651.11 and 1.111.145 g/ml were scored, respectively, as truly endosomal and lysosomal. 

Phrase: "Components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "appearing at densities 1.0651.11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0178587:densities [Quantitative Concept]
   719   C0700364:APPEAR [Qualitative Concept]

Phrase: "and"

Phrase: "1.111.145 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: ","

Phrase: "respectively,"

Phrase: "as"

Phrase: "truly endosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0034850:Endosome [Cell Component]

Phrase: "and"

Phrase: "lysosomal."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0521450:Lysosomal [Body Location or Region]
   928 E C0024369:Lysosome [Cell Component]
   928 E C2984253:Lysosome [Functional Concept]
Processing 00000000.tx.78: In each fraction the integrity of radiolabeled peptides was assayed by precipitation with trichloroacetic acid (TCA), as reported previously (5, 7). 

Phrase: "In each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "the integrity of radiolabeled peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "assayed by precipitation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "with trichloroacetic acid (TCA),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.79: Two hundred microliters of each subcellular fraction was mixed with 2 ml of ice-cold 10% TCA for 2 h at 4 C. 

Phrase: "Two hundred microliters of each subcellular fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439243:microliter [Quantitative Concept]

Phrase: "was"

Phrase: "mixed with 2 ml of ice-cold 10% TCA"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   777   C3642200:10^2/mL [Quantitative Concept]
   760   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0456963:Ice cold [Qualitative Concept]
   739   C0001128:Acid [Chemical]
   739   C0009264:Cold [Natural Phenomenon or Process]
   739   C0009443:Cold [Disease or Syndrome]
   739   C0020746:Ice [Inorganic Chemical]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0205430:Mixed [Functional Concept]
   739   C0234192:Cold [Physiologic Function]
   739   C0439526:/mL [Quantitative Concept]
   739   C3160715:Mixed [Finding]
   706 E C1421951:MIX [Gene or Genome]
   706 E C1720722:Mix [Qualitative Concept]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.80: The samples were then centrifuged at 10,000 x g for 20 min at 4 C, and the supernatants and pellets were evaluated for radioactivity using a Packard -counter. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged at 10,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C,"

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "evaluated for radioactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034553:Radioactivity [Natural Phenomenon or Process]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Packard -counter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0677601:Counter [Manufactured Object]
   861   C1705206:Counter [Medical Device]
Processing 00000000.tx.81: Immunoblot studies Electrophoresed samples were transferred as previously described (22, 28), and the blots were immunoblotted with polyclonal antirat procathepsin B diluted 1/600, and then with HRP-conjugated goat antirabbit IgG as previously described (22, 28). 

Phrase: "Immunoblot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "Electrophoresed samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "transferred as previously"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0348011:transferred [Functional Concept]
   756 E C0040671:Transfer [Mental Process]
   756 E C1705822:Transfer [Activity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(22,"

Phrase: "28"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the blots"

Phrase: "were"

Phrase: "immunoblotted with polyclonal antirat procathepsin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0072033:procathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   719   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1/600,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "then with HRP-conjugated goat antirabbit IgG"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0063351:IGG-HRP [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0018019:goat [Mammal]
   748   C0019941:HRP [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0522529:Conjugated [Spatial Concept]
   748   C1265549:goat [Mammal]
   748   C1510458:Goat [Mammal]
   748   C1883708:Then [Temporal Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(22,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.82: In vitro proteolysis of native and [125I]TyrA14-labeled peptides Soluble endosomal extract (ENs) (1 ng) was incubated for varying lengths of time at 37 C with 5 x 10-5 M wild-type insulin, the H2-analog, [AspB10]insulin, [GluA13,GluB10]insulin, insulin A chain, insulin B chain or insulin B chain fragment ArgB22-AlaB30 in 200 l of 50 mM citrate-phosphate pH 4. 

Phrase: "In vitro proteolysis of native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597304:Proteolysis [Molecular Function]

Phrase: "and ["

Phrase: "125I"

Phrase: "]TyrA14-labeled peptides Soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: ")"

Phrase: "(1 ng)"

Phrase: "was"

Phrase: "incubated for varying lengths of time"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0040223:Time [Temporal Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1444754:Lengths [Quantitative Concept]
   753   C3541383:Time [Temporal Concept]
   719 E C1706316:LENGTH [Research Activity]

Phrase: "at 37 C"

Phrase: "with 5 x 10-5 M wild-type insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the H2-analog,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "[AspB10"

Phrase: "]insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "[GluA13,"

Phrase: "GluB10"

Phrase: "]insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin A chain,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin B chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin B chain fragment ArgB22-AlaB30 in 200 l"

Phrase: "of 50 mM citrate-phosphate pH 4."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C2678549:PH-4 [Gene or Genome]
   799   C0008857:Citrate [Organic Chemical]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0031701:phosphate [Organophosphorus Compound]
   799   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.83: The samples were then acidified with acetic acid (15%) and immediately loaded onto a reverse-phase HPLC column. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "acidified with acetic acid"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "loaded onto a reverse-phase HPLC column."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1555029:Reverse [Idea or Concept]
   748   C1706132:Column [Idea or Concept]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.84: In vitro degradation of the [125I]TyrA14-HI or -H2-analog using ENs was also studied. 

Phrase: "In vitro degradation of the [125I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "]TyrA14-HI or -H2-analog"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0243071:Analog [Chemical Viewed Structurally]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.85: The radiolabeled ligands (75 fmol) were incubated with 10 g of soluble endosomal protein and various concentrations of unlabeled human insulin or insulin analogs in 100 l of 75 mM citrate-phosphate buffer pH 4. 

Phrase: "The radiolabeled ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligands [Chemical]

Phrase: "(75 fmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439195:fmol [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with 10 g of soluble endosomal protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0060916:protein g [Amino Acid, Peptide, or Protein]
   767   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439267:g% [Quantitative Concept]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "various concentrations of unlabeled human insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "or"

Phrase: "insulin analogs in 100 l"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   781   C0259168:analog L [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0243071:analogs [Chemical Viewed Structurally]

Phrase: "of 75 mM citrate-phosphate buffer pH 4."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   829   C3256468:citrate buffer [Pharmacologic Substance]
   818   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   818   C2678549:PH-4 [Gene or Genome]
   795   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0008857:Citrate [Organic Chemical]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   795   C0031701:phosphate [Organophosphorus Compound]
   795   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.86: Following incubation at 37 C, the amount of radiolabeled insulin- and H2-analog-degraded was measured by TCA-precipitation as described above. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation at 37 C,"

Phrase: "the amount of radiolabeled insulin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "H2-analog-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "was"

Phrase: "measured by TCA-precipitation"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "as described above."
Processing 00000000.tx.87: In some experiments, ENs was immunodepleted for cathepsin B, cathepsin L, IDE, TPP II or TOP prior in vitro proteolysis of [125I]TyrA14-HI and [125I]-glucagon at pH 4. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "was"

Phrase: "immunodepleted for cathepsin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332804:CATHEPSIN B [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cathepsin L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054871:Cathepsin L [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332807:CATHEPSIN L [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "TPP II"

Phrase: "or"

Phrase: "TOP prior in vitro proteolysis of [125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]-glucagon at pH 4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.88: ENs was incubated with antibodies for 16 h at 4 C in 200 l of 20 mM sodium phosphate buffer pH 7. 

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "was"

Phrase: "incubated with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C1439852:Incubated [Laboratory Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C in 200 l"

Phrase: "of 20 mM sodium phosphate buffer pH 7."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   845   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   818   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   818   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   795   C0031701:phosphate [Organophosphorus Compound]
   795   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.89: The monoclonal and polyclonal IgGs were precipitated by the addition of 50 l of protein G-Sepharose. 

Phrase: "The monoclonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746619:monoclonal [Finding]

Phrase: "and"

Phrase: "polyclonal IgGs"

Phrase: "were"

Phrase: "precipitated by the addition of 50 l of protein G-Sepharose."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   756   C0060916:protein g [Amino Acid, Peptide, or Protein]
   754 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   754   C0439294:g l [Quantitative Concept]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0036681:Sepharose [Carbohydrate]
   738   C0439267:g% [Quantitative Concept]
   738   C1883712:Addition [Functional Concept]
   704   C1882443:PRECIPITATE [Phenomenon or Process]
Processing 00000000.tx.90: After rotating for 2 h at 4 C, the fractions were centrifuged for 5 min at 10,000 x g, and the resultant supernatants were subjected to proteolysis of radiolabeled ligands at pH 4 using the TCA precipitation assay. 

Phrase: "After rotating"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0231458:rotating [Spatial Concept]
   928 E C0040480:Twisting [Physiologic Function]
   928 E C0231467:Twisted [Spatial Concept]
   928 E C1265748:Twisting [Pathologic Function]
   928 E C1881716:TWISTING [Phenomenon or Process]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C,"

Phrase: "the fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "centrifuged for 5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "at 10,000 x g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "the resultant supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "subjected to proteolysis of radiolabeled ligands"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0023688:Ligands [Chemical]
   753   C0597304:Proteolysis [Molecular Function]
   753   C1527121:Radiolabeled [Qualitative Concept]
   719 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "at pH 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TCA precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.91: HPLC separation of human insulin and insulin analog peptides Reverse-phase HPLC was performed on a Beckman Coulter, Inc. 

Phrase: "HPLC separation of human insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "and"

Phrase: "insulin analog peptides Reverse-phase HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0008562:HPLC [Laboratory Procedure]

Phrase: "was"

Phrase: "performed on a Beckman Coulter,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Inc."
Processing 00000000.tx.92: System Gold model 127 liquid chromatograph equipped with a Rheodyne sample injector fitted with a 500 l loop and a Bondapak C18 column (Waters, 0.39 x 30 cm; 10 m particle size). 

Phrase: "System Gold model 127 liquid chromatograph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0302647:chromatograph [Medical Device]
   777   C0008565:Liquid Chromatography [Laboratory Procedure]

Phrase: "equipped with a Rheodyne sample injector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0181342:Injector [Medical Device]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "fitted with a 500 l loop"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0036572:Fit [Sign or Symptom]
   753   C0419518:Loop [Medical Device]
   753   C0424576:Fit [Finding]
   753   C0445022:Loop [Spatial Concept]
   753   C2349186:Fit [Activity]

Phrase: "and"

Phrase: "a Bondapak C18 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "(Waters,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043047:Waters [Inorganic Chemical,Pharmacologic Substance]
   966 E C0599638:WATER [Substance]
   966 E C1550678:Water [Inorganic Chemical]
   916 E C0443350:Watery [Qualitative Concept]

Phrase: "0.39 x 30 cm"

Phrase: "; 10 m particle size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030608:Particle Size [Quantitative Concept]
   812   C0456389:size [Spatial Concept]
   812   C0597177:Particle [Chemical Viewed Structurally]

Phrase: ")."
Processing 00000000.tx.93: Samples were chromatographed using as eluent a mixture of 0.1% TFA in water (solvent A) and 0.1% TFA in acetonitrile (solvent B) with a flow rate of 1 ml/min. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "chromatographed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0302647:chromatograph [Medical Device]

Phrase: "using as eluent"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1524063:Using [Functional Concept]
   790   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "a mixture of 0.1% TFA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439962:Mixture [Substance]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "A)"

Phrase: "and"

Phrase: "0.1% TFA in acetonitrile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "B) with a flow rate of 1 ml/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.94: Elution was carried out using two sequential linear gradients of 015% solvent B (5 min) and 1539% solvent B (32 min), followed by an isocratic elution of 39% solvent B (13 min). 

Phrase: "Elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two sequential linear gradients of 015% solvent B (5 min)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0812409:gradients [Quantitative Concept]
   706 E C0439182:% gradient [Quantitative Concept]

Phrase: "and"

Phrase: "1539% solvent B (32 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0702093:/min [Temporal Concept]

Phrase: "followed by an isocratic elution"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1441565:Elution [Laboratory Procedure]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "of 39% solvent B (13 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0702093:/min [Temporal Concept]
Processing 00000000.tx.95: Eluates were monitored on-line for absorbance at 214 nm with a LC-166 spectrophotometer (Beckman Coulter, Inc.). 

Phrase: "Eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "on-line for absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]
   770   C1720176:On [Functional Concept]
   770   C1720294:On [Intellectual Product]

Phrase: "at 214 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "with a LC-166 spectrophotometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0183400:Spectrophotometer [Medical Device]

Phrase: "(Beckman Coulter,"

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.96: Characterization of endosomal acidic insulinase activity The soluble endosomal lysate was loaded onto a TSK-GEL G3000 SWXL HPLC column (Tosoh Corporation, 0.78 x 30 cm) equilibrated at 4 C with 50 mM Na-phosphate buffer, pH 6. 

Phrase: "Characterization of endosomal acidic insulinase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "The soluble endosomal lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "loaded onto a TSK-GEL G3000 SWXL HPLC column"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   742   C0008562:HPLC [Laboratory Procedure]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C1185738:Column [Body Part, Organ, or Organ Component]
   742   C1382104:Gel [Substance]
   742   C1706132:Column [Idea or Concept]
   742   C1708715:Loaded [Activity]
   742   C1823517:TSK [Gene or Genome]
   708 E C1550025:Load [Idea or Concept]
   708 E C1704782:Load [Manufactured Object]

Phrase: "(Tosoh Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "0.78 x 30 cm)"

Phrase: "equilibrated at 4 C"

Phrase: "with 50 mM Na-phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.97: The column was washed with 30 ml Na-phosphate buffer pH 6.0 using a flow rate of 0.5 ml/min. 

Phrase: "The column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "washed with 30 ml Na-phosphate buffer pH 6.0"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   760   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   757   C0492253:PH BUFFER [Medical Device]
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0020283:[pH] [Quantitative Concept]
   739   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   739   C0031701:phosphate [Organophosphorus Compound]
   739   C0439526:/mL [Quantitative Concept]
   739   C0450407:ph+ [Finding]
   739   C0450408:ph++ [Finding]
   739   C0450409:ph+++ [Finding]
   739   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1272460:{NA} [Qualitative Concept]
   739   C1548982:Washed [Idea or Concept]
   739   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   706 E C0441648:Wash [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a flow rate of 0.5 ml/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2826285:Flow Rate [Quantitative Concept]
   744   C0806140:Flow [Natural Phenomenon or Process]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.98: Eluates were monitored on-line for absorbance at 214 nm with a LC-166 spectrophotometer (Beckman Coulter, Inc.). 

Phrase: "Eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "on-line for absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]
   770   C1720176:On [Functional Concept]
   770   C1720294:On [Intellectual Product]

Phrase: "at 214 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "with a LC-166 spectrophotometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0183400:Spectrophotometer [Medical Device]

Phrase: "(Beckman Coulter,"

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.99: Each fraction (0.5 ml) was immediately adjusted to pH 4 with 0.5 M citrate-phosphate buffer and evaluated for [125I]TyrA14-HI and -H2-analog-degrading activity by the TCA-precipitation assay. 

Phrase: "Each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "(0.5 ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439526:/mL [Quantitative Concept]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "adjusted to pH 4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2678549:PH-4 [Gene or Genome]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C0456081:Adjusted [Functional Concept]

Phrase: "with 0.5 M citrate-phosphate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C3256468:citrate buffer [Pharmacologic Substance]
   827   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0031701:phosphate [Organophosphorus Compound]
   799   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "evaluated for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0220825:Evaluated [Functional Concept]

Phrase: "[125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and -"

Phrase: "H2-analog-degrading activity by the TCA-precipitation assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.100: Fractions eluted from the gel-filtration HPLC column that contained insulin-degrading activity with the highest specific activity (fractions 2021; see Fig. 5A) were pooled and used for in vitro proteolysis of native HI, competition studies and determination of optimal pH for the degradation of the HI and H2-analog peptides. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "eluted from the gel-filtration HPLC column"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0008559:Gel Filtration [Laboratory Procedure]
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0016107:filtration [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1382104:Gel [Substance]
   748   C1706132:Column [Idea or Concept]

Phrase: "that contained insulin-degrading activity with the highest specific activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   757   C1145751:insulin activity [Molecular Function]
   741   C0020459:high insulin [Disease or Syndrome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1561536:*Activity [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(fractions 2021"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "used for in vitro proteolysis of native HI,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   764   C0021135:In Vitro [Intellectual Product]
   764   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
   762   C0240016:Insulin used [Finding]
   745   C1524063:Use of [Functional Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0086418:Human [Human]
   742   C0302891:Native [Functional Concept]
   742   C0597304:Proteolysis [Molecular Function]
   742   C1273517:used [Finding]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "competition studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0679932:competition [Social Behavior]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "determination of optimal pH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "for the degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "of the HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "H2-analog peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.101: In some experiments, affinity purification of EAI was also performed as previously described (5). 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "affinity purification of EAI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008551:affinity purification [Laboratory Procedure]
   753   C0243114:purification [Functional Concept]
   753   C1998793:Purification [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.102: Partially purified EAI was then incubated at 37 C with 10-5 M HI in 200 l of 300 mM citrate-phosphate, pH 4. 

Phrase: "Partially"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 10-5 M HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in 200 l"

Phrase: "of 300 mM citrate-phosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 4."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.103: The samples were then analyzed by reverse-phase HPLC as described above. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by reverse-phase HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "as described above."
Processing 00000000.tx.104: View larger version (27K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.105: Partial characterization of endosomal HI-degrading activity on a gel-filtration HPLC column and after an insulin affinity chromatography. 

Phrase: "Partial characterization of endosomal HI-degrading activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "on a gel-filtration HPLC column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "and after an insulin affinity chromatography."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0008551:Chromatography, Affinity [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C1515981:And [Idea or Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.106: Endosomes were disrupted by hypotonic shock, and the soluble endosomal extract (ENs) (150 g) was applied to a TSK-gel G3000 HPLC column. 

Phrase: "Endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "disrupted by hypotonic shock,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C0332454:Disrupted [Qualitative Concept]

Phrase: "and"

Phrase: "the soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: ")"

Phrase: "(150 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "applied to a TSK-gel G3000 HPLC column."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0008562:HPLC [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0185125:Applied [Health Care Activity]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1382104:Gel [Substance]
   744   C1706132:Column [Idea or Concept]
   744   C1823517:TSK [Gene or Genome]
   711 E C1632850:Apply [Functional Concept]
   711 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.107: A, Absorbance profile at 214 nm. 

Phrase: "A,"

Phrase: "Absorbance profile at 214 nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1979963:Profile [Laboratory Procedure]
   760   C2003903:Profile [Functional Concept]
Processing 00000000.tx.108: Arrow indicates the elution of rat serum albumin (SA; 66-kDa) identified by SDS-PAGE followed by Coomassie Blue-staining (results not shown). 

Phrase: "Arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "the elution of rat serum albumin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1441565:Elution [Laboratory Procedure]

Phrase: "(SA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "; 66-kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "identified by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "followed by Coomassie Blue-staining"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0487602:Staining [Laboratory Procedure]
   760   C1260957:Blue [Qualitative Concept]
   760   C1704680:Staining [Finding]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.109: Arrowhead indicates the peak of acidic insulinase activity (fractions 2021). 

Phrase: "Arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: "indicates"

Phrase: "the peak of acidic insulinase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0444505:Peak [Quantitative Concept]

Phrase: "(fractions 2021"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.110: In Panel B, each fraction was tested for its ability to degrade 50 fmol of [125I]TyrA14-HI or -H2-analog for 15 min at 37 C and pH 4 using the TCA-precipitation assay. 

Phrase: "In Panel B,"

Phrase: "each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "tested for its ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "degrade"

Phrase: "50 fmol of [125I"

Phrase: "]TyrA14-HI or -H2-analog for 15 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0243071:Analog [Chemical Viewed Structurally]

Phrase: "at 37 C"

Phrase: "and"

Phrase: "pH 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TCA-precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.111: C, Fractions 20 and 21 were pooled and incubated at pH 4 with 10-5 M HI for 30 min, and the hydrolysis products generated were then analyzed by reverse-phase HPLC using the same elution gradient as that described in Fig. 

Phrase: "C,"

Phrase: "Fractions 20"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "21"

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "incubated at pH 4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2678549:PH-4 [Gene or Genome]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 10-5 M HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the hydrolysis products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by reverse-phase HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same elution gradient as that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.112: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.113: D, EAI was partially purified using an affinity purification protocol at acidic pH according to (5 ), and then incubated in 200 mM citrate-phosphate pH 4 with 10-5 M HI. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "was"

Phrase: "partially"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an affinity purification protocol at acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0442711:Protocol [Intellectual Product]
   748   C1507394:Protocol [Intellectual Product]
   748   C1522729:Protocol [Intellectual Product]
   748   C2348563:Protocol [Intellectual Product]

Phrase: "according to"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated in 200 mM citrate-phosphate pH 4"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C2678549:PH-4 [Gene or Genome]
   744   C0008857:Citrate [Organic Chemical]
   744   C0020283:[pH] [Quantitative Concept]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   744   C0450407:ph+ [Finding]
   744   C0450408:ph++ [Finding]
   744   C0450409:ph+++ [Finding]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "with 10-5 M HI."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.114: After 15 min at 37 C, the hydrolysis products generated were then analyzed by reverse-phase HPLC using the same elution gradient as that described in Fig. 

Phrase: "After 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C,"

Phrase: "the hydrolysis products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by reverse-phase HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same elution gradient as that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.115: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.116: The degradation products observed in Panels C and D and numbered 17 display retention times identical with those seen with ENs in Fig. 

Phrase: "The degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "observed in Panels C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441833:Panel [Idea or Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "17 display retention times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   812   C0035280:Retention [Mental Process]
   812   C0040223:times [Temporal Concept]
   812   C0333117:Retention [Functional Concept]
   812   C1632851:Times [Quantitative Concept]
   812   C1753315:retention [Cell Function]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]

Phrase: "identical with those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "seen with ENs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C1417023:ENS [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.117: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.118: Direct analysis using ion spray mass spectrometry Peptides were dissolved at a final concentration of 510 pmol/l in 20% acetonitrile containing 0.1% HCOOH. 

Phrase: "Direct analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ion spray mass spectrometry Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "dissolved at a final concentration of 510 pmol/l"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0439284:pmol/L [Quantitative Concept]
   742   C0086045:Concentration [Mental Process]
   742   C0205088:Final [Temporal Concept]
   742   C0439192:pmol [Quantitative Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1546485:Final [Idea or Concept]
   708   C1549535:Dissolve [Functional Concept]

Phrase: "in 20% acetonitrile containing 0.1% HCOOH."
Processing 00000000.tx.119: Ion spray mass spectra were recorded on a simple-quadrupole mass spectrometer API (Perkin-Elmer Corp., Norwalk, CT) equipped with an ion-spray (nebulizer-assisted electrospray) source (Sciex, Toronto, Canada). 

Phrase: "Ion spray mass spectra"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0037813:Mass Spectrum [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]
   779   C1883073:Spectrum [Quantitative Concept]
   779   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "on a simple-quadrupole mass spectrometer API (Perkin-Elmer Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0683758:Corp. [Organization]

Phrase: "Norwalk,"

Phrase: "CT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "equipped with an ion-spray"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0022023:Ion [Element, Ion, or Isotope]
   760   C1700702:ION [Functional Concept]
   760   C1704413:{Spray} [Quantitative Concept]
   760   C2003858:Spray [Functional Concept]

Phrase: "(nebulizer-assisted electrospray"

Phrase: ")"

Phrase: "source"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449416:Source [Finding]
  1000   C1705919:Source [Idea or Concept]

Phrase: "(Sciex,"

Phrase: "Toronto,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.120: The solutions were continuously infused with a medical infusion pump (Model 11, Harvard Apparatus, South Natick, MA) at a flow rate of 5 l/min. 

Phrase: "The solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "continuously"

Phrase: "infused with a medical infusion pump"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021436:Infusion Pump [Medical Device]
   790   C1547123:Infusion pump [Spatial Concept]
   753   C0182537:Pump [Medical Device]
   753   C0205476:Medical [Functional Concept]
   753   C0574032:Infusion [Therapeutic or Preventive Procedure]
   753   C1706421:Pump [Manufactured Object]
   753   C1827465:Infusion [Functional Concept]

Phrase: "(Model 11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "Harvard Apparatus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "South Natick,"

Phrase: "MA) at a flow rate of 5 l/min."
Processing 00000000.tx.121: Polypropylene glycol (PPG) was used to calibrate quadrupole. 

Phrase: "Polypropylene glycol (PPG)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0071666:polypropylene glycol [Organic Chemical,Pharmacologic Substance]
   861   C0017945:Glycol [Organic Chemical]
   861   C0017951:Glycol [Organic Chemical]
   861   C0032582:Polypropylene [Biomedical or Dental Material,Organic Chemical]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calibrate"

Phrase: "quadrupole."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347727:Quadrupole [Research Device]
Processing 00000000.tx.122: Ion spray mass spectra were acquired at unit resolution by scanning from m/z 400 to 2400 with a step size of 0.1 amu and a dwell time of 2 msec. 

Phrase: "Ion spray mass spectra"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0037813:Mass Spectrum [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]
   779   C1883073:Spectrum [Quantitative Concept]
   779   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "acquired at unit resolution"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0439148:Unit [Quantitative Concept]
   770   C0439661:Acquired [Temporal Concept]
   770   C1514893:Resolution [Idea or Concept]
   770   C1519795:Unit [Quantitative Concept]
   770   C1704753:Unit [Manufactured Object]
   770   C1706463:Resolution [Quantitative Concept]
   770   C1880519:Unit [Quantitative Concept]
   770   C2699488:Resolution [Conceptual Entity]
   770   C3245488:acquired [Intellectual Product]
   737 E C1706701:Acquire [Activity]

Phrase: "by scanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034606:Scanning [Diagnostic Procedure]
  1000   C0441633:Scanning [Diagnostic Procedure]

Phrase: "from"

Phrase: "m/"

Phrase: "z 400 to 2400"

Phrase: "with a step size"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0808077:Stepsize [Organism Attribute]
   861   C0456389:size [Spatial Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "of 0.1 amu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0678223:amu [Quantitative Concept]
   827   C1532624:amu [Quantitative Concept]

Phrase: "and"

Phrase: "a dwell time of 2 msec."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0429659:Dwell time [Finding]
   783   C0808270:Time 2 [Finding]
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
Processing 00000000.tx.123: Five spectra were summed (MCA mode). 

Phrase: "Five spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "summed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515051:Sum [Quantitative Concept]

Phrase: "(MCA mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513371:Mode [Functional Concept]
   861   C1705738:Mode [Quantitative Concept]
   861   C2347637:Mode [Quantitative Concept]
   861   C2348146:Mode [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.124: The potential of the spray needle was held at + 5 kV. 

Phrase: "The potential of the spray needle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "was"

Phrase: "held"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1948036:held [Idea or Concept]
  1000   C2987518:hELD [Amino Acid, Peptide, or Protein]
   966 E C1553387:Hold [Idea or Concept]
   966 E C1948035:Hold [Activity]

Phrase: "at + 5 kV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0556639:kV [Quantitative Concept]
Processing 00000000.tx.125: Spectra were recorded at an orifice voltage of + 70 V. 

Phrase: "Spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "recorded at an orifice voltage of + 70 V."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0668861:V 70 [Organic Chemical,Pharmacologic Substance]
   744   C0444567:Orifice [Body Space or Junction]
   744   C0598352:Voltage [Quantitative Concept]
   711   C0034869:Record [Intellectual Product]
Processing 00000000.tx.126: The computer program Mac BIO Spec was used for calculation of the molecular masses of the peptides. 

Phrase: "The computer program Mac BIO Spec"

Phrase: "was"

Phrase: "used for calculation of the molecular masses of the peptides."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   743   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   741   C1524063:Use of [Functional Concept]
   739   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   739   C1273517:used [Finding]
   739   C1441506:Calculation [Activity]
   739   C1521991:Molecular [Qualitative Concept]
   706 E C0042153:use [Functional Concept]
   706 E C0457083:Use [Functional Concept]
   706   C0577559:Mass [Finding]
   706   C1306372:*Mass [Quantitative Concept]
   706 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.127: HPLC-electrospray ionization (ESI)-mass spectrometry (MS) coupling Samples (35 nmol in 100 l) were analyzed by HPLC coupled with ESI-MS. 

Phrase: "HPLC-electrospray ionization (ESI)-mass spectrometry (MS) coupling Samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0370003:Sample [Substance]
   762   C2347026:Sample [Conceptual Entity]
   710   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]

Phrase: "(35 nmol in 100 l)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0439282:nmol/L [Quantitative Concept]
   760   C0439191:NMOLE [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by HPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "coupled with ESI-MS."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   790   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C1516801:Electrospray Ionization [Laboratory Procedure]
   753   C0436196:Spectrometry [Laboratory Procedure]
   753   C0577559:Mass [Finding]
   753   C0596801:Ionization [Phenomenon or Process]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1948027:Coupled [Functional Concept]
   753   C3152252:Mass [Quantitative Concept]
   719 E C0010222:couple [Family Group]
Processing 00000000.tx.128: Chromatographic separation was carried out by HPLC using an PE Applied Biosystems (Foster City, CA) 140B automated gradient controller pump module equipped with a Perkin-Elmer Corp. 

Phrase: "Chromatographic separation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036679:Separation [Pathologic Function]
   861   C0237868:Separation [Social Behavior]
   861   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by HPLC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an PE Applied Biosystems"

Phrase: "(Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA) 140B"

Phrase: "automated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205554:Automated [Functional Concept]
   966 E C1072074:Automate [Eukaryote]

Phrase: "gradient controller pump module"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1709061:Module [Conceptual Entity]
   712 E C1031041:Modulus [Eukaryote]

Phrase: "equipped with a Perkin-Elmer Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0683758:Corp. [Organization]
Processing 00000000.tx.129: LC 290 detector operating at 214 nm, and its output was connected to a Perkin-Elmer Corp. 

Phrase: "LC 290 detector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0180392:Detector [Medical Device]
   827   C1705235:Detector [Manufactured Object]

Phrase: "operating at 214 nm,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   737   C3242339:operate [Functional Concept]

Phrase: "and"

Phrase: "its output"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709366:Output [Conceptual Entity]

Phrase: "was"

Phrase: "connected to a Perkin-Elmer Corp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0683758:Corp. [Organization]
   719   C2986575:Connect [Activity]
Processing 00000000.tx.130: R 100A integrator. 

Phrase: "R 100A integrator."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0309311:INTEGRATOR [Amino Acid, Peptide, or Protein,Pharmacologic Substance,Vitamin]
   827   C1706057:Integrator [Medical Device]
Processing 00000000.tx.131: A reverse-phase C18-column (2 x 150 mm, Chrompack, lichrospher 1005, The Netherlands) was used. 

Phrase: "A reverse-phase C18-column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "(2 x 150 mm,"

Phrase: "Chrompack,"

Phrase: "lichrospher 1005,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.132: The injector was a Rheodyne valve with a 100 l loop (Cotati, CA). 

Phrase: "The injector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181342:Injector [Medical Device]

Phrase: "was"

Phrase: "a Rheodyne valve with a 100 l loop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0184252:VALVE [Medical Device]
   744   C1186983:Valve [Body Part, Organ, or Organ Component]
   744   C1704414:Valve [Medical Device]

Phrase: "(Cotati,"

Phrase: "CA)."
Processing 00000000.tx.133: Samples were chromatographed using as eluent a mixture of 0.05% TFA in water (solvent A) and 0.05% TFA in acetonitrile (solvent B) with a flow rate of 0.2 ml/min. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "chromatographed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0302647:chromatograph [Medical Device]

Phrase: "using as eluent"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1524063:Using [Functional Concept]
   790   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "a mixture of 0.05% TFA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439962:Mixture [Substance]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "A)"

Phrase: "and"

Phrase: "0.05% TFA in acetonitrile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "B) with a flow rate of 0.2 ml/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0045550:B 2 [Organic Chemical,Pharmacologic Substance]
   739   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.134: Elution was carried out as described above (see HPLC procedure section). 

Phrase: "Elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "HPLC procedure section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: ")."
Processing 00000000.tx.135: The column effluent was split 1:5 to give a flow-rate of 40 l/min into the electrospray nebulizer. 

Phrase: "The column effluent"

Phrase: "was"

Phrase: "split 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1534709:Split [Functional Concept]
   861   C1881714:SPLIT [Phenomenon or Process]

Phrase: ":"

Phrase: "5 to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a flow-rate of 40 l/min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2826285:Flow Rate [Quantitative Concept]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "into the electrospray nebulizer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027524:Nebuliser [Medical Device]
   861   C1709156:Nebulizer [Manufactured Object]
Processing 00000000.tx.136: Total ion current plots of all masses (TIC) and ESI-MS spectra were stored on a quadra 700 Macintosh computer and Mac Spec 3.2 software was used to plot, acquire and treat the ESI-MS data. 

Phrase: "Total ion current plots of all masses"

Phrase: "(TIC)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040188:Tic, NOS [Mental or Behavioral Dysfunction]
  1000   C0278076:Tic [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "ESI-MS spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   836   C0037813:Mass Spectrum [Laboratory Procedure]
   771   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   771   C1883073:Spectrum [Quantitative Concept]
   771   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "stored on a quadra 700 Macintosh computer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0009622:Computer [Manufactured Object]
   748   C0453947:Mackintosh [Manufactured Object]
   714   C1698986:Store [Functional Concept]

Phrase: "and"

Phrase: "Mac Spec 3.2 software"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0037585:Software [Intellectual Product,Manufactured Object]
   708   C1416831:MAC-2 [Gene or Genome]
   708   C3539738:MAC-2 [Gene or Genome]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "plot"

Phrase: ","

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "the ESI-MS data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]
   771   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
Processing 00000000.tx.137: The contour plot of data from LC/MS (m/z vs. retention time) made characteristic series of masses evident at different elution times after substraction of the eluent spectra. 

Phrase: "The contour plot of data"

Phrase: "from LC/MS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "("

Phrase: "m/"

Phrase: "z"

Phrase: "vs. retention time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0035280:Retention [Mental Process]
   861   C0040223:Time [Temporal Concept]
   861   C0333117:Retention [Functional Concept]
   861   C1753315:retention [Cell Function]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: ")"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "characteristic series of masses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "evident at different elution times"

Phrase: "after substraction"

Phrase: "of the eluent spectra."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.138: The voltage of the extraction cone was adjusted to 70 V and the potential of the spray needle was held at +5 kV. 

Phrase: "The voltage of the extraction cone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0598352:Voltage [Quantitative Concept]

Phrase: "was"

Phrase: "adjusted to 70 V"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0668861:V 70 [Organic Chemical,Pharmacologic Substance]
   770   C0456081:Adjusted [Functional Concept]

Phrase: "and"

Phrase: "the potential of the spray needle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "was"

Phrase: "held"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1948036:held [Idea or Concept]
  1000   C2987518:hELD [Amino Acid, Peptide, or Protein]
   966 E C1553387:Hold [Idea or Concept]
   966 E C1948035:Hold [Activity]

Phrase: "at +5 kV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0556639:kV [Quantitative Concept]
Processing 00000000.tx.139: Ionspray mass spectra were acquired in the TIC mode from m/z 400-2400 amu, with a step size of 0.2 amu and a dwell time of 0.5 ms.  

Phrase: "Ionspray mass spectra"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C0037813:Mass Spectrum [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "acquired in the TIC mode"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0040188:Tic, NOS [Mental or Behavioral Dysfunction]
   760   C0278076:Tic [Mental or Behavioral Dysfunction]
   760   C0439661:Acquired [Temporal Concept]
   760   C1513371:Mode [Functional Concept]
   760   C1705738:Mode [Quantitative Concept]
   760   C2347637:Mode [Quantitative Concept]
   760   C2348146:Mode [Quantitative Concept]
   760   C3245488:acquired [Intellectual Product]
   726 E C1706701:Acquire [Activity]

Phrase: "from"

Phrase: "m/"

Phrase: "z 400-2400 amu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0678223:amu [Quantitative Concept]
   812   C1532624:amu [Quantitative Concept]

Phrase: "with a step size"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0808077:Stepsize [Organism Attribute]
   861   C0456389:size [Spatial Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "of 0.2 amu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0678223:amu [Quantitative Concept]
   827   C1532624:amu [Quantitative Concept]

Phrase: "and"

Phrase: "a dwell time of 0.5 ms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0429659:Dwell time [Finding]
   748   C0040223:Time [Temporal Concept]
   748   C3541383:Time [Temporal Concept]
Processing 00000000.tx.140: Results Top Abstract Introduction Materials and Methods Results Discussion References  Identification and kinetic analyses of insulin and insulin-analog intermediates Figure 1 shows the HPLC elution profiles, measured by UV absorbance at 214 nm, of the 0-min incubation of native peptides (left panels) and after incubating native peptides with the ENs for the indicated time at pH 4 (right panels). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "kinetic analyses of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "insulin-analog intermediates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]
   734   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "Figure"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the HPLC elution profiles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "measured by UV absorbance"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0041625:UV [Natural Phenomenon or Process]
   770   C0444706:Measured [Qualitative Concept]
   770   C1268822:Absorbance [Clinical Attribute]
   770   C1961129:uV [Quantitative Concept]
   770   C2825050:Absorbance [Phenomenon or Process]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "at 214 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "of the 0-min incubation"

Phrase: "of native peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(left panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and after incubating native peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C0302891:Native [Functional Concept]
   760   C1439852:incubating [Laboratory Procedure]
   760   C1515981:And [Idea or Concept]

Phrase: "with the ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "for the indicated time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "at pH 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "(right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.141: Major intermediate peptide peaks (6 for HI, the H2-analog and [AspB10]-HI, and 8 for the [GluA13,GluB10]-HI) were observed in addition to the undegraded peptides (peak 7), which had decreased in peak height with variable rates of processing (Fig. 1). 

Phrase: "Major intermediate peptide peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0444505:peaks [Quantitative Concept]

Phrase: "(6 for HI,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0086418:Human [Human]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "the H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "and ["

Phrase: "AspB10"

Phrase: "]-HI,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "8 for the [GluA13,"

Phrase: "GluB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "observed in addition to the undegraded peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C1441672:Observed [Functional Concept]
   748   C1883712:Addition [Functional Concept]

Phrase: "(peak 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "had"

Phrase: "decreased in peak height"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   870   C0424641:Decrease in height [Finding]
       E   height decrease
   819   C2732728:Decreased height [Finding]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C0444505:Peak [Quantitative Concept]
   770   C0489786:Height [Organism Attribute]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "with variable rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "of processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.142: The rate of hydrolysis of each peptide was accurately determined by following the disappearance of the parent peptide by quantitation of the peak areas (Fig. 2), thus cleavage at any single bond would be detected. 

Phrase: "The rate of hydrolysis of each peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "accurately"

Phrase: "determined by"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the disappearance of the parent peptide"

Phrase: "by quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantitation [Quantitative Concept]

Phrase: "of the peak areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "thus cleavage at any single bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "would"

Phrase: "be"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.143: HI degradation showed a faster initial hydrolysis than that of the H2-analog (t1/2 of 19 and 44 min, respectively) (7). 

Phrase: "HI degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]
   734   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a faster initial hydrolysis than that of the H2-analog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "(t1/2 of 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1413227:T1 [Gene or Genome]

Phrase: "and"

Phrase: "44 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.144: When [AspB10]-HI and [GluA13,GluB10]-HI were used as substrates, the rate of hydrolysis was faster than that of HI with t1/2 of 10 and 9 min respectively (Fig. 2). 

Phrase: "When"

Phrase: "[AspB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "GluA13,"

Phrase: "GluB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "used as substrates,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1710236:Substrate [Manufactured Object]
   756 E C1947944:Use [Intellectual Product]

Phrase: "the rate of hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "faster than that of HI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0015663:Fast [Finding]
   719   C0456962:Fast [Qualitative Concept]

Phrase: "with t1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413227:T1 [Gene or Genome]

Phrase: "of 10"

Phrase: "and"

Phrase: "9 min respectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.145: View larger version (21K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.146: HPLC elution profiles of the degradation products resulting from the incubation of wild-type insulin and insulin analogs with a soluble endosomal extract. 

Phrase: "HPLC elution profiles of the degradation products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1979963:Profile [Laboratory Procedure]
   714   C2003903:Profile [Functional Concept]

Phrase: "resulting from the incubation of wild-type insulin"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C1883559:Wild Type [Organism Attribute]
   767   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C0678226:resulting [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1547052:*Type [Quantitative Concept]
   744   C1579433:Insulin [Pharmacologic Substance]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "insulin analogs with a soluble endosomal extract."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0243071:analogs [Chemical Viewed Structurally]
Processing 00000000.tx.147: Endosomes were disrupted by hypotonic shock, and the soluble endosomal extract (ENs) (1 ng) was incubated with 10-6 M human insulin (HI), [HisA8, HisB4, GluB10, HisB27]-HI (H2-analog), [AspB10]-HI or [GluA13, GluB10]-HI for the indicated time at pH 4 and 37 C. 

Phrase: "Endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "disrupted by hypotonic shock,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C0332454:Disrupted [Qualitative Concept]

Phrase: "and"

Phrase: "the soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: ")"

Phrase: "(1 ng)"

Phrase: "was"

Phrase: "incubated with 10-6 M human insulin (HI),"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0439187:/10^6 [Quantitative Concept]
   778   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   778   C1881839:10^6 [Quantitative Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086418:Human [Human]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "[HisA8,"

Phrase: "HisB4,"

Phrase: "GluB10,"

Phrase: "HisB27"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "[AspB10"

Phrase: "]-HI or [GluA13,"

Phrase: "GluB10"

Phrase: "]-HI for the indicated time"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "at pH 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "37 C."
Processing 00000000.tx.148: The proteolytic reaction was stopped with acetic acid (15%) and the incubation mixtures were analyzed by reverse-phase HPLC (right panels) as described in Experimental procedures. 

Phrase: "The proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped with acetic acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: "and"

Phrase: "the incubation mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "analyzed by reverse-phase HPLC (right panels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205090:Right [Spatial Concept]
   748   C0205390:Phase [Temporal Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C0936012:Analyzed [Research Activity]
   748   C1555029:Reverse [Idea or Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "as"

Phrase: "described in Experimental procedures."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.149: All panels show absorbance profiles at 214 nm. 

Phrase: "All panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "absorbance profiles at 214 nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]
Processing 00000000.tx.150: Intact insulin, H2-analog, [AspB10]-HI and [GluA13, GluB10]-HI had elution times of 44, 46, 48, and 43 min, respectively (left panels). 

Phrase: "Intact insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "H2-analog,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "[AspB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "GluA13,"

Phrase: "GluB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "had"

Phrase: "elution times of 44,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "46,"

Phrase: "48,"

Phrase: "and"

Phrase: "43 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "respectively"

Phrase: "(left panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.151: The endosomal proteins alone did not give any detectable peak (results not shown). 

Phrase: "The endosomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "any detectable peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.152: The major peptide pools, numbered sequentially 17, were collected from the time course profile indicated. 

Phrase: "The major peptide pools,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0337051:pools [Geographic Area]
   793 E C1509144:pool [Clinical Attribute]
   793 E C2349200:Pool [Functional Concept]

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "sequentially 17,"

Phrase: "were"

Phrase: "collected from the time course profile"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0449247:Time course [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.153: These pools were subjected to mass spectrometry analyses (see Table 1).  

Phrase: "These pools"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0337051:pools [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]
   966 E C2349200:Pool [Functional Concept]

Phrase: "were"

Phrase: "subjected to mass spectrometry analyses (see Table 1)."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0681850:Subject [Group]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.154: View larger version (19K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.155: Kinetics of processing of wild-type insulin and insulin analogs by a soluble endosomal extract. 

Phrase: "Kinetics of processing of wild-type insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0022702:Kinetics [Natural Phenomenon or Process]
   748   C0220865:kinetics [Functional Concept]
   748   C2825046:Kinetics [Occupation or Discipline]

Phrase: "and"

Phrase: "insulin analogs by a soluble endosomal extract."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0243071:analogs [Chemical Viewed Structurally]
Processing 00000000.tx.156: The in vitro proteolysis of HI and the three insulin analog peptides was measured by HPLC analysis as described in Fig. 

Phrase: "The in vitro proteolysis of HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597304:Proteolysis [Molecular Function]

Phrase: "and"

Phrase: "the three insulin analog peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "measured by HPLC analysis"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0008562:HPLC [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.157: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.158: Results are expressed as the amount of peptide degraded (% of control) after a 15-, 30-, or 60-min incubation, and normalized (100%) to that seen in the absence of added endosomal protein. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as the amount of peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1265611:Amount [Quantitative Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(%"

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "after a 15-,"

Phrase: "30-,"

Phrase: "or"

Phrase: "60-min incubation,"

Phrase: "and"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "(100%"

Phrase: ")"

Phrase: "to that"

Phrase: "seen in the absence of added endosomal protein."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205397:Seen [Qualitative Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C1524062:Added [Functional Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   711 E C0042789:see [Organism Function]
   711 E C1883712:Add [Functional Concept]
   711 E C1947903:See [Activity]
Processing 00000000.tx.159: Results are the mean  SD of three different experiments performed on endosomal fractions prepared from separate liver fractionations.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SD of three different experiments"

Phrase: "performed on endosomal fractions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "prepared from separate liver fractionations."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0443299:Separate [Spatial Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   726   C0016640:fractionation [Laboratory Procedure]
   726   C0524811:fractionation [Therapeutic or Preventive Procedure]
   726   C1521827:Prepare [Functional Concept]
   726   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.160: Sites of cleavage of insulin and insulin-analog intermediates Each of the major HPLC peaks was analyzed using mass spectrometry to determine the molecular mass of peptide products. 

Phrase: "Sites of cleavage of insulin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C2945843:Site of [Qualitative Concept]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "insulin-analog"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "Each of the major HPLC peaks"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205164:Major [Qualitative Concept]
   753   C0444505:peaks [Quantitative Concept]
   753   C1457900:Each [Quantitative Concept]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mass spectrometry to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "determine"

Phrase: "the molecular mass of peptide products."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
Processing 00000000.tx.161: Table 1 lists the peptide peaks, their retention times, theoretical and experimental molecular masses, and structures. 

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "lists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0745732:List [Conceptual Entity]
  1000   C3272378:LIST [Intellectual Product]

Phrase: "the peptide peaks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "their retention times,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0035280:Retention [Mental Process]
   861   C0040223:times [Temporal Concept]
   861   C0333117:Retention [Functional Concept]
   861   C1632851:Times [Quantitative Concept]
   861   C1753315:retention [Cell Function]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "theoretical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871935:Theoretical [Idea or Concept]

Phrase: "and"

Phrase: "experimental molecular masses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]

Phrase: "and"

Phrase: "structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]
Processing 00000000.tx.162: Figure 3 depicts the initial and later peptide bonds cleaved by rat EAI activity, and the intermediates identified in this study. 

Phrase: "Figure 3"

Phrase: "depicts"

Phrase: "the initial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205265:Initial [Temporal Concept]
  1000   C1279901:Initial [Qualitative Concept]
  1000   C1555582:Initial [Idea or Concept]
  1000   C1705685:INITIAL [Functional Concept]

Phrase: "and"

Phrase: "later peptide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C0678595:peptide bond [Natural Phenomenon or Process]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "cleaved by rat EAI activity,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C1150184:insulinase activity [Molecular Function]
   748   C0001128:Acidic [Chemical]
   748   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0205177:Activity [Functional Concept]
   748   C0205242:Cleaved [Spatial Concept]
   748   C0333853:Cleaved [Cell]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1415875:INSULINASE [Gene or Genome]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0205103:Intermediate [Spatial Concept]
   966   C1550465:intermediate [Idea or Concept]
   966   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "identified in this study."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205396:Identified [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.163: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.164: Masses and assigned structures of the cleavage products generated from human and mutant insulins by endosomal acidic insulinase activity  View larger version (9K): [in this window] [in a new window]  Figure 3. 

Phrase: "Masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0577559:Mass [Finding]
   966   C1306372:*Mass [Quantitative Concept]
   966   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "assigned structures of the cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "generated from human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086418:Human [Human]
   790   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "mutant insulins by endosomal acidic insulinase activity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   757   C1145751:insulin activity [Molecular Function]
   748   C0021641:insulins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C3537244:Insulins [Pharmacologic Substance]
   714 E C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   714 E C1579433:Insulin [Pharmacologic Substance]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.165: Peptide bonds cleaved and structure of intermediates generated by endosomal acidic insulinase activity. 

Phrase: "Peptide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0678595:peptide bond [Natural Phenomenon or Process]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "and"

Phrase: "structure of intermediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678594:Structure [Spatial Concept]

Phrase: "generated by endosomal acidic insulinase activity."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1150184:insulinase activity [Molecular Function]
   753   C0001128:Acidic [Chemical]
   753   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1415875:INSULINASE [Gene or Genome]
   753   C1561536:*Activity [Idea or Concept]
   753   C3146294:Generated [Activity]
Processing 00000000.tx.166: The number refer to the intermediates as identified in Fig. 

Phrase: "The number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "refer to the intermediates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205543:refer [Functional Concept]
   737   C0205103:Intermediate [Spatial Concept]
   737   C1550465:intermediate [Idea or Concept]
   737   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "as"

Phrase: "identified in Fig."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205396:Identified [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
Processing 00000000.tx.167: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.168: The symbols + and - indicate, respectively, major and minor pathway of degradation. 

Phrase: "The symbols +"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679214:symbols [Idea or Concept]
   966 E C1698987:symbol [Intellectual Product]

Phrase: "and -"

Phrase: "indicate"

Phrase: ","

Phrase: "respectively,"

Phrase: "major"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205164:Major [Qualitative Concept]

Phrase: "and"

Phrase: "minor pathway of degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1511758:Degradation Pathway [Conceptual Entity]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.169: Peptide products 4a and 4b are not identified using [GluA13, GluB10]-HI as a substrate.  

Phrase: "Peptide products 4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450373:4a [Intellectual Product]
   827   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "4b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[GluA13,"

Phrase: "GluB10"

Phrase: "]-HI as a substrate."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.170: Using HI as a substrate (Table 1), we observed that as early as 1 min of incubation (results not shown), two major new peaks (peaks 3 and 6) and intact HI (peak 7) can be detected (see Fig. 1). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HI as a substrate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "as"

Phrase: "early as 1 min of incubation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301862:Min 1 [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1279919:Early [Temporal Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "two major new peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0444505:peaks [Quantitative Concept]

Phrase: "(peaks 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: ")"

Phrase: "and"

Phrase: "intact HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(peak 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "can"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.171: The two peptides corresponded to the hexapeptide B2530 (peak 3) and the remaining N-terminal residues B124 connected to the intact A-chain A121 (A121-B124; peak 6) (Fig. 3). 

Phrase: "The two peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "corresponded to the hexapeptide B2530"

Phrase: "(peak 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the remaining N-terminal residues B124"

Phrase: "connected to the intact A-chain A121"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205266:Intact [Qualitative Concept]
   748   C0337112:Chain [Manufactured Object]
   748   C1414323:A121 [Gene or Genome]
   748   C1524075:Chain [Idea or Concept]
   748   C1554187:Intact [Idea or Concept]
   748   C1704997:A121 [Gene or Genome]
   714   C2986575:Connect [Activity]

Phrase: "(A121-B124"

Phrase: "; peak 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.172: A minor intermediate that corresponded to the insulin molecule with the 5-amino acid peptide B2630 missing and coeluted with HI was referred to as peak 7a. 

Phrase: "A minor intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205103:Intermediate [Spatial Concept]
   861   C1550465:intermediate [Idea or Concept]
   861   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "that"

Phrase: "corresponded to the insulin molecule"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0567416:Molecule [Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with the 5-amino acid peptide B2630 missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C1551393:Missing [Idea or Concept]
   799   C1705492:Missing [Qualitative Concept]
   799   C3272743:MISSING [Qualitative Concept]
   766 E C2349206:Miss [Conceptual Entity]

Phrase: "and"

Phrase: "coeluted with HI"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0086418:Human [Human]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "peak 7a."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.173: At later incubation times (>10 min; see Fig. 1), both peaks 3 and 6 have begun to decrease along with the appearance of HPLC pools 1, 2, 4, and 5. 

Phrase: "At later incubation times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "("

Phrase: ">10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "both"

Phrase: "peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "6"

Phrase: "have"

Phrase: "begun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease along with the appearance of HPLC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0233426:Appearance [Organism Attribute]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C0700364:Appearance [Qualitative Concept]

Phrase: "pools"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "and"

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.174: Peaks 2 and 1 correlated with to the subsequent fate of the B2530 hexapeptide in which the N-terminal PheB25 and TyrB26 were sequentially eliminated. 

Phrase: "Peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "correlated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1707520:Correlated [Qualitative Concept]

Phrase: "to the subsequent fate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1539479:FATE [Gene or Genome]
   789 E C1302234:Fatal [Qualitative Concept]
   789 E C1705232:Fatal [Finding]

Phrase: "of the B2530 hexapeptide"

Phrase: "in which"

Phrase: "the N-terminal PheB25"

Phrase: "and"

Phrase: "TyrB26"

Phrase: "were"

Phrase: "sequentially"

Phrase: "eliminated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]
Processing 00000000.tx.175: Peptides 5e and 5d were the same peptide as peptide 6, but the C-terminal ArgB22 and GluB21 were sequentially clipped off. 

Phrase: "Peptides 5e"

Phrase: "and"

Phrase: "5d"

Phrase: "were"

Phrase: "the same peptide as peptide 6,"

Phrase: "but"

Phrase: "the C-terminal ArgB22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "and"

Phrase: "GluB21"

Phrase: "were"

Phrase: "sequentially"

Phrase: "clipped off."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0175722:Clip [Medical Device]
   799   C1705205:Clip [Medical Device]
Processing 00000000.tx.176: The internal dipeptide LeuB15-TyrB16 was then removed from peptides 5e and 5d to generate peptide 5c (A121B114/1723) and 5b (A121-B114/1722), respectively. 

Phrase: "The internal dipeptide LeuB15-TyrB16"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removed from peptides 5e"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0849355:Removed [Qualitative Concept]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "5d to"

Phrase: "generate"

Phrase: "peptide 5c"

Phrase: "(A121B114/1723"

Phrase: ")"

Phrase: "and"

Phrase: "5b"

Phrase: "(A121-B114/1722"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1414323:A121 [Gene or Genome]
   827   C1704997:A121 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.177: The HPLC pool 5 contains an additional component A121-B113/1722) (peak 5a), thereby indicating the removal of the AlaB14 residue from the peptide 5b. 

Phrase: "The HPLC pool 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0008562:HPLC [Laboratory Procedure]
   827   C0337051:Pool [Geographic Area]
   827   C1509144:pool [Clinical Attribute]
   827   C2349200:Pool [Functional Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an additional component A121-B113/1722"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0449432:Component [Manufactured Object]
   804   C1414323:A121 [Gene or Genome]
   804   C1524062:Additional [Functional Concept]
   804   C1704997:A121 [Gene or Genome]
   804   C1705248:Component [Conceptual Entity]
   733 E C1883712:Addition [Functional Concept]

Phrase: ")"

Phrase: "(peak 5a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "indicating"

Phrase: "the removal of the AlaB14 residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from the peptide 5b."
Processing 00000000.tx.178: Peak 4 was a mixture of portions of the carboxyl end of the A-chain (A115) and B-chain (B114 and B113). 

Phrase: "Peak 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "was"

Phrase: "a mixture of portions of the carboxyl end of the A-chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0439962:Mixture [Substance]

Phrase: "(A115"

Phrase: ")"

Phrase: "and"

Phrase: "B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "(B114"

Phrase: "and"

Phrase: "B113"

Phrase: ")."
Processing 00000000.tx.179: Therefore, the GluA15-LeuA16 bond of peptides 5a and b has been cleaved off to form peptides 4a and b. 

Phrase: "Therefore,"

Phrase: "the GluA15-LeuA16 bond of peptides 5a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   757   C0678595:peptide bond [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "cleaved off to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205242:Cleaved [Spatial Concept]
   790   C0333853:Cleaved [Cell]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "peptides 4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "b."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.180: The degradation of the H2-analog, [AspB10]-HI and [GluA13,GluB10]-HI revealed a similar pattern (Table 1). 

Phrase: "The degradation of the H2-analog,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "[AspB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "GluA13,"

Phrase: "GluB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a similar pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.181: However, using [GluA13,GluB10]-HI as a substrate, the degradation products have only been cleaved at the B-chain peptide bonds. 

Phrase: "However,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[GluA13,"

Phrase: "GluB10"

Phrase: "]-HI as a substrate,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "the degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "have"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "been"

Phrase: "cleaved at the B-chain peptide bonds."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0070338:peptide B [Amino Acid, Peptide, or Protein]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0205242:Cleaved [Spatial Concept]
   748   C0333853:Cleaved [Cell]
   748   C0337112:Chain [Manufactured Object]
   748   C1524075:Chain [Idea or Concept]
   745   C0678595:peptide bond [Natural Phenomenon or Process]
Processing 00000000.tx.182: Thus, the GluA15-LeuA16 bond did not appear to be further degraded by EAI activity within the [GluA13,GluB10]-HI mutant. 

Phrase: "Thus,"

Phrase: "the GluA15-LeuA16 bond"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "degraded by EAI activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1150184:insulinase activity [Molecular Function]
   753   C0001128:Acidic [Chemical]
   753   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1415875:INSULINASE [Gene or Genome]
   753   C1561536:*Activity [Idea or Concept]
   753   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "within the [GluA13,"

Phrase: "GluB10"

Phrase: "]-HI mutant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
   734   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.183: We then evaluated the ability of native ligands to inhibit [125I]TyrA14-HI degradation by ENs (Fig. 4). 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the ability of native ligands to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "[125I"

Phrase: "]TyrA14-HI degradation by ENs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.184: HI was found to inhibit [125I]TyrA14-HI proteolysis by ENs in a dose-dependent manner similar to that of the H2-analog and [GluA13,GluB10]-HI, with an IC50 of 24 x 10-5 M (Fig. 4A). 

Phrase: "HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "[125I"

Phrase: "]TyrA14-HI proteolysis by ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "similar to that of the H2-analog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "and ["

Phrase: "GluA13,"

Phrase: "GluB10"

Phrase: "]-HI,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with an IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600495:IC50 [Quantitative Concept]

Phrase: "of 24 x 10-5"

Phrase: "M ("

Phrase: "Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.185: [AspB10]-HI was approximately 2 times more effective than HI at competing for proteolysis of radiolabeled HI (IC50 of 10-5 M). 

Phrase: "[AspB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "approximately 2 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "more effective than HI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]

Phrase: "at competing"

Phrase: "for proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "of radiolabeled HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IC50 of 10-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0600495:IC50 [Quantitative Concept]

Phrase: "M)."
Processing 00000000.tx.186: Thus, the insulin mutants and HI share a common binding site on the EAI enzyme. 

Phrase: "Thus,"

Phrase: "the insulin mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a common binding site on the EAI enzyme."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0005456:Binding Site [Receptor]
   760   C0682969:Binding Site [Amino Acid Sequence]
   757   C1149286:enzyme binding [Molecular Function]
   739   C0205145:Site [Spatial Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]
Processing 00000000.tx.187: To test further the relative catalytic selectivity of EAI toward the insulin molecule, we evaluated the ability of various peptides of approximately 3.57.5 kDa to inhibit [125I]TyrA14-HI degradation at a concentration of 5 x 10-5 M (Fig. 4B). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the relative catalytic selectivity of EAI"

Phrase: "toward the insulin molecule,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the ability of various peptides of approximately 3.57.5 kDa to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "[125I"

Phrase: "]TyrA14-HI degradation at a concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "of 5 x 10-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0450380:5/5 [Quantitative Concept]
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "M ("

Phrase: "Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.188: Among the glucagon, EGF and IGF-I peptides, only glucagon was able to inhibit radiolabeled HI degradation but less effectively than HI and the insulin analog peptides (22% of inhibition). 

Phrase: "Among the glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "EGF"

Phrase: "and"

Phrase: "IGF-I peptides,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   734   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334089:IGF I [Gene or Genome]

Phrase: "only glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "radiolabeled HI degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3547574:insulin degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]

Phrase: "but"

Phrase: "less effectively than HI"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   797   C0439092:Less Than [Intellectual Product]
           less
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086418:Human [Human]
   760   C0547044:Less [Qualitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "the insulin analog peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   734   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(22% of inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.189: View larger version (23K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.190: Competition of HI, the insulin mutants and other peptides for the degradation of [125I]TyrA14-HI by endosomal acidic insulinase activity. 

Phrase: "Competition of HI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679932:competition [Social Behavior]

Phrase: "the insulin mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "other peptides for the degradation of [125I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1523817:peptide degradation [Molecular Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "]TyrA14-HI by endosomal acidic insulinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   767   C1145751:insulin activity [Molecular Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.191: Endosomes were disrupted by hypotonic shock, and the soluble endosomal extract (ENs) (0.1 mg/ml) was incubated with [125I]TyrA14-HI (75 fmol) at 37 C and pH 4 with the indicated concentrations of unlabeled ligands (A) or with the indicated peptides at a concentration of 5 x 10-5 M (B). 

Phrase: "Endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "disrupted by hypotonic shock,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C0332454:Disrupted [Qualitative Concept]

Phrase: "and"

Phrase: "the soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: ")"

Phrase: "(0.1 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(75 fmol) at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439195:fmol [Quantitative Concept]

Phrase: "and"

Phrase: "pH 4 with the indicated concentrations of unlabeled ligands"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C2678549:PH-4 [Gene or Genome]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0023688:Ligands [Chemical]
   742   C0086045:Concentrations [Mental Process]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C1444656:Indicated [Finding]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "(A)"

Phrase: "or with the indicated peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C1444656:Indicated [Finding]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 5 x 10-5 M (B)."
Processing 00000000.tx.192: The amount of degraded radiolabeled insulin was determined by precipitation with trichloroacetic acid. 

Phrase: "The amount of degraded radiolabeled insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "determined by precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with trichloroacetic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.193: Results, mean  SD of three different experiments performed on endosomal fractions prepared from separate liver fractionation, are expressed as percentage of degradation determined in the absence of unlabeled added peptides.  

Phrase: "Results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "mean  SD of three different experiments"

Phrase: "performed on endosomal fractions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "prepared from separate liver fractionation,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0016640:fractionation [Laboratory Procedure]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0443299:Separate [Spatial Concept]
   760   C0524811:fractionation [Therapeutic or Preventive Procedure]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   760   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   726   C1521827:Prepare [Functional Concept]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "are"

Phrase: "expressed as percentage of degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243125:degradation [Functional Concept]
   760   C0439165:Percentage [Quantitative Concept]
   760   C0699900:Degradation [Organism Function]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "determined in the absence of unlabeled added peptides."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   744   C0332197:absence [Quantitative Concept]
   744   C1524062:Added [Functional Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   711 E C1883712:Add [Functional Concept]
Processing 00000000.tx.194: To ensure the involvement of only one enzyme in the initial cleavages of both HI and the insulin mutants, we partially purified the enzyme responsible to follow cleavages of the HI molecule using two independent assay systems (Fig. 5), a gel-filtration HPLC procedure and an insulin-affinity chromatography procedure (5). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "the involvement of only one enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in the initial cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "of both HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the insulin mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "we partially"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "the enzyme responsible to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1273518:Responsible to [Finding]

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "cleavages of the HI molecule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0010813:cleavage [Cell Function]
   719   C0596311:Cleavage [Phenomenon or Process]
   719   C1330957:cleavage [Cell Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two independent assay systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "a gel-filtration HPLC procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C1948041:Procedure [Therapeutic or Preventive Procedure]
   812   C2700391:Procedure [Activity]
   812   C3274430:PROCEDURE [Health Care Activity]
   812   C3538935:Procedure [Idea or Concept]
   812   C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "an insulin-affinity chromatography procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C1948041:Procedure [Therapeutic or Preventive Procedure]
   812   C2700391:Procedure [Activity]
   812   C3274430:PROCEDURE [Health Care Activity]
   812   C3538935:Procedure [Idea or Concept]
   812   C3539779:Procedure [Intellectual Product]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.195: The elution profile of the acidic insulinase activity on the TSK-gel G3000 HPLC column was clearly separated from the majority of the soluble endosomal proteins (Fig. 5, A and B). 

Phrase: "The elution profile of the acidic insulinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]

Phrase: "on the TSK-gel G3000 HPLC column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "clearly"

Phrase: "separated from the majority of the soluble endosomal proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086972:Separated [Finding]
   742   C0443299:separated [Spatial Concept]
   742   C0680220:majority [Social Behavior]
   742   C0687118:Separated [Functional Concept]
   742   C1749467:soluble [Cell Component]
   742   C1948047:Soluble [Qualitative Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.196: The apparent molecular weight of the enzyme under nondenaturing conditions was below 66-kDa based on its elution from the TSK-gel G3000 column. 

Phrase: "The apparent molecular weight of the enzyme"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0026385:Molecular Weight [Quantitative Concept]
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C0750489:apparent [Idea or Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1705104:Weight [Idea or Concept]

Phrase: "under nondenaturing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "was below 66-kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
   770   C1532717:kDa [Quantitative Concept]

Phrase: "based on its elution"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1441565:Elution [Laboratory Procedure]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from the TSK-gel G3000 column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]
Processing 00000000.tx.197: Fractions with the highest insulinase activity (fractions 2021) were pooled and used for the characterization of HPLC products (Fig. 5C), competition studies (Fig. 6A), and pH profiles (Fig. 6B) using both HI and the H2-analog as substrates. 

Phrase: "Fractions with the highest insulinase activity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C1264633:Fractions [Quantitative Concept]
   742   C0439161:Fractional activity [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "(fractions 2021"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "used for the characterization of HPLC products"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   757   C1524063:Use of [Functional Concept]
   748   C0008562:HPLC [Laboratory Procedure]
   748   C1273517:used [Finding]
   748   C1514468:Products [Entity]
   748   C1880022:Characterization [Activity]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1704444:Product [Quantitative Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "(Fig. 5C"

Phrase: ")"

Phrase: ","

Phrase: "competition studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0679932:competition [Social Behavior]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "pH profiles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0429225:pH profile [Laboratory Procedure]
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the H2-analog as substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243071:Analog [Chemical Viewed Structurally]
Processing 00000000.tx.198: The HPLC elution pattern, the competition curves, and the pH-rate profiles were found to be comparable to those obtained using crude ENs fractions. 

Phrase: "The HPLC elution pattern,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]

Phrase: "the competition curves,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "the pH-rate profiles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C0429225:pH profile [Laboratory Procedure]
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "comparable to those obtained"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "crude ENs fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.199: A similar HPLC elution profile (Fig. 5D) was also obtained using HI incubated at pH 4 with EAI partially purified on insulin affinity chromatography according to the method of Authier et al. 

Phrase: "A similar HPLC elution profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1979963:Profile [Laboratory Procedure]
   812   C2003903:Profile [Functional Concept]

Phrase: "(Fig. 5D"

Phrase: ")"

Phrase: "was"

Phrase: "also"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "incubated at pH 4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2678549:PH-4 [Gene or Genome]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with EAI partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1415875:INSULINASE [Gene or Genome]

Phrase: "purified on insulin affinity chromatography"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0008551:Chromatography, Affinity [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1998793:Purified [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "according to the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Authier et al."
Processing 00000000.tx.200: (5). 

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.201: All of these results provide strong evidence that the vast majority (if not all) of the reported cleavages are probably due to a single enzyme. 

Phrase: "All of these results"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the vast majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680220:majority [Social Behavior]

Phrase: "("

Phrase: "if"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all) of the reported cleavages"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0444868:All [Quantitative Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   760   C3539085:All [Idea or Concept]
   726   C0010813:cleavage [Cell Function]
   726   C0596311:Cleavage [Phenomenon or Process]
   726   C1330957:cleavage [Cell Function]
   726 E C3273238:Report [Intellectual Product]

Phrase: "are"

Phrase: "probably due to a single enzyme."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0750492:Probably [Idea or Concept]
   753   C3146286:Due [Idea or Concept]
Processing 00000000.tx.202: View larger version (17K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.203: Assessment of endosomal acidic insulinase activity after a gel-filtration HPLC protocol and immunodepletion procedures. 

Phrase: "Assessment of endosomal acidic insulinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]

Phrase: "after a gel-filtration HPLC protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0442711:Protocol [Intellectual Product]
   812   C1507394:Protocol [Intellectual Product]
   812   C1522729:Protocol [Intellectual Product]
   812   C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "immunodepletion procedures."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.204: Endosomal acidic insulinase activity was partially purified using a TSK-gel G3000 HPLC column (see Fig. 5, A and B) and incubated with [125I]TyrA14-HI (75 fmol) at 37 C and pH 4 with the indicated concentrations of unlabeled HI or H2-analog peptides (A). 

Phrase: "Endosomal acidic insulinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "partially"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a TSK-gel G3000 HPLC column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(75 fmol) at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439195:fmol [Quantitative Concept]

Phrase: "and"

Phrase: "pH 4 with the indicated concentrations of unlabeled HI"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   760   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C2678549:PH-4 [Gene or Genome]
   739   C0020283:[pH] [Quantitative Concept]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0086045:Concentrations [Mental Process]
   739   C0086418:Human [Human]
   739   C0450407:ph+ [Finding]
   739   C0450408:ph++ [Finding]
   739   C0450409:ph+++ [Finding]
   739   C1444656:Indicated [Finding]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   706 E C1446561:Concentration [Quantitative Concept]

Phrase: "or"

Phrase: "H2-analog peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.205: The amount of degraded radiolabeled HI was determined by precipitation with TCA, and results are expressed as in Fig. 

Phrase: "The amount of degraded radiolabeled HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "determined by precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with TCA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed"

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.206: 4A. 

Phrase: "4A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]
Processing 00000000.tx.207: In Panel B, partially purified EAI was incubated at different pH values for 10 min with [125I]TyrA14-HI or -H2-analog, after which the amount of degraded radiolabeled ligand was determined by precipitation with TCA. 

Phrase: "In Panel B,"

Phrase: "partially"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "was"

Phrase: "incubated at different pH values"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0042295:Values [Qualitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1705242:Different [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "with"

Phrase: "[125I"

Phrase: "]TyrA14-HI or -H2-analog,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0243071:Analog [Chemical Viewed Structurally]

Phrase: "after"

Phrase: "which the amount of degraded radiolabeled ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "determined by precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with TCA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.208: C, ENs was immunodepleted of various proteases using independently rabbit antirat procathepsin B (CB), -rat cathepsin L (CL), -rat tripeptidylpeptidase II (TPP II), -rat Thimet Oligopeptidase (TOP), and mouse antihuman insulin-degrading enzyme (IDE) at a dilution of 1/500. 

Phrase: "C,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "was"

Phrase: "immunodepleted of various proteases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1947941:Proteases [Enzyme]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "independently rabbit antirat procathepsin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0072033:procathepsin B [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(CB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ", -"

Phrase: "rat cathepsin L (CL), -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0207383:cathepsin L, rat [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0054871:Cathepsin L [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332807:CATHEPSIN L [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "rat tripeptidylpeptidase II"

Phrase: "(TPP II"

Phrase: ")"

Phrase: ", -"

Phrase: "rat Thimet Oligopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mouse antihuman insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "at a dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "of 1/500."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.209: After immunoprecipitation using protein G-Sepharose and centrifugation, the resultant supernatants were tested for the ability to degrade [125I]TyrA14-HI or [125I]-glucagon at pH 4 using the TCA-precipitation assay.  

Phrase: "After immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "protein G-Sepharose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036681:Sepharose [Carbohydrate]
   734   C0060916:protein g [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "the resultant supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "tested for the ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "degrade"

Phrase: "[125I"

Phrase: "]TyrA14-HI or [125I"

Phrase: "]-glucagon at pH 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TCA-precipitation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.210: Hepatic endosomal fractions are known to contain numerous peptidases such as IDE (31), cathepsin B (22, 28), as well as undefined tripeptidylaminopeptidase activity (22). 

Phrase: "Hepatic endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "numerous peptidases such as IDE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0030940:Peptidases [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C1947941:Peptidase [Enzyme]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(22,"

Phrase: "28"

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "undefined tripeptidylaminopeptidase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.211: We therefore used well characterized antibodies to assess the EAI activity (Fig. 6C). 

Phrase: "We therefore"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "well characterized antibodies to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the EAI activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.212: Immunoprecipitation with antibodies to cathepsins B and L, and IDE failed to remove insulinase activity as measured at pH 4. 

Phrase: "Immunoprecipitation with antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "to cathepsins B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0699919:Cathepsins B [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C1332804:CATHEPSIN B [Gene or Genome]

Phrase: "and"

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "insulinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150184:insulinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "measured at pH 4."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C2678549:PH-4 [Gene or Genome]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.213: However, as expected more than 60% of endosomal acidic glucagonase activity was depleted by anticathepsin B antibody (22). 

Phrase: "However,"

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "more than 60% of endosomal acidic glucagonase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0001128:Acidic [Chemical]
   744   C0205172:More [Functional Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "depleted by anticathepsin B antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0333668:Depleted [Functional Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.214: Comparable results were obtained using antibodies directed against putative endosomal peptidases such as tripeptidylaminopeptidase II (TPP II) (24) and Thimet Oligopeptidase (TOP) (25). 

Phrase: "Comparable results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against putative endosomal peptidases"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0030940:Peptidases [Amino Acid, Peptide, or Protein,Enzyme]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
   726 E C1947941:Peptidase [Enzyme]

Phrase: "such as tripeptidylaminopeptidase II"

Phrase: "(TPP II"

Phrase: ")"

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "Thimet Oligopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.215: A- and B-chains of insulin as substrates of endosomal acidic insulinase Two substrates of the same protease are expected to compete with each other for the enzyme site, and thus, one substrate will act as a competitive inhibitor of the other. 

Phrase: "A-"

Phrase: "and"

Phrase: "B-chains of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   770   C0337112:chains [Manufactured Object]
   770   C1524075:Chains [Idea or Concept]

Phrase: "as substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "of endosomal acidic insulinase Two substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1710236:Substrate [Manufactured Object]

Phrase: "of the same protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "are"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compete with each other"

Phrase: "for the enzyme site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "thus,"

Phrase: "one substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "will"

Phrase: "act as a competitive inhibitor of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0679932:competitive [Social Behavior]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "other."
Processing 00000000.tx.216: We have used this strategy to find new substrates for EAI derived from the insulin molecule ( Figs. 79). 

Phrase: "We"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this strategy to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "new substrates for EAI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710236:Substrate [Manufactured Object]

Phrase: "derived from the insulin molecule"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0567416:Molecule [Substance]
   760   C1441547:Derived [Qualitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3245521:derived [Idea or Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "( Figs. 79"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.217: In competition assays, both the insulin A-chain (Fig. 7C) and B-chain (Fig. 8C) were potent in competing with radiolabeled insulin for proteolysis by ENs. 

Phrase: "In competition assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "both"

Phrase: "the insulin A-chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 7C"

Phrase: ")"

Phrase: "and"

Phrase: "B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "(Fig. 8C"

Phrase: ")"

Phrase: "were"

Phrase: "potent in competing"

Phrase: "with radiolabeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "by ENs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]
Processing 00000000.tx.218: Although insulin A-chain (IC50 of 2 x 10-5 M) was able to inhibit the degradation of radiolabeled insulin comparable to that of intact insulin, insulin B-chain (IC50 of 6 x 10-7 M) was found to be 30 times more potent than intact insulin and A-chain. 

Phrase: "Although"

Phrase: "insulin A-chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IC50 of 2 x 10-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the degradation of radiolabeled insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "comparable to that of intact insulin,"

Phrase: "insulin B-chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IC50 of 6 x 10-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "30 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "more potent than intact insulin"

Phrase: "and"

Phrase: "A-chain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.219: View larger version (25K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.220: Assessment of the proteolysis of insulin A-chain by endosomal acidic insulinase activity. 

Phrase: "Assessment of the proteolysis of insulin A-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1261322:Assessment [Health Care Activity]
   744   C1516048:Assessment [Activity]

Phrase: "by endosomal acidic insulinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.221: Endosomes were disrupted by hypotonic shock, and the soluble endosomal extract (ENs) was evaluated for its ability to degrade intact A-chain at pH 4 and 37 C. 

Phrase: "Endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "disrupted by hypotonic shock,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C0332454:Disrupted [Qualitative Concept]

Phrase: "and"

Phrase: "the soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "evaluated for its ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C0220825:Evaluated [Functional Concept]

Phrase: "degrade"

Phrase: "intact A-chain at pH 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0337112:Chain [Manufactured Object]
   753   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "37 C."
Processing 00000000.tx.222: In Panel A, ENs (1 ng) was incubated with 10-6 M insulin A-chain for 90 min. 

Phrase: "In Panel A,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "(1 ng)"

Phrase: "was"

Phrase: "incubated with 10-6 M insulin A-chain"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   770   C0439187:/10^6 [Quantitative Concept]
   770   C1881839:10^6 [Quantitative Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0337112:Chain [Manufactured Object]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1524075:Chain [Idea or Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "for 90 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.223: The proteolytic reaction was then stopped with acetic acid (15%) and the incubation mixture was analyzed by reverse-phase HPLC. 

Phrase: "The proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stopped with acetic acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: "and"

Phrase: "the incubation mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "analyzed by reverse-phase HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.224: Both panels show absorbance profiles at 214 nm. 

Phrase: "Both panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "absorbance profiles at 214 nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]
Processing 00000000.tx.225: Intact A-chain (upper panel) had an elution time of 23 min. 

Phrase: "Intact A-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "had"

Phrase: "an elution time of 23 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
Processing 00000000.tx.226: The endosomal proteins themselves did not give any detectable peak (results not shown). 

Phrase: "The endosomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "themselves"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "any detectable peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.227: The major degradation products (lower panel), numbered sequentially 16, were subjected to mass spectrometry analyses (see Table 2). 

Phrase: "The major degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "sequentially 16,"

Phrase: "were"

Phrase: "subjected to mass spectrometry analyses (see Table 2)."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0681850:Subject [Group]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.228: In Panel B, the rate of insulin A-chain (closed circles) and HI (dashed line) proteolysis was determined as described in Panel A by following the disappearance of the peak area corresponding to the parent peptide. 

Phrase: "In Panel B,"

Phrase: "the rate of insulin A-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "(closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "and"

Phrase: "HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "was"

Phrase: "determined"

Phrase: "as"

Phrase: "described in Panel A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441833:Panel [Idea or Concept]
   770   C1552738:described [Idea or Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]

Phrase: "by"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the disappearance of the peak area"

Phrase: "corresponding to the parent peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030551:parent [Family Group]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C2699423:Parent [Conceptual Entity]
Processing 00000000.tx.229: Results are expressed as peptide degraded (% of control) and normalized (100%) to that seen in the absence of added endosomal protein. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(%"

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "(100%"

Phrase: ")"

Phrase: "to that"

Phrase: "seen in the absence of added endosomal protein."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205397:Seen [Qualitative Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C1524062:Added [Functional Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   711 E C0042789:see [Organism Function]
   711 E C1883712:Add [Functional Concept]
   711 E C1947903:See [Activity]
Processing 00000000.tx.230: In Panel C, ENs (0.1 mg/ml) was incubated with [125I]TyrA14-HI (75 fmol) with the indicated concentrations of unlabeled A-chain (closed circles) or HI (dashed line). 

Phrase: "In Panel C,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "(0.1 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(75 fmol) with the indicated concentrations of unlabeled A-chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0439195:fmol [Quantitative Concept]

Phrase: "(closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "or"

Phrase: "HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.231: The amount of degraded radiolabeled insulin was determined by precipitation with TCA. 

Phrase: "The amount of degraded radiolabeled insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "determined by precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with TCA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.232: Results are expressed as a percentage of the amount of radioactive insulin degraded in the absence of unlabeled peptide.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as a percentage of the amount of radioactive insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0034553:radioactive [Natural Phenomenon or Process]
   739   C0439165:Percentage [Quantitative Concept]
   739   C1265611:Amount [Quantitative Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1549488:Percentage [Idea or Concept]
   739   C1561533:Percentage [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "degraded in the absence of unlabeled peptide."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.233: View larger version (26K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.234: Assessment of the proteolysis of insulin B-chain by endosomal acidic insulinase activity. 

Phrase: "Assessment of the proteolysis of insulin B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1261322:Assessment [Health Care Activity]
   744   C1516048:Assessment [Activity]

Phrase: "by endosomal acidic insulinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.235: Endosomes were disrupted by hypotonic shock, and the soluble endosomal extract (ENs) was evaluated for its ability to degrade intact B-chain at pH 4 and 37 C. 

Phrase: "Endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "disrupted by hypotonic shock,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C0332454:Disrupted [Qualitative Concept]

Phrase: "and"

Phrase: "the soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "evaluated for its ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C0220825:Evaluated [Functional Concept]

Phrase: "degrade"

Phrase: "intact B-chain at pH 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0337112:Chain [Manufactured Object]
   753   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "37 C."
Processing 00000000.tx.236: In Panel A, ENs (1 ng) was incubated with 10-6 M insulin B-chain for 2 min. 

Phrase: "In Panel A,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "(1 ng)"

Phrase: "was"

Phrase: "incubated with 10-6 M insulin B-chain"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   770   C0439187:/10^6 [Quantitative Concept]
   770   C1881839:10^6 [Quantitative Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0337112:Chain [Manufactured Object]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1524075:Chain [Idea or Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "for 2 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.237: The proteolytic reaction was then stopped with acetic acid (15%) and the incubation mixture was analyzed by reverse-phase HPLC. 

Phrase: "The proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stopped with acetic acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: "and"

Phrase: "the incubation mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "analyzed by reverse-phase HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.238: Both panels show absorbance profiles at 214 nm. 

Phrase: "Both panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "absorbance profiles at 214 nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]
Processing 00000000.tx.239: Intact B-chain (upper panel and peak 9 in lower panel) had an elution time of 47 min. 

Phrase: "Intact B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "peak 9 in lower panel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Panel [Idea or Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C0444505:Peak [Quantitative Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C1999270:Panel [Intellectual Product]
   760   C2003888:Lower [Activity]
   760   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "had"

Phrase: "an elution time of 47 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
Processing 00000000.tx.240: The endosomal proteins themselves did not give any detectable peak (results not shown). 

Phrase: "The endosomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "themselves"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "any detectable peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.241: The major degradation products (lower panel), numbered sequentially 18 as well as intact B-chain (peak 9), were subjected to mass spectrometry analyses (see Table 3). 

Phrase: "The major degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "sequentially 18"

Phrase: "as well as"

Phrase: "intact B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]

Phrase: "(peak 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "subjected to mass spectrometry analyses (see Table 3)."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0681850:Subject [Group]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.242: In Panel B, the rate of insulin B-chain (closed circles) and HI (dashed line) proteolysis was determined as described in Panel A by following the disappearance of the peak area corresponding to the parent peptide. 

Phrase: "In Panel B,"

Phrase: "the rate of insulin B-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "(closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "and"

Phrase: "HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "was"

Phrase: "determined"

Phrase: "as"

Phrase: "described in Panel A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441833:Panel [Idea or Concept]
   770   C1552738:described [Idea or Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]

Phrase: "by"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the disappearance of the peak area"

Phrase: "corresponding to the parent peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030551:parent [Family Group]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C2699423:Parent [Conceptual Entity]
Processing 00000000.tx.243: Results are expressed as peptide degraded (% of control) and normalized (100%) to that seen in the absence of added endosomal protein. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(%"

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "(100%"

Phrase: ")"

Phrase: "to that"

Phrase: "seen in the absence of added endosomal protein."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205397:Seen [Qualitative Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C1524062:Added [Functional Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   711 E C0042789:see [Organism Function]
   711 E C1883712:Add [Functional Concept]
   711 E C1947903:See [Activity]
Processing 00000000.tx.244: In Panel C, ENs (0.1 mg/ml) was incubated with [125I]TyrA14-HI (75 fmol) with the indicated concentrations of unlabeled B-chain (closed circles) or HI (dashed line). 

Phrase: "In Panel C,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "(0.1 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(75 fmol) with the indicated concentrations of unlabeled B-chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0439195:fmol [Quantitative Concept]

Phrase: "(closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "or"

Phrase: "HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.245: The amount of degraded radiolabeled insulin was determined by precipitation with TCA. 

Phrase: "The amount of degraded radiolabeled insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "determined by precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with TCA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.246: Results are expressed as a percentage of the amount of radioactive insulin degraded in the absence of unlabeled peptide.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as a percentage of the amount of radioactive insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0034553:radioactive [Natural Phenomenon or Process]
   739   C0439165:Percentage [Quantitative Concept]
   739   C1265611:Amount [Quantitative Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1549488:Percentage [Idea or Concept]
   739   C1561533:Percentage [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "degraded in the absence of unlabeled peptide."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.247: View larger version (26K): [in this window] [in a new window]  Figure 9. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 9."
Processing 00000000.tx.248: Assessment of the proteolysis of insulin ArgB22-AlaB30 B-chain fragment by endosomal acidic insulinase activity. 

Phrase: "Assessment of the proteolysis of insulin ArgB22-AlaB30 B-chain fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1261322:Assessment [Health Care Activity]
   738   C1516048:Assessment [Activity]

Phrase: "by endosomal acidic insulinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.249: Endosomes were disrupted by hypotonic shock, and the soluble endosomal extract (ENs) was evaluated for its ability to degrade the insulin ArgB22-AlaB30 B-chain fragment at pH 4 and 37 C. 

Phrase: "Endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "disrupted by hypotonic shock,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C0332454:Disrupted [Qualitative Concept]

Phrase: "and"

Phrase: "the soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "evaluated for its ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C0220825:Evaluated [Functional Concept]

Phrase: "degrade"

Phrase: "the insulin ArgB22-AlaB30 B-chain fragment at pH 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "37 C."
Processing 00000000.tx.250: In Panel A, ENs (1 ng) was incubated with 10-6 M ArgB22-AlaB30 fragment for 5 min. 

Phrase: "In Panel A,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "(1 ng)"

Phrase: "was"

Phrase: "incubated with 10-6 M ArgB22-AlaB30 fragment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0439187:/10^6 [Quantitative Concept]
   770   C1881839:10^6 [Quantitative Concept]
   744   C0332255:fragment [Functional Concept]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.251: The proteolytic reaction was then stopped with acetic acid (15%) and the incubation mixture was analyzed by reverse-phase HPLC. 

Phrase: "The proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stopped with acetic acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: "and"

Phrase: "the incubation mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "analyzed by reverse-phase HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.252: Both panels show absorbance profiles at 214 nm. 

Phrase: "Both panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "absorbance profiles at 214 nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]
Processing 00000000.tx.253: Intact ArgB22-AlaB30 peptide (upper panel and peak 5 in lower panel) had an elution time of 20 min. 

Phrase: "Intact ArgB22-AlaB30 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "peak 5 in lower panel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Panel [Idea or Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C0444505:Peak [Quantitative Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C1999270:Panel [Intellectual Product]
   760   C2003888:Lower [Activity]
   760   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "had"

Phrase: "an elution time of 20 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
Processing 00000000.tx.254: The endosomal proteins themselves did not give any detectable peak (results not shown). 

Phrase: "The endosomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "themselves"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "any detectable peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.255: The major degradation products (lower panel), numbered 14 and 6, as well as intact peptide (peak 5), were subjected to mass spectrometry analyses (see Table 4). 

Phrase: "The major degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "14"

Phrase: "and"

Phrase: "6,"

Phrase: "as well as"

Phrase: "intact peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(peak 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "subjected to mass spectrometry analyses (see Table 4)."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0681850:Subject [Group]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.256: In Panel B, the rate of ArgB22-AlaB30 (closed circles) and HI (dashed line) proteolysis was determined as described in Panel A by following the disappearance of the peak area corresponding to the parent peptide. 

Phrase: "In Panel B,"

Phrase: "the rate of ArgB22-AlaB30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "(closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "and"

Phrase: "HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "was"

Phrase: "determined"

Phrase: "as"

Phrase: "described in Panel A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441833:Panel [Idea or Concept]
   770   C1552738:described [Idea or Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]

Phrase: "by"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the disappearance of the peak area"

Phrase: "corresponding to the parent peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030551:parent [Family Group]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C2699423:Parent [Conceptual Entity]
Processing 00000000.tx.257: Results are expressed as peptide degraded (% of control) and normalized (100%) to that seen in the absence of added endosomal protein. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(%"

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "(100%"

Phrase: ")"

Phrase: "to that"

Phrase: "seen in the absence of added endosomal protein."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205397:Seen [Qualitative Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C1524062:Added [Functional Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   711 E C0042789:see [Organism Function]
   711 E C1883712:Add [Functional Concept]
   711 E C1947903:See [Activity]
Processing 00000000.tx.258: In Panel C, ENs (0.1 mg/ml) was incubated with [125I]TyrA14-HI (75 fmol) with the indicated concentrations of unlabeled ArgB22-AlaB30 fragment (closed circles) or HI (dashed line). 

Phrase: "In Panel C,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "(0.1 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(75 fmol) with the indicated concentrations of unlabeled ArgB22-AlaB30 fragment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0439195:fmol [Quantitative Concept]

Phrase: "(closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "or"

Phrase: "HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.259: The amount of degraded radiolabeled insulin was determined by precipitation with TCA. 

Phrase: "The amount of degraded radiolabeled insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "determined by precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with TCA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.260: Results are expressed as a percentage of the amount of radioactive insulin degraded in the absence of unlabeled peptide.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as a percentage of the amount of radioactive insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0034553:radioactive [Natural Phenomenon or Process]
   739   C0439165:Percentage [Quantitative Concept]
   739   C1265611:Amount [Quantitative Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1549488:Percentage [Idea or Concept]
   739   C1561533:Percentage [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "degraded in the absence of unlabeled peptide."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.261: These competition studies correlate with the results obtained from degradation studies using reverse-phase HPLC analysis (Figs. 7, A and B, and 8, A and B). 

Phrase: "These competition studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0679932:competition [Social Behavior]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "correlate with the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "obtained from degradation studies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   770   C0947630:studies [Laboratory Procedure]
   770   C1301820:Obtained [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1706701:Obtain [Activity]
   737 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "reverse-phase HPLC analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C2986798:Phase Analysis [Occupational Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "(Figs. 7,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "8,"

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.262: The rate of peptide hydrolysis was found to be low with A-chain (t1/2 53 min) and very high with B-chain (t1/2 < 3 min). 

Phrase: "The rate of peptide hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "low with A-chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]

Phrase: "(t1/2 53 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "very high with B-chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0442804:Very high [Finding]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "(t1/2 < 3 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]
Processing 00000000.tx.263: As indicated in Table 2, A-chain was cleaved at Gln15-Leu16 bond, thereby releasing the N-terminal peptide A115 (the major peak 5) and the C-terminal peptide A1621 (peak 3). 

Phrase: "As"

Phrase: "indicated in Table 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1444656:Indicated [Finding]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: "A-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "was"

Phrase: "cleaved at Gln15-Leu16 bond,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]

Phrase: "thereby"

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the N-terminal peptide A115"

Phrase: "("

Phrase: "the major peak 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205164:Major [Qualitative Concept]
   827   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the C-terminal peptide A1621"

Phrase: "(peak 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.264: Cleavages in close proximity to this site at LeuA13-TyrA14, TyrA14-GlnA15, LeuA16-GluA17 and GluA17-AsnA18 were also observed as evidenced by fragments A1821 (peak 1), A1721 (peak 2), A1421 (peak 4), A113 (peak 5), A1416 and A114 (peak 6). 

Phrase: "Cleavages in close proximity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0010813:cleavage [Cell Function]
   737   C0596311:Cleavage [Phenomenon or Process]
   737   C1330957:cleavage [Cell Function]

Phrase: "to this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "at LeuA13-TyrA14,"

Phrase: "TyrA14-GlnA15,"

Phrase: "LeuA16-GluA17"

Phrase: "and"

Phrase: "GluA17-AsnA18"

Phrase: "were"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "as"

Phrase: "evidenced by fragments A1821"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332255:fragments [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   737   C0332120:Evidence [Functional Concept]
   737 E C1708096:Fragment [Qualitative Concept]

Phrase: "(peak 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A1721"

Phrase: "(peak 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A1421"

Phrase: "(peak 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A113"

Phrase: "(peak 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A1416"

Phrase: "and"

Phrase: "A114"

Phrase: "(peak 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.265: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.266: Masses and assigned structures of the cleavage products generated from GA1-NA21 insulin A-chain peptide by endosomal acidic insulinase activity  Using insulin B-chain as substrate (Table 3), the peptide fragments B124 (peak 8) and B2530 (peak 1) were obtained, confirming a cleavage site between PheB24 and PheB25 residues. 

Phrase: "Masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0577559:Mass [Finding]
   966   C1306372:*Mass [Quantitative Concept]
   966   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "assigned structures of the cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "generated from GA1-NA21 insulin A-chain peptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0337112:Chain [Manufactured Object]
   744   C1524075:Chain [Idea or Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C3146294:Generated [Activity]

Phrase: "by endosomal acidic insulinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "insulin B-chain as substrate"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0337112:Chain [Manufactured Object]
   760   C1524075:Chain [Idea or Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the peptide fragments B124"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0030935:Peptide Fragments [Amino Acid, Peptide, or Protein]

Phrase: "(peak 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "B2530"

Phrase: "(peak 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "a cleavage site between PheB24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "PheB25 residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.267: Other products revealed cleavage sites in the central region of the B-chain between residues GluB13 and LeuB17 at GluB13-AlaB14 (peaks 3 and 7), AlaB14-LeuB15 (peaks 4 and 7), LeuB15-TyrB16 (peaks 5 and 6) and TyrB16-LeuB17 (peaks 5 and 6) bonds. 

Phrase: "Other products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "cleavage sites in the central region of the B-chain"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   741   C2827466:Central Site [Professional or Occupational Group]
   741   C2945843:Site of [Qualitative Concept]
   739   C0205145:Sites [Spatial Concept]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]

Phrase: "between residues GluB13"

Phrase: "and"

Phrase: "LeuB17 at GluB13-AlaB14"

Phrase: "(peaks 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "AlaB14-LeuB15"

Phrase: "(peaks 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "LeuB15-TyrB16"

Phrase: "(peaks 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: ")"

Phrase: "and"

Phrase: "TyrB16-LeuB17"

Phrase: "(peaks 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: ")"

Phrase: "bonds."
Processing 00000000.tx.268: These data suggest that the areas A1516, B1317 and B2425 contain residues important for the binding of insulin and the individual A- and B-chains to EAI, as well as their subsequent hydrolysis by the enzyme. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the areas A1516,"

Phrase: "B1317"

Phrase: "and"

Phrase: "B2425"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "important for the binding of insulin"

Phrase: "and"

Phrase: "the individual A-"

Phrase: "and"

Phrase: "B-chains to EAI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0337112:chains [Manufactured Object]
   753   C1524075:Chains [Idea or Concept]

Phrase: "as well as"

Phrase: "their subsequent hydrolysis by the enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020291:Hydrolysis [Natural Phenomenon or Process]
Processing 00000000.tx.269: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.270: Masses and assigned structures of the cleavage products generated from FB1AB30 insulin B-chain peptide by endosomal acidic insulinase activity  Proteolysis of the C-terminal nonapeptide of the insulin B-chain by endosomal acidic insulinase The results presented thus far established that the insulin B-chain represents a high affinity substrate for EAI. 

Phrase: "Masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0577559:Mass [Finding]
   966   C1306372:*Mass [Quantitative Concept]
   966   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "assigned structures of the cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "generated from FB1AB30 insulin B-chain peptide"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   774   C0070338:peptide B [Amino Acid, Peptide, or Protein]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0337112:Chain [Manufactured Object]
   748   C1524075:Chain [Idea or Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3146294:Generated [Activity]

Phrase: "by endosomal acidic insulinase activity  Proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0597304:Proteolysis [Molecular Function]
   733 E C1947941:proteolytic [Enzyme]

Phrase: "of the C-terminal nonapeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "of the insulin B-chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by endosomal acidic insulinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "thus far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "the insulin B-chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a high affinity substrate for EAI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.271: We next looked for the structural requirements of this molecular interaction. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "looked for the structural requirements of this molecular interaction."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1167622:Molecular Interaction [Molecular Function]
   742   C0678594:Structural [Spatial Concept]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1704675:Interaction [Functional Concept]
   708   C0233426:look [Organism Attribute]
   708   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.272: Therefore, we used as a substrate the C-terminus B2230 B-chain fragment, which comprises the major initial site of cleavage of the entire insulin molecule, i.e. the PheB24-PheB25 peptide bond (Fig. 9). 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "used as a substrate"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C1710236:Substrate [Manufactured Object]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "the C-terminus B2230 B-chain fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the major initial site of cleavage of the entire insulin molecule,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C2945843:Site of [Qualitative Concept]
   738   C0205145:Site [Spatial Concept]
   738   C1515974:Site [Body Location or Region]
   738   C2825164:Site [Spatial Concept]
   718   C0596968:molecular site [Functional Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the PheB24-PheB25 peptide bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.273: The B2230 peptide was found to inhibit the degradation of radiolabeled insulin by ENs in a dose-dependent manner, similar to that of the intact B-chain (IC50 of 8 x 10-7 M) (Fig. 9C compare to Fig. 8C), indicating that the C-terminal region of the B-chain is essential for the high-affinity binding of insulin to EAI. 

Phrase: "The B2230 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the degradation of radiolabeled insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "by ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "in a dose-dependent manner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "similar to that of the intact B-chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "(IC50 of 8 x 10-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0600495:IC50 [Quantitative Concept]

Phrase: "M) ("

Phrase: "Fig. 9C"

Phrase: "compare to Fig. 8C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   770   C1707455:Compare [Activity]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the C-terminal region of the B-chain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0017446:Region [Geographic Area]
   744   C0205088:Terminal [Temporal Concept]
   744   C0205147:Region [Spatial Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]

Phrase: "is"

Phrase: "essential for the high-affinity binding of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205224:Essential [Qualitative Concept]

Phrase: "to EAI."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]
Processing 00000000.tx.274: The fragmentation of the B2230 peptide by ENs as evaluated by HPLC revealed that the endosomal protease degraded the B2230 fragment two times faster than that observed for intact insulin (Fig. 9, A and B). 

Phrase: "The fragmentation of the B2230 peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332472:Fragmentation [Anatomical Abnormality]
   753   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "by ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417023:ENS [Gene or Genome]

Phrase: "as"

Phrase: "evaluated by HPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the endosomal protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "the B2230 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "two times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1948050:Two Times [Quantitative Concept]
   861   C0040223:times [Temporal Concept]
   861   C0205448:Two [Quantitative Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "faster than that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0015663:Fast [Finding]
   756   C0456962:Fast [Qualitative Concept]

Phrase: "observed for intact insulin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0205266:Intact [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1554187:Intact [Idea or Concept]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Fig. 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.275: Five major intermediates were produced from the parent B2230 peptide (peak 5), one of which (peak 4) accounted for more than 50% of the cleavage products, suggesting that it represents the major processed form of the C-terminus B-chain. 

Phrase: "Five major intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "were"

Phrase: "produced from the parent B2230 peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030551:parent [Family Group]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C2699423:Parent [Conceptual Entity]

Phrase: "(peak 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "(peak 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "accounted for more"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1551359:account [Idea or Concept]
   756   C2741673:Account # [Clinical Attribute]
   756   C2981730:Account [Classification]

Phrase: "than 50%"

Phrase: "of the cleavage products,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the major processed form of the C-terminus B-chain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]
Processing 00000000.tx.276: Mass spectrometry analysis (Table 4) revealed that the B2230 fragment was cleaved at the PheB24-PheB25, PheB25-TyrB26 and TyrB26-ProB27 bonds as was observed with the entire insulin molecule (see Fig. 3). 

Phrase: "Mass spectrometry analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the B2230 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cleaved at the PheB24-PheB25,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]

Phrase: "PheB25-TyrB26"

Phrase: "and"

Phrase: "TyrB26-ProB27 bonds"

Phrase: "as"

Phrase: "was"

Phrase: "observed with the entire insulin molecule"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0439751:Entire [Quantitative Concept]
   753   C0444667:Entire [Quantitative Concept]
   753   C0567416:Molecule [Substance]
   753   C1441672:Observed [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.277: We found three N-terminally truncated forms of the B2230 peptide (peak 1 (B2730), peak 2 (B2630), and peak 4 (B2530)], of which one, the B2530 product represented the major intermediate. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "three N-terminally truncated forms of the B2230 peptide"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   708 E C1522492:Form [Functional Concept]

Phrase: "(peak 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(B2730"

Phrase: ")"

Phrase: ","

Phrase: "peak 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(B2630"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "peak 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(B2530"

Phrase: ")"

Phrase: "],"

Phrase: "of which one,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "the B2530 product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the major intermediate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205103:Intermediate [Spatial Concept]
   861   C1550465:intermediate [Idea or Concept]
   861   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.278: Peaks 3 and 6 corresponded to the remaining N-terminal residues of the above peptide products. 

Phrase: "Peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "6"

Phrase: "corresponded to the remaining N-terminal residues of the above peptide products."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   736   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   736   C0205088:Terminal [Temporal Concept]
   736   C1514468:Products [Entity]
   736   C1527428:Remaining [Qualitative Concept]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   703 E C1704444:Product [Quantitative Concept]
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.279: View this table: [in this window] [in a new window]  Table 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.280: Masses and assigned structures of the cleavage products generated from the C-terminal RB22AB30 insulin B-chain fragment by endosomal acidic insulinase activity  In vitro endosome-lysosome transfer of HI and the H2-analog molecules Using the in situ liver model system for endosome-lysosome fusion (29, 30), we examined the subcellular distribution of the [125I]TyrA14-H2-analog associated with the LPS fraction over time as compared with that of wild-type [125I]TyrA14-HI (Fig. 10). 

Phrase: "Masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0577559:Mass [Finding]
   966   C1306372:*Mass [Quantitative Concept]
   966   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "assigned structures of the cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "generated from the C-terminal RB22AB30 insulin B-chain fragment"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   782   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   760   C1707271:C-Terminal [Amino Acid Sequence]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0205088:Terminal [Temporal Concept]
   739   C0332255:fragment [Functional Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C1524075:Chain [Idea or Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]
   739   C3146294:Generated [Activity]

Phrase: "by endosomal acidic insulinase activity  In vitro endosome-lysosome transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0040671:Transfer [Mental Process]
   791   C1705822:Transfer [Activity]

Phrase: "of HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the H2-analog molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the in situ liver model system for endosome-lysosome fusion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0026339:Model System [Intellectual Product,Research Device]
   760   C3161035:Model System [Intellectual Product]
   739   C0449913:System [Functional Concept]
   739   C1553451:System [Manufactured Object]
   739   C1704459:System [Medical Device]

Phrase: "(29,"

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the subcellular distribution of the [125I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "]TyrA14-H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "associated with the LPS fraction"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0023810:LPS [Lipid]
   760   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C2697656:LPS [Gene or Genome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "as"

Phrase: "compared with that of wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "[125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.281: Rats were administered an iv injection of radiolabeled HI or H2-analog (Fig. 10B) and killed 10 min after injection when most of the ligand would be located in the endosomes (7). 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "an iv injection of radiolabeled HI"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0199782:Injection of insulin [Therapeutic or Preventive Procedure]
           Insulin injection
   778   C0021494:IV injection [Functional Concept]
   774   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1828121:Injection [Functional Concept]

Phrase: "or"

Phrase: "H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "(Fig. 10B"

Phrase: ")"

Phrase: "and"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "10 min after injection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "when"

Phrase: "most of the ligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0023688:Ligand [Chemical]
   770   C0205393:Most [Quantitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "located in the endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034850:Endosomes [Cell Component]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.282: Analytical subfractionation on Nycodenz gradients of the LPS fractions prepared from these livers showed that both radioactive ligands appeared in a single broad peak of density 1.061.105 g/ml, which coincided with the Golgi marker galactosyltransferase and the endosomal procathepsin B enzyme, and was clearly distinguishable from the peak of activity of the lysosomal enzyme markers acid phosphatase and mature cathepsin B (Fig. 10A). 

Phrase: "Analytical subfractionation on Nycodenz gradients of the LPS fractions"

Phrase: "prepared from these livers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0023884:Livers [Body Part, Organ, or Organ Component]
   737 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   737 E C1278929:Liver [Body Part, Organ, or Organ Component]
   737   C1521827:Prepare [Functional Concept]
   737 E C2346688:LIVER [Food]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both radioactive ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligands [Chemical]

Phrase: "appeared in a single broad peak"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0332464:Broad [Spatial Concept]
   753   C0444505:Peak [Quantitative Concept]
   719   C0700364:APPEAR [Qualitative Concept]

Phrase: "of density 1.061.105 g/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1300565:g/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "which"

Phrase: "coincided with the Golgi marker galactosyltransferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0005516:Marker [Clinical Attribute]
   753   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0018042:Golgi [Cell Component]
   753   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the endosomal procathepsin B enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "clearly distinguishable from the peak of activity of the lysosomal enzyme markers acid phosphatase"

Phrase: "and"

Phrase: "mature cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332804:CATHEPSIN B [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 10A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553642:10a [Medical Device]

Phrase: ")."
Processing 00000000.tx.283: Analysis of the LPS fractions after a 15 and 30 min incubation at 37 C in the presence of ATP and an ATP-regenerating system showed that 21 and 20%, respectively, of labeled HI and 25 and 41%, respectively, of labeled H2-analog had moved to a peak density 1.111.14 g/ml coinciding with the peak for the lysosomal enzyme markers (see Fig. 10A). 

Phrase: "Analysis of the LPS fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "after a 15"

Phrase: "and"

Phrase: "30 min incubation at 37 C in"

Phrase: "the presence of ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "an ATP-regenerating system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that 21"

Phrase: "and"

Phrase: "20%,"

Phrase: "respectively,"

Phrase: "of labeled HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "25"

Phrase: "and"

Phrase: "41%,"

Phrase: "respectively,"

Phrase: "of labeled H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "had"

Phrase: "moved to a peak density 1.111.14 g/ml coinciding"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   756   C1299988:Moved to [Functional Concept]
           moved
   756   C1300565:g/mL [Quantitative Concept]
   754   C0060902:G 111 [Organic Chemical,Pharmacologic Substance]
   754   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   754 E C1637390:mL/g [Quantitative Concept]
   738   C0178587:density [Quantitative Concept]
   738   C0439267:g% [Quantitative Concept]
   738   C0439526:/mL [Quantitative Concept]
   738   C0444505:Peak [Quantitative Concept]
   738   C1269909:moved [Functional Concept]
   738   C2699029:Moved [Activity]
   704 E C0560560:move [Organism Function]
   704 E C0578671:move [Finding]

Phrase: "with the peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "for the lysosomal enzyme markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0005516:Marker [Clinical Attribute]
   734   C0391845:Lysosomal enzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 10A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553642:10a [Medical Device]

Phrase: ")."
Processing 00000000.tx.284: Whereas a high rate of transfer to the soluble cytosolic pool (density < 1.06 g/ml) was observed after [125I]TyrA14-HI administration (41 and 51% of total radioactivity recovered after a 15 and 30 min incubation, respectively), only moderate amounts of [125I]TyrA14-H2 analog were recovered at the top of the gradient (22% of total radioactivity after a 30 min incubation). 

Phrase: "Whereas"

Phrase: "a high rate of transfer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205250:High [Qualitative Concept]
   760   C0871208:Rate [Activity]
   760   C1299351:High [Qualitative Concept]
   760   C1521828:Rate [Quantitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "to the soluble cytosolic pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0337051:Pool [Geographic Area]
   827   C1509144:pool [Clinical Attribute]
   827   C2349200:Pool [Functional Concept]

Phrase: "(density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "< 1.06 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "observed after"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1441672:Observed [Functional Concept]

Phrase: "[125I"

Phrase: "]TyrA14-HI administration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0199782:insulin administration [Therapeutic or Preventive Procedure]
   812   C0001554:Administration [Occupational Activity]
   812   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "(41"

Phrase: "and"

Phrase: "51% of total radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034553:Radioactivity [Natural Phenomenon or Process]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]

Phrase: "recovered after a 15"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0521108:recovered [Qualitative Concept]
   737 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "30 min incubation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "only moderate amounts of [125I"

Phrase: "]TyrA14-H2 analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "were"

Phrase: "recovered at the top of the gradient"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0439182:% gradient [Quantitative Concept]
   748   C0521108:recovered [Qualitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1704458:Top [Spatial Concept]
   714 E C2004454:recover [Organism Function]

Phrase: "(22% of total radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034553:Radioactivity [Natural Phenomenon or Process]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]

Phrase: "after a 30 min incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.285: The data suggest that the endo-lysosomal compartment extraluminally released HI intermediates at a higher rate than the H2-analog. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the endo-lysosomal compartment extraluminally released HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   818   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "intermediates at a higher rate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205103:Intermediate [Spatial Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   760   C1550465:intermediate [Idea or Concept]
   760   C2827755:INTERMEDIATE [Laboratory or Test Result]
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than the H2-analog."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]
Processing 00000000.tx.286: The endo-lysosomal transfer of the internalized HI and H2-analog was energy-dependent as it required ATP and an ATP-regenerating system (results not shown). 

Phrase: "The endo-lysosomal transfer of the internalized HI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0040671:Transfer [Mental Process]
   742   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "was"

Phrase: "energy-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "as"

Phrase: "it"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "ATP"

Phrase: "and"

Phrase: "an ATP-regenerating system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.287: Moreover, it was not due to nonspecific aggregation of organelles during incubation of LPS supernatants because no major change in the density distribution of marker enzymes was observed during the fusion process (see Fig. 10A). 

Phrase: "Moreover,"

Phrase: "it"

Phrase: "was"

Phrase: "not due to nonspecific aggregation of organelles"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0029219:Organelles [Cell Component]
   748   C0205370:Non-specific [Qualitative Concept]
   748   C0332621:Aggregation [Functional Concept]
   748   C0439168:% aggregation [Quantitative Concept]
   748   C0750540:Nonspecific [Idea or Concept]
   748   C1518422:Not [Functional Concept]
   748   C3146286:Due [Idea or Concept]

Phrase: "during incubation"

Phrase: "of LPS supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "because"

Phrase: "no major change in the density distribution of marker enzymes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0442739:No change [Finding]
   757   C0541594:change density [Qualitative Concept]
   757   C1548568:No change [Intellectual Product]
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "observed during the fusion process"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332466:Fusion [Functional Concept]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]
   760   C1441672:Observed [Functional Concept]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 10A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553642:10a [Medical Device]

Phrase: ")."
Processing 00000000.tx.288: View larger version (29K): [in this window] [in a new window]  Figure 10. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 10."
Processing 00000000.tx.289: Time course of transfer of [125I]TyrA14-HI and [125I]TyrA14-H2-analog from the endosomal to the lysosomal position on Nycodenz gradients. 

Phrase: "Time course of transfer of [125I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449247:Time course [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "125I"

Phrase: "]TyrA14-H2-analog from the endosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243071:Analog [Chemical Viewed Structurally]

Phrase: "to the lysosomal position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "on Nycodenz gradients."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0812409:gradients [Quantitative Concept]
   827 E C0439182:% gradient [Quantitative Concept]
Processing 00000000.tx.290: In Panel A, the postmitochondrial supernatant (LPS fraction) was isolated from control rats and immediately subfractionated on linear Nycodenz density gradients (open symbols), or incubated with ATP and an ATP-regenerating system at 37 C for 30 min followed by subfractionation on linear Nycodenz density gradients (closed symbols). 

Phrase: "In Panel A,"

Phrase: "the postmitochondrial supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "(LPS fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "isolated from control rats"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "subfractionated on linear Nycodenz density gradients"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0178587:density [Quantitative Concept]
   753   C0205132:Linear [Spatial Concept]
   753   C0729204:Nycodenz [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0812409:gradients [Quantitative Concept]
   719 E C0439182:% gradient [Quantitative Concept]

Phrase: "(open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "incubated with ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "an ATP-regenerating system at 37 C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by subfractionation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "on linear Nycodenz density gradients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0178587:density [Quantitative Concept]
   812   C0812409:gradients [Quantitative Concept]
   779 E C0439182:% gradient [Quantitative Concept]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "(closed symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.291: Galactosyltransferase (GT; circles) and acid phosphatase (AP; squares) activities were determined and results expressed as a percentage of total enzymatic activity recovered. 

Phrase: "Galactosyltransferase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(GT"

Phrase: "; circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "and"

Phrase: "acid phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001109:Acid Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001128:Acid [Chemical]
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0202406:Acid [Laboratory Procedure]
   861   C1149880:phosphatase [Molecular Function]

Phrase: "(AP"

Phrase: "; squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205120:Square [Spatial Concept]
   966   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: "activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "expressed as a percentage of total enzymatic activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C2267219:Enzymatic Activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0441655:Activity [Activity]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "recovered."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]
Processing 00000000.tx.292: The inset shows the content of procathepsin B (p-CB) and mature cathepsin B (CB) evaluated by immunoblotting with polyclonal antirat procathepsin B. 

Phrase: "The inset"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the content of procathepsin B (p-CB)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "mature cathepsin B (CB)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332804:CATHEPSIN B [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "evaluated by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "with polyclonal antirat procathepsin B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0072033:procathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.293: Twenty microliters of each subfraction were loaded onto each lane. 

Phrase: "Twenty microliters of each subfraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439243:microliter [Quantitative Concept]

Phrase: "were"

Phrase: "loaded onto each lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.294: In Panel B, LPS fractions were isolated 10 min after rats were injected with [125I]TyrA14-HI (2 x 107 cpm; open symbols) or -H2-analog (2 x 107 cpm; closed symbols). 

Phrase: "In Panel B,"

Phrase: "LPS fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "10 min after rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "were"

Phrase: "injected with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1720154:Inject [Functional Concept]

Phrase: "[125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2 x 107 cpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0653998:2-CPM [Organic Chemical,Pharmacologic Substance]

Phrase: "; open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "or -H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "(2 x 107 cpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0653998:2-CPM [Organic Chemical,Pharmacologic Substance]

Phrase: "; closed symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.295: LPS fractions were incubated with ATP and an ATP-regenerating system at 4 C for 30 min (circles), or 37 C for 15 min (squares), or 37 C for 30 min (triangles). 

Phrase: "LPS fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "incubated with ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "an ATP-regenerating system at 4 C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "for 30 min (circles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1282913:Circle [Spatial Concept]
   793   C1551714:Circle [Population Group]
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "37 C for 15 min (squares"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "37 C for 30 min (triangles"

Phrase: ")."
Processing 00000000.tx.296: Results are expressed as percentages of the total radiolabel on the gradient. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as percentages of the total radiolabel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   714   C0439165:Percentage [Quantitative Concept]
   714   C1549488:Percentage [Idea or Concept]
   714   C1561533:Percentage [Idea or Concept]

Phrase: "on the gradient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]
Processing 00000000.tx.297: In Panel C, LPS fractions were isolated 10 min after rats were injected with [125I]TyrA14-HI (2 x 107 cpm; open symbols) or -H2-analog (2 x 107 cpm; closed symbols). 

Phrase: "In Panel C,"

Phrase: "LPS fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "10 min after rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "were"

Phrase: "injected with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1720154:Inject [Functional Concept]

Phrase: "[125I"

Phrase: "]TyrA14-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2 x 107 cpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0653998:2-CPM [Organic Chemical,Pharmacologic Substance]

Phrase: "; open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "or -H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "(2 x 107 cpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0653998:2-CPM [Organic Chemical,Pharmacologic Substance]

Phrase: "; closed symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.298: LPS fractions were incubated with ATP and an ATP-regenerating system at 4 C for 30 min (circles) or 37 C for 15 min (squares), or 37 C for 30 min (triangles). 

Phrase: "LPS fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "incubated with ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "an ATP-regenerating system at 4 C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "for 30 min (circles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1282913:Circle [Spatial Concept]
   793   C1551714:Circle [Population Group]
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: ")"

Phrase: "or"

Phrase: "37 C for 15 min (squares"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "37 C for 30 min (triangles"

Phrase: ")."
Processing 00000000.tx.299: The amount of degraded radiolabeled ligand was determined by precipitation with TCA.  

Phrase: "The amount of degraded radiolabeled ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "determined by precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with TCA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.300: To evaluate the contribution of endosomal and lysosomal components to the radiolabeled ligand degradation, the integrity of the ligands was assessed by precipitation with TCA (Fig. 10C), an assay which underestimates actual degradation but is convenient and rapid. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the contribution of endosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "lysosomal components to the radiolabeled ligand degradation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "the integrity of the ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "assessed by precipitation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1516048:Assessed [Activity]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with TCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(Fig. 10C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422424:10C [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "an assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "which"

Phrase: "underestimates"

Phrase: "actual degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "but"

Phrase: "is"

Phrase: "convenient"

Phrase: "and"

Phrase: "rapid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]
Processing 00000000.tx.301: When the LPS fraction was kept at 4 C, the degradation of HI was low in high density lysosomal components (density 1.111.14 g/ml; 23%), moderate in low density endocytic structures (density 1.061.105 g/ml; 33%) and high in the soluble cytosolic pool (density < 1.06 g/ml; 74%). 

Phrase: "When"

Phrase: "the LPS fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "kept at 4 C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0333118:Keep [Functional Concept]

Phrase: "the degradation of HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "low in high density lysosomal components"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1550472:low [Idea or Concept]

Phrase: "(density 1.111.14 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1300565:g/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "; 23%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "moderate in low density endocytic structures"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0178587:density [Quantitative Concept]
   753   C0205081:Moderate [Qualitative Concept]
   753   C0205251:low [Qualitative Concept]
   753   C0678594:structures [Spatial Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1550472:low [Idea or Concept]
   753   C1881878:Moderate [Qualitative Concept]

Phrase: "(density 1.061.105 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1300565:g/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "; 33%"

Phrase: ")"

Phrase: "and"

Phrase: "high in the soluble cytosolic pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "(density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "< 1.06 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "; 74%"

Phrase: ")."
Processing 00000000.tx.302: Incubation at 37 C produced an increase in acid-soluble radioactivity recovered at the top of the gradient (89% TCA-soluble radioactivity) suggesting that small size breakdown products diffused out of the membrane endo-lysosomal compartment. 

Phrase: "Incubation at 37 C"

Phrase: "produced"

Phrase: "an increase in acid-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "recovered at the top of the gradient"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0439182:% gradient [Quantitative Concept]
   748   C0521108:recovered [Qualitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1704458:Top [Spatial Concept]
   714 E C2004454:recover [Organism Function]

Phrase: "(89% TCA-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that small size breakdown products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "diffused out of the membrane endo-lysosomal compartment."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   798   C0230812:Membrane of the Lysosome [Cell Component]
           Lysosomal membrane
           Membrane of lysosome
   766   C2330755:Compartment of lysosome [Body Space or Junction]
   744   C0012222:Diffused [Natural Phenomenon or Process]
   744   C0014175:Endo [Disease or Syndrome]
   744   C0025255:Membrane [Tissue]
   744   C0439787:Out [Spatial Concept]
   744   C0521450:Lysosomal [Body Location or Region]
   744   C0596901:Membrane [Cell Component]
   744   C0849355:Out [Qualitative Concept]
   744   C1185625:Compartment [Body Space or Junction]
   744   C1427293:ENDO [Gene or Genome]
   744   C1706182:Membrane [Manufactured Object]
   744   C2986730:Compartment [Spatial Concept]
   711 E C0205219:Diffuse [Qualitative Concept]
Processing 00000000.tx.303: However, whereas the degradation state of the H2-analog in the soluble cytosolic fractions was comparable to that of HI, the amount of degraded H2-analog did not exceed 14% within endocytic structures and 10% within the lysosomal compartment (Fig. 10C). 

Phrase: "However,"

Phrase: "whereas"

Phrase: "the degradation state of the H2-analog"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]

Phrase: "in the soluble cytosolic fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "comparable to that of HI,"

Phrase: "the amount of degraded H2-analog"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exceed"

Phrase: "14% within endocytic structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "10% within the lysosomal compartment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0521450:Lysosomal [Body Location or Region]
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "(Fig. 10C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422424:10C [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.304: As previously reported by us (29), the release of TCA-soluble radioactivity at the top of the gradients which accompanied the endosomal proteolysis of HI was greatly reduced when LPS fractions were incubated at 37 C without ATP and an ATP-regenerating system (results not shown).  

Phrase: "As"

Phrase: "previously"

Phrase: "reported by us (29"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C1709908:Reported By [Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the release of TCA-soluble radioactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "at the top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "of the gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0812409:gradients [Quantitative Concept]
   966 E C0439182:% gradient [Quantitative Concept]

Phrase: "which"

Phrase: "accompanied"

Phrase: "the endosomal proteolysis of HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "was"

Phrase: "greatly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "when"

Phrase: "LPS fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "without ATP"

Phrase: "and"

Phrase: "an ATP-regenerating system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.305: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  This is the first study using rat endosomal acidic insulinase (rat EAI) in which the products of native HI and HI-analog peptides have been isolated and the amino acid sequence of the portions of the A- and B-chains determined by mass spectrometry. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This"

Phrase: "is"

Phrase: "the first study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rat endosomal acidic insulinase (rat EAI) in which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1415875:INSULINASE [Gene or Genome]

Phrase: "the products of native HI"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   809   C0795635:Human insulin product [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   783   C0021641:insulin products [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "HI-analog peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "been"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "the amino acid sequence of the portions of the A-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0202406:Acid [Laboratory Procedure]
   739   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "B-chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: "determined by mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.306: Proteolysis of HI by EAI results in one cleavage in the A-chain and eight in the B-chain. 

Phrase: "Proteolysis of HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]

Phrase: "by EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "results in one cleavage"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0010813:cleavage [Cell Function]
   770   C0205447:One [Quantitative Concept]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1274040:Result [Functional Concept]
   770   C1330957:cleavage [Cell Function]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in the A-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "eight in the B-chain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205454:Eight [Quantitative Concept]
   760   C0337112:Chain [Manufactured Object]
   760   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.307: The endosomal protease cleaves the A-chain at the GlnA15-LeuA16 bond. 

Phrase: "The endosomal protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "cleaves"

Phrase: "the A-chain at the GlnA15-LeuA16 bond."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0337112:Chain [Manufactured Object]
   744   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.308: The eight B-chain cleavages occur in two main regions of the polypeptide, one comprising the C-terminus part ArgB22-ThrB27 (5 sites) and the second appearing in the central region GluB13-LeuB17 (3 sites). 

Phrase: "The eight B-chain cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0010813:cleavage [Cell Function]
   779   C0596311:Cleavage [Phenomenon or Process]
   779   C1330957:cleavage [Cell Function]

Phrase: "occur in two main regions of the polypeptide,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0205225:Main [Qualitative Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   744   C1542147:Main [Qualitative Concept]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]
   711   C0017446:Region [Geographic Area]
   711   C0205147:Region [Spatial Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "comprising"

Phrase: "the C-terminus part ArgB22-ThrB27"

Phrase: "(5 sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the second appearing in the central region GluB13-LeuB17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0700364:APPEAR [Qualitative Concept]

Phrase: "(3 sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.309: The degradation steps proceed via an ordered sequential pathway: 1) two primary end products of HI degradation are generated resulting from a major cleavage at residues PheB24-PheB25 and a minor cleavage at residues PheB25-TyrB26; 

Phrase: "The degradation steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "proceed via an ordered sequential pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C1548958:Sequential [Idea or Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705176:Ordered [Qualitative Concept]
   753   C1705178:Ordered [Activity]
   753   C1705294:Sequential [Qualitative Concept]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "two primary end products of HI degradation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   782   C0795635:Human insulin product [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   767   C0021641:insulin products [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0444930:End [Spatial Concept]
   744   C1514468:Products [Entity]
   744   C2746065:End [Temporal Concept]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "are"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "resulting from a major cleavage"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0010813:cleavage [Cell Function]
   760   C0205164:Major [Qualitative Concept]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C0678226:resulting [Functional Concept]
   760   C1330957:cleavage [Cell Function]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "at residues PheB24-PheB25"

Phrase: "and"

Phrase: "a minor cleavage at residues PheB25-TyrB26"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: ";"
Processing 00000000.tx.310: 2) this is followed by the sequential removal of the C-terminal PheB24 and GlyB23 with the concomitant release of residues AlaB14, LeuB15 and TyrB16 from the central region of the B-chain; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "this"

Phrase: "is"

Phrase: "followed by the sequential removal of the C-terminal PheB24"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0332283:Followed by [Temporal Concept]
           followed
   760   C1707271:C-Terminal [Amino Acid Sequence]
   739   C0015252:Removal [Therapeutic or Preventive Procedure]
   739   C0205088:Terminal [Temporal Concept]
   739   C0728940:Removal [Therapeutic or Preventive Procedure]
   739   C1548958:Sequential [Idea or Concept]
   739   C1705294:Sequential [Qualitative Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   706 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "GlyB23 with the concomitant release of residues AlaB14,"

Phrase: "LeuB15"

Phrase: "and"

Phrase: "TyrB16 from the central region of the B-chain"

Phrase: ";"
Processing 00000000.tx.311: and 3) the A-chain is then processed by one cleavage, which occurs at GlnA15-LeuA16. 

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "the A-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "is"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "processed by one cleavage,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0010813:cleavage [Cell Function]
   770   C0205447:One [Quantitative Concept]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   770   C1522240:Processed [Phenomenon or Process]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "occurs at GlnA15-LeuA16."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.312: Comparison of the nine bonds in the HI molecule hydrolyzed by EAI reveals that three have aromatic (Phe and Tyr) and four have hydrophobic residues (Leu and Ala) on their carboxyl side. 

Phrase: "Comparison of the nine bonds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "in the HI molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]
   734   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "hydrolyzed by EAI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001128:Acidic [Chemical]
   760   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1415875:INSULINASE [Gene or Genome]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "have"

Phrase: "aromatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0772162:Aromatic [Organic Chemical,Pharmacologic Substance]

Phrase: "(Phe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phe [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1421250:TYR [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "have"

Phrase: "hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(Leu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Ala) on their carboxyl side."
Processing 00000000.tx.313: In contrast, the residues identified on the amino side of the hydrolyzed bonds (aromatic, hydrophobic, hydrophilic, basic and acid amino acids) do not reveal any definite structural requirement for the enzyme. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "identified on the amino side of the hydrolyzed bonds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205396:Identified [Qualitative Concept]
   742   C0441987:Side [Spatial Concept]
   742   C1550043:Identified [Finding]
   742   C1551388:Identified [Functional Concept]

Phrase: "(aromatic, hydrophobic, hydrophilic, basic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1527178:Basic [Functional Concept]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "and"

Phrase: "acid amino acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   964   C0815040:Amino Acids, Acidic [Amino Acid, Peptide, or Protein]
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]

Phrase: ")"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "any definite structural requirement for the enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.314: However, the finding that HI is primarily cleaved at the most hydrophobic peptide bonds PheB24-PheB25-TyrB26 is still consistent with a preference for nonpolar aromatic amino acid residues on the amino side. 

Phrase: "However,"

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "primarily"

Phrase: "cleaved at the most hydrophobic peptide bonds PheB24-PheB25-TyrB26"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   741   C0683120:hydrophobic bond [Natural Phenomenon or Process]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0205242:Cleaved [Spatial Concept]
   739   C0333853:Cleaved [Cell]
   739   C0598629:Hydrophobic [Qualitative Concept]
   726   C0678595:peptide bond [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "still consistent with a preference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for nonpolar aromatic amino acid residues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]
   717   C0301713:Amino Acid, Aromatic [Amino Acid, Peptide, or Protein]

Phrase: "on the amino side."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]
Processing 00000000.tx.315: Thus, endosomal insulinase might preferentially catalyze the hydrolysis of bonds that have an aromatic or hydrophobic amino acid residue on both the carboxyl and amino sides but it can also tolerate other residues on the amino side. 

Phrase: "Thus,"

Phrase: "endosomal insulinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULINASE [Gene or Genome]

Phrase: "might"

Phrase: "preferentially"

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "the hydrolysis of bonds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "that"

Phrase: "have"

Phrase: "an aromatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0772162:Aromatic [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "hydrophobic amino acid residue on both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "the carboxyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596260:Carboxyl [Organic Chemical]

Phrase: "and"

Phrase: "amino sides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441987:Side [Spatial Concept]

Phrase: "but"

Phrase: "it"

Phrase: "can"

Phrase: "also"

Phrase: "tolerate"

Phrase: "other residues on the amino side."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.316: Previous studies described the use of monoiodinated insulins and radio-sequencing procedures to identify on the sequenator the tyrosyl residue at which the radioactivity came off (32, 33). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "the use of monoiodinated insulins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1524063:Use of [Functional Concept]
   781   C0240016:INSULIN USE [Finding]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "radio-sequencing procedures to"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0025664:procedures [Intellectual Product]
   812   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C2700391:procedures [Activity]
   779 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   779 E C3274430:PROCEDURE [Health Care Activity]
   779 E C3538935:Procedure [Idea or Concept]
   779 E C3539779:Procedure [Intellectual Product]

Phrase: "identify on the sequenator"

Phrase: "the tyrosyl residue at which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "the radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "came off"

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.317: However, some of the intermediates might not have had the radioactive label and therefore escaped detection. 

Phrase: "However,"

Phrase: "some of the intermediates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]
   737   C0205103:Intermediate [Spatial Concept]
   737   C1550465:intermediate [Idea or Concept]
   737   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "might"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "had"

Phrase: "the radioactive label"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2986808:Radioactive Label [Indicator, Reagent, or Diagnostic Aid]
   861   C0034553:radioactive [Natural Phenomenon or Process]
   861   C0181496:Label [Manufactured Object]
   861   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "therefore"

Phrase: "escaped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0870509:escape [Mental Process]
   966   C1880554:ESCAPE [Event]

Phrase: "detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.318: Moreover, the radioactive iodine on the molecule might have had an effect on the endosomal proteolytic system. 

Phrase: "Moreover,"

Phrase: "the radioactive iodine on the molecule"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1441129:Radioactive Iodine [Element, Ion, or Isotope,Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0021966:Iodine- [Inorganic Chemical]
   753   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0034553:radioactive [Natural Phenomenon or Process]
   753   C0885449:iodine [Pharmacologic Substance]
   753   C2348268:Iodine [Element, Ion, or Isotope]
           Molecular Iodine

Phrase: "might"

Phrase: "have"

Phrase: "had"

Phrase: "an effect on the endosomal proteolytic system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.319: The position of the radioactive iodine may also affect the relative degradation rates of different substrates because different monoiodinated insulins are degraded at different rates (34). 

Phrase: "The position of the radioactive iodine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "may"

Phrase: "also"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the relative degradation rates of different substrates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "because"

Phrase: "different monoiodinated insulins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0021641:insulins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C3537244:Insulins [Pharmacologic Substance]
   793 E C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793 E C1579433:Insulin [Pharmacologic Substance]
   755 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "are"

Phrase: "degraded at different rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1705242:Different [Qualitative Concept]
   770   C1881707:DEGRADED [Phenomenon or Process]
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.320: From these studies (32, 33), it has been suggested that endosomal processing of insulin induces cleavages at A13-A14, B14-B15, and B24-B25 bonds. 

Phrase: "From these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "(32,"

Phrase: "33"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that endosomal processing of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1158354:insulin processing [Molecular Function]
   760   C1709694:Processing [Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cleavages at A13-A14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0010813:cleavage [Cell Function]
   737   C0596311:Cleavage [Phenomenon or Process]
   737   C1330957:cleavage [Cell Function]

Phrase: "B14-B15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417636:B15 [Gene or Genome]

Phrase: "and"

Phrase: "B24-B25 bonds."
Processing 00000000.tx.321: We have confirmed here that these peptide bonds were effectively cleaved within the HI molecule. 

Phrase: "We"

Phrase: "have"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "here"

Phrase: "that"

Phrase: "these peptide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0678595:peptide bond [Natural Phenomenon or Process]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "effectively"

Phrase: "cleaved within the HI molecule."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086418:Human [Human]
   753   C0205242:Cleaved [Spatial Concept]
   753   C0333853:Cleaved [Cell]
   753   C0567416:Molecule [Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.322: However, using a more sensitive approach, we found nine cleavage sites, of which six have not been previously reported. 

Phrase: "However,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a more sensitive approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "nine cleavage sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "of which six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "previously"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.323: Moreover, the application of mass spectrometry for such a study leads to elucidation, for the first time, of the entire structure of twelve insulin intermediates generated within hepatic endosomes. 

Phrase: "Moreover,"

Phrase: "the application of mass spectrometry"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185125:Application [Health Care Activity]
   760   C1947919:Application [Intellectual Product]
   760   C2347934:Application [Intellectual Product]
   760   C3539080:APPLICATION [Quantitative Concept]

Phrase: "for such"

Phrase: "a study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "leads to elucidation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "for the first time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "of the entire structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "of twelve insulin intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "generated within hepatic endosomes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   770   C3146294:Generated [Activity]
Processing 00000000.tx.324: EAI activity also differs from the exopeptidase cysteine-protease cathepsin B that processes internalized EGF and glucagon within rat liver endosomes by inducing proteolytic modifications at their C-terminus and N-terminus regions (22, 28). 

Phrase: "EAI activity also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1150184:insulinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "differs from the exopeptidase cysteine-protease cathepsin B"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1332804:CATHEPSIN B [Gene or Genome]
   770   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0117059:Exopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1947941:Protease [Enzyme]

Phrase: "that processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "internalized"

Phrase: "EGF"

Phrase: "and"

Phrase: "glucagon within rat liver endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by inducing proteolytic modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: "at their C-terminus"

Phrase: "and"

Phrase: "N-terminus regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "(22,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.325: The substrate and cleavage specificity of EAI is an intriguing issue. 

Phrase: "The substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "cleavage specificity of EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "is"

Phrase: "an intriguing issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033213:Issue [Finding]
   861   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.326: The question as to which specific properties are shared by EAI substrates has not yet been answered. 

Phrase: "The question as to which specific properties"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522634:Question [Intellectual Product]

Phrase: "are"

Phrase: "shared by EAI substrates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0001128:Acidic [Chemical]
   753   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0237876:shared [Social Behavior]
   753   C1415875:INSULINASE [Gene or Genome]
   753   C1522138:Shared [Functional Concept]
   719   C1710236:Substrate [Manufactured Object]

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "answered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706817:Answer [Intellectual Product]
Processing 00000000.tx.327: Exploiting the fact that two substrates competing for the same enzyme inhibit one another, we have found three new substrates of EAI genetically derived from the HI molecule. 

Phrase: "Exploiting"

Phrase: "the fact"

Phrase: "that two substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "competing for the same enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0445247:Same [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "another,"

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "three new substrates of EAI genetically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1710236:Substrate [Manufactured Object]

Phrase: "derived from the HI molecule."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086418:Human [Human]
   753   C0567416:Molecule [Substance]
   753   C1441547:Derived [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3245521:derived [Idea or Concept]
Processing 00000000.tx.328: Using HPLC analysis in which hydrolysis was measured by the generation of degradation products from unlabeled peptides, we demonstrated variable rates of ligand processing, i.e. high ([AspB10]-HI and [GluA13,GluB10]-HI), moderate (HI) and low (H2-analog) (Fig. 2). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HPLC analysis in which hydrolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "measured by the generation of degradation products"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0079411:Generation [Temporal Concept]
   748   C0243125:degradation [Functional Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0699900:Degradation [Organism Function]
   748   C1514468:Products [Entity]
   748   C3146294:Generation [Activity]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "from unlabeled peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "variable rates of ligand processing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "i.e. high"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "("

Phrase: "[AspB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "GluA13,"

Phrase: "GluB10"

Phrase: "]-HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "(HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "(H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: ")"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.329: However, mass spectrometry analyses revealed that the degradation products generated from wild-type HI and HI-mutants by endosomal insulinase were very similar. 

Phrase: "However,"

Phrase: "mass spectrometry analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "generated from wild-type HI"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086418:Human [Human]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1547052:*Type [Quantitative Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "HI-mutants by endosomal insulinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "very similar."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.330: Thus, the altered endosomal clearance of the mutant insulins does not arise from qualitative differences of ligand processing. 

Phrase: "Thus,"

Phrase: "the altered endosomal clearance of the mutant insulins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0449297:Clearance [Qualitative Concept]
   744   C1382187:Clearance [Clinical Attribute]
   744   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "arise from qualitative differences of ligand processing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0023688:Ligand [Chemical]
   748   C0205556:Qualitative [Qualitative Concept]
   748   C1709694:Processing [Activity]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.331: Additionally, the substituted amino acids in the insulin analogs did not correspond to primary sites of cleavage of HI within endosomes. 

Phrase: "Additionally,"

Phrase: "the substituted amino acids in the insulin analogs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correspond to primary sites of cleavage of HI"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   764   C0449695:primary sites [Spatial Concept]
   764   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C2945843:Site of [Qualitative Concept]
   742   C0010813:cleavage [Cell Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0086418:Human [Human]
   742   C0205145:Sites [Spatial Concept]
   742   C0205225:Primary [Qualitative Concept]
   742   C0439631:Primary [Therapeutic or Preventive Procedure]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "within endosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]
Processing 00000000.tx.332: Finally, on the basis of IC50 values, competition studies revealed that wild-type and mutant insulins displayed nearly equivalent affinity for the endosomal protease. 

Phrase: "Finally,"

Phrase: "on the basis of IC50 values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "competition studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0679932:competition [Social Behavior]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant insulins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0021641:insulins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C3537244:Insulins [Pharmacologic Substance]
   827 E C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827 E C1579433:Insulin [Pharmacologic Substance]
   789 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "nearly equivalent affinity for the endosomal protease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.333: The 1040 M IC50 values for HI and insulin analogs do not preclude these peptides from being physiological substrates for EAI. 

Phrase: "The 1040 M IC50 values for HI"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0042295:Values [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "insulin analogs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0243071:analogs [Chemical Viewed Structurally]
   755 E C0679213:analogies [Idea or Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "preclude"

Phrase: "these peptides from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "being"

Phrase: "physiological substrates for EAI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.334: However, although the IC50 value of HI for EAI appears 100- to 1000-fold higher than for the other suggested insulin protease IDE (35), the endosomal concentration of free insulin could be relatively high and may well approach or exceed the observed IC50 value due to the small volume of endosomes [10-17 liters (36, 37)]. 

Phrase: "However,"

Phrase: "although"

Phrase: "the IC50 value of HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "for EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "100-"

Phrase: "to 1000-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0205250:High [Qualitative Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]
   750 E C0489786:Height [Organism Attribute]

Phrase: "for the"

Phrase: "other suggested insulin protease IDE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   885   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   885   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "the endosomal concentration of free insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "relatively high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "or"

Phrase: "exceed"

Phrase: "the observed IC50 value due to the small volume of endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0205165:small value [Qualitative Concept]
   738   C1522609:Value [Quantitative Concept]

Phrase: "[10-17 liters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0475211:liter [Quantitative Concept]

Phrase: "(36,"

Phrase: "37"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.335: Moreover, Leu- and Met-enkephalin, which are known physiological substrates for neprilysin, exhibit kinetic Km values of 47 and 13 M, respectively (38). 

Phrase: "Moreover,"

Phrase: "Leu-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Met-enkephalin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014295:Met-Enkephalin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0014298:Enkephalin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C1550543:Meet [Idea or Concept]

Phrase: "which"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "physiological substrates for neprilysin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710236:Substrate [Manufactured Object]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "kinetic Km values of 47"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "13 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "respectively"

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.336: Alternatively, the high IC50 value of HI for EAI and the high proteolytic activity and affinity of EAI for insulin B-chain and a B2230 insulin fragment may also suggest that EAI is a nonspecific peptidase activity whose physiological substrates within the endosomal apparatus, other than insulin, have yet to be defined. 

Phrase: "Alternatively,"

Phrase: "the high IC50 value of HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522609:Value [Quantitative Concept]

Phrase: "for EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "and"

Phrase: "the high proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C0597304:Proteolytic [Molecular Function]
   827   C1561536:*Activity [Idea or Concept]
   827   C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "affinity of EAI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for insulin B-chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "a B2230 insulin fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "is"

Phrase: "a nonspecific peptidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150095:peptidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "whose physiological substrates within the endosomal apparatus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1710236:Substrate [Manufactured Object]

Phrase: "other than insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "yet to"

Phrase: "be"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.337: In support of this, there is evidence in the literature that nonspecific endosomal proteases are active toward a number of internalized polypeptides and growth factors (3). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this,"

Phrase: "there"

Phrase: "is"

Phrase: "evidence in the literature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "that nonspecific endosomal proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Proteases [Enzyme]

Phrase: "are"

Phrase: "active toward a number of internalized polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.338: For instance, we have recently demonstrated that cathepsin B, a general cysteine protease, down-regulates internalized EGF and glucagon within endosomes by inducing proteolytic cleavages of these ligands (22, 28). 

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "that cathepsin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a general cysteine protease,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "internalized EGF"

Phrase: "and"

Phrase: "glucagon within endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by inducing proteolytic cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0010813:cleavage [Cell Function]
   793   C0596311:Cleavage [Phenomenon or Process]
   793   C1330957:cleavage [Cell Function]

Phrase: "of these ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "(22,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.339: The availability of analogs with very high affinity for the insulin receptor enabled us to elucidate whether the structural determinants required for binding to the receptor and EAI were identical. 

Phrase: "The availability of analogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "with very high affinity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0442804:Very high [Finding]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C2700149:HIGH [Intellectual Product]

Phrase: "for the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "whether"

Phrase: "the structural determinants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521761:Determinant [Functional Concept]

Phrase: "required for binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   790   C1514873:Required [Functional Concept]

Phrase: "to the receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "were"

Phrase: "identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.340: The three insulin analogs used in this study all displayed an increase in binding affinity to receptors (between 327 and 687%) and an increase in the metabolic and mitogenic potencies (between 207 and 573%) as compared with HI (100%) (8, 11, 17). 

Phrase: "The three insulin analogs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0243071:analogs [Chemical Viewed Structurally]
   721 E C0679213:analogies [Idea or Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "all"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "an increase in binding affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "to receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "between 327"

Phrase: "and"

Phrase: "687%"

Phrase: ")"

Phrase: "and"

Phrase: "an increase in the metabolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "mitogenic potencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3245505:Potential [Qualitative Concept]

Phrase: "("

Phrase: "between 207"

Phrase: "and"

Phrase: "573%"

Phrase: ")"

Phrase: "as"

Phrase: "compared with HI"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0086418:Human [Human]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1707455:Compared [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(100%"

Phrase: ")"

Phrase: "(8,"

Phrase: "11,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.341: Thus, our results which showed variable rates of analog processing (from high to low) compared with insulin suggest a fundamental difference between the mechanisms by which the endosomal protease and the receptors recognized these molecules. 

Phrase: "Thus,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "variable rates of analog processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "("

Phrase: "from high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "to low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: ")"

Phrase: "compared with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1707455:Compared [Activity]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a fundamental difference between the mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "by which"

Phrase: "the endosomal protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "and"

Phrase: "the receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "recognized"

Phrase: "these molecules."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.342: This agreed with the finding that the insulin B-chain, which displayed a complete loss of receptor affinity, had one of the highest affinities for EAI and the highest rate of proteolysis by the protease. 

Phrase: "This"

Phrase: "agreed with the finding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C2825141:Finding [Finding]
   737   C3641827:Agree [Intellectual Product]

Phrase: "that"

Phrase: "the insulin B-chain,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "which"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a complete loss of receptor affinity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "had"

Phrase: "one of the highest affinities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "for EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "and"

Phrase: "the highest rate of proteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "by the protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]
Processing 00000000.tx.343: However, among the three regions of insulin important for binding of the ligand to its receptor (8) the B2426 region, which has been implicated in the high-affinity binding of insulin to its receptor (9, 10), appeared to also confer high-affinity binding to EAI. 

Phrase: "However,"

Phrase: "among the three regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "important for binding of the ligand"

Phrase: "to its receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(8"

Phrase: ")"

Phrase: "the B2426 region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the high-affinity binding of insulin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0020459:high insulin [Disease or Syndrome]
   767   C1623517:insulin binding [Molecular Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0205250:High [Qualitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1299351:High [Qualitative Concept]
   744   C1510827:Affinity [Natural Phenomenon or Process]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "to its receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(9,"

Phrase: "10"

Phrase: ")"

Phrase: ","

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "confer"

Phrase: "high-affinity binding to EAI."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205250:High [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1299351:High [Qualitative Concept]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   748   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.344: The influence of endosomal ligand degradation on the steady-state distribution of internalized ligands and their transit times throughout the endo-lysosomal compartment has been previously inferred from a comparison of insulin and EGF internalization in liver parenchyma (7, 28, 29, 30). 

Phrase: "The influence of endosomal ligand degradation"

Phrase: "on the steady-state distribution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]
   734   C0678587:steady state [Natural Phenomenon or Process]

Phrase: "of internalized ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligands [Chemical]

Phrase: "and"

Phrase: "their transit times throughout the endo-lysosomal compartment"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0040223:times [Temporal Concept]
   744   C1301827:transit [Functional Concept]
   744   C1632851:Times [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "inferred from a comparison of insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0679201:Inferred [Mental Process]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1707455:Comparison [Activity]
   753   C3245504:inferred [Idea or Concept]

Phrase: "and"

Phrase: "EGF internalization in liver parenchyma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0871786:internalization [Mental Process]

Phrase: "(7,"

Phrase: "28,"

Phrase: "29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.345: Whereas EGF was selectively resistant to endosomal dissociation and only partially degraded within hepatic endosomes by the cysteine protease cathepsin B (28), insulin was subject to rapid endosomal proteolysis (5, 7). 

Phrase: "Whereas"

Phrase: "EGF"

Phrase: "was"

Phrase: "selectively resistant to endosomal dissociation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "only partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "degraded within hepatic endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "by the cysteine protease cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332804:CATHEPSIN B [Gene or Genome]
   812   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was subject to rapid endosomal proteolysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439831:Rapid [Qualitative Concept]
   753   C0597304:Proteolysis [Molecular Function]
   753   C0681850:Subject [Group]
   753   C1421478:WAS [Gene or Genome]
   753   C1550501:{Subject} [Idea or Concept]
   753   C1706203:Subject [Idea or Concept]
   753   C2349001:Subject [Human]
   753   C2697811:Subject [Functional Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.346: Although it has been difficult to demonstrate, even in the presence of protease inhibitors, the accumulation of radiolabeled insulin in lysosomes of liver parenchyma (39), the targeting of EGF to lysosomes was easily observed using the in situ rat liver model (40). 

Phrase: "Although"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "demonstrate"

Phrase: ","

Phrase: "even in the presence of protease inhibitors,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1947941:Protease [Enzyme]
   745 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "the accumulation of radiolabeled insulin"

Phrase: "in lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "of liver parenchyma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0736268:Liver parenchyma [Body Part, Organ, or Organ Component]
   861   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "the targeting of EGF"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521840:Targeting [Functional Concept]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "to lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "was"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the in situ rat liver model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.347: Other evidence has come from the differences in endosomal degradation of transforming growth factor- and EGF after internalization, which coincided with altered intracellular trafficking and was linked to the different biopotency observed for the two ligands (41). 

Phrase: "Other evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "has"

Phrase: "come from the differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in endosomal degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "of transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "EGF after internalization,"

Phrase: "which"

Phrase: "coincided with altered intracellular"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C0392747:Altered [Functional Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "was"

Phrase: "linked to the different biopotency"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1705242:Different [Qualitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "observed for the two ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023688:Ligands [Chemical]
   760   C0205448:Two [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.348: As a consequence, we elected to study the in vitro endosome-lysosome transfer of a genetically engineered tool, the insulin analog H2 containing four amino acid substitutions, and which is a poor substrate for EAI activity [(7); this study]. 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "we"

Phrase: "elected"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the in vitro endosome-lysosome transfer of a genetically engineered tool,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0040671:Transfer [Mental Process]
   738   C1705822:Transfer [Activity]

Phrase: "the insulin analog H2 containing four amino acid substitutions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   760   C1555721:Substitution [Idea or Concept]
   760   C1706204:Substitution [Activity]

Phrase: "and"

Phrase: "which"

Phrase: "is"

Phrase: "a poor substrate for EAI activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710236:Substrate [Manufactured Object]

Phrase: "["

Phrase: "(7"

Phrase: ")"

Phrase: ";"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "]."
Processing 00000000.tx.349: The different properties of insulin and the H2-analog following binding to the insulin receptor now allowed for a test of the influence of ligand proteolysis on the endosomal sorting of ligands using a homologous receptor system. 

Phrase: "The different properties of insulin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "the H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "binding to the insulin receptor now"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   820   C1149501:insulin receptor binding [Molecular Function]
   783   C0597358:Receptor Binding [Molecular Function]
   783   C1623517:insulin binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "allowed for a test of the influence of ligand proteolysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0022885:Test [Laboratory Procedure]
   739   C0023688:Ligand [Chemical]
   739   C0039593:Test [Functional Concept]
   739   C0392366:test [Intellectual Product]
   739   C0597304:Proteolysis [Molecular Function]
   739   C0683607:allowed [Social Behavior]

Phrase: "on the endosomal sorting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237886:Sorting [Mental Process]
   861   C0700314:sorting [Cell Function]
   861   C1947906:Sorting [Activity]

Phrase: "of ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a homologous receptor system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.350: To the best of our knowledge, the present study is the first such direct test of this hypothesis using an in vivo model. 

Phrase: "To the best"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]

Phrase: "of our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "such direct test of this hypothesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0237913:Hypothesis Test [Intellectual Product]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an in vivo model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1515657:In Vivo Model [Research Activity]
   827   C3161035:Model [Intellectual Product]
   734   C1515655:In Vivo [Spatial Concept]
Processing 00000000.tx.351: Using cell-free assays originally developed for asialofetuin, a ligand of the asialoglycoprotein receptor (42), we have recently proposed an in vitro model for the transfer of endocytosed ligand-receptor complexes to lysosomes in hepatic tissue (29, 30). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cell-free assays originally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "developed for asialofetuin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0052492:asialo-fetuin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a ligand of the asialoglycoprotein receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1621296:receptor ligand [Molecular Function]
   753   C0023688:Ligand [Chemical]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "an in vitro model for the transfer of endocytosed ligand-receptor complexes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515654:In Vitro Model [Research Activity]
   736   C3161035:Model [Intellectual Product]

Phrase: "to lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "in hepatic tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0736268:Hepatic Tissue [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.352: We have shown that in a liver cell-free system containing in vivo endocytosed insulin, glucagon, GalBSA and EGF, these ligands are transferred in vitro from endosomes to lysosomes (29, 30). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in a liver cell-free system"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   814   C0007625:Cell-Free System [Cell Component]
   778   C0227525:Liver cell [Cell]
   778   C1183428:cell free [Cell]
   748   C0007634:Cell [Cell]
   748   C0023884:Liver [Body Part, Organ, or Organ Component]
   748   C0332296:free [Functional Concept]
   748   C0449913:System [Functional Concept]
   748   C0736268:LIVER [Body Part, Organ, or Organ Component]
   748   C1269647:Cell [Cell]
   748   C1278929:Liver [Body Part, Organ, or Organ Component]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1704653:Cell [Medical Device]
   748   C1880497:Free [Qualitative Concept]
   748   C1948049:Cell [Spatial Concept]
   748   C1996904:Free [Qualitative Concept]
   748   C2346688:LIVER [Food]
   723 E C2697585:Hepatocellular [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "in vivo endocytosed insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "GalBSA"

Phrase: "and"

Phrase: "EGF,"

Phrase: "these ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "are"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "in vitro from endosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "to lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.353: In addition to these ligands, the cell-free transfer of the H2-analog molecule was observed in endosomes isolated at a late stage of endocytosis [time of killing, 10 min (7)] and required the addition of cytosol and an ATP-regenerating system (29, 30, 42). 

Phrase: "In addition to these ligands,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "the cell-free transfer of the H2-analog molecule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0040671:Transfer [Mental Process]
   742   C1705822:Transfer [Activity]

Phrase: "was"

Phrase: "observed in endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C1441672:Observed [Functional Concept]

Phrase: "isolated at a late stage of endocytosis"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C1279941:Late stage [Temporal Concept]
   748   C0014139:Endocytosis [Cell Function]
   748   C0205087:Late [Temporal Concept]
   748   C0205390:Stage [Temporal Concept]
   748   C0205409:Isolated [Functional Concept]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   748   C1548221:Isolated [Idea or Concept]
   748   C2984285:Endocytosis [Functional Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "[time of killing,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "10 min (7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "the addition of cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "and"

Phrase: "an ATP-regenerating system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(29,"

Phrase: "30,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.354: However, the endosomal sorting of the H2-analog differed from the other polypeptides in several respects: 1) whereas degradation products were largely recovered in the soluble cytosolic fraction during the endo-lysosomal transfer of HI [this study (29)], the H2-analog transfer, as with the EGF transfer (30), was not accompanied by a net increase in intermediate products recovered in the upper part of the gradient; 

Phrase: "However,"

Phrase: "the endosomal sorting of the H2-analog"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0237886:Sorting [Mental Process]
   748   C0700314:sorting [Cell Function]
   748   C1947906:Sorting [Activity]
   738   C3548417:sorting endosome [Cell Component]

Phrase: "differed from the"

Phrase: "other polypeptides in several respects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "whereas"

Phrase: "degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "largely"

Phrase: "recovered in the soluble cytosolic fraction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0521108:recovered [Qualitative Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1383501:Cytosolic [Cell Component]
   753   C1554103:Fraction [Idea or Concept]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   719 E C2004454:recover [Organism Function]

Phrase: "during the endo-lysosomal transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "of HI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "["

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(29"

Phrase: ")"

Phrase: "],"

Phrase: "the H2-analog transfer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "as with the EGF transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040671:Transfer [Mental Process]
   760   C1705822:Transfer [Activity]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accompanied by a net increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442805:Increase [Functional Concept]
   704   C0439739:Reticular [Spatial Concept]

Phrase: "in intermediate products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "recovered in the upper part of the gradient"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C1292711:Part of [Spatial Concept]
   744   C0439182:% gradient [Quantitative Concept]
   744   C0449719:Part [Spatial Concept]
   744   C0521108:recovered [Qualitative Concept]
   744   C0812409:Gradient [Quantitative Concept]
   744   C1282910:Upper [Spatial Concept]
   744   C1709471:Part [Quantitative Concept]
   711 E C2004454:recover [Organism Function]

Phrase: ";"
Processing 00000000.tx.355: 2) lysosomal recovery after a 10 min incubation at 37 C was low (<15%) in the presence of insulin [this study (29)], moderate (1520%) with EGF (30) and glucagon (29), and high (2025%) with the H2-analog (this study), GalBSA and asialofetuin (29). 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "lysosomal recovery after a 10 min incubation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237820:Recovery [Activity]
   748   C1555688:recovery [Idea or Concept]
   748   C2004454:Recovery [Organism Function]

Phrase: "at 37 C"

Phrase: "was"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "("

Phrase: "<15%"

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "["

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(29"

Phrase: ")"

Phrase: "],"

Phrase: "moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "(1520%"

Phrase: ")"

Phrase: "with EGF (30"

Phrase: ")"

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(2025%"

Phrase: ")"

Phrase: "with the H2-analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "("

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "GalBSA"

Phrase: "and"

Phrase: "asialofetuin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052492:asialo-fetuin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.356: Thus, we suggest that endosomal proteolysis influences the steady-state distribution of internalized ligands throughout the endo-lysosomal compartment. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that endosomal proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597304:Proteolysis [Molecular Function]
   789 E C1947941:proteolytic [Enzyme]

Phrase: "influences"

Phrase: "the steady-state distribution of internalized ligands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "throughout the endo-lysosomal compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.357: The difference in endosomal degradation of these ligands following internalization also coincided with altered receptor trafficking and receptor phosphotyrosine profiles in the endosome and lysosome organelles (1, 28, 30, 43). 

Phrase: "The difference in endosomal degradation of these ligands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "internalization also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871786:internalization [Mental Process]

Phrase: "coincided with altered receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Altered [Functional Concept]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "receptor phosphotyrosine profiles in the endosome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "lysosome organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelles [Cell Component]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "28,"

Phrase: "30,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.358: Thus, a low lysosomal transfer of the and  subunits of the insulin receptor occurred during endosome-lysosome interaction (29), whereas the targeting of the EGF receptor for degradation in lysosomes was clearly demonstrated using the in situ rat liver model (40), the in vitro endosome-lysosome fusion system (30), and various cell lines (44). 

Phrase: "Thus,"

Phrase: "a low lysosomal transfer of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "subunits of the insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1711351:Subunit [Quantitative Concept]

Phrase: "occurred during endosome-lysosome interaction"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0024369:Lysosome [Cell Component]
   760   C0034850:Endosome [Cell Component]
   760   C1704675:Interaction [Functional Concept]
   760   C1709305:Occurred [Activity]
   760   C2984253:Lysosome [Functional Concept]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the targeting of the EGF receptor"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1521840:Targeting [Functional Concept]
   719 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "for degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "in lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "was"

Phrase: "clearly"

Phrase: "demonstrated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the in situ rat liver model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "the in vitro endosome-lysosome fusion system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "various cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.359: Studies are underway to determine whether, in response to the insulin analog H2, subsequent insulin receptor activation in the endosome (7) causes a translocation of the insulin receptor to the lysosome compartment.  

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "underway to"

Phrase: "determine"

Phrase: "whether"

Phrase: ","

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to the insulin analog H2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0919509:H2 [Gene or Genome]
   827   C1419394:H2 [Gene or Genome]
   734   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "subsequent insulin receptor activation in the endosome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "(7"

Phrase: ")"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a translocation of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040715:Translocation [Cell or Molecular Dysfunction]
   753   C2987521:Translocation [Activity]

Phrase: "to the lysosome compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.360: Acknowledgments  This paper is dedicated to the memory of our friend and collaborator Gdon Le Dranac (Facult de Pharmacie Paris XI, Chtenay-Malabry, France), who died on February 28th, 2000. 

Phrase: "Acknowledgments"

Phrase: "This paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "is"

Phrase: "dedicated to the memory of our friend"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0025260:Memory [Mental Process]
   748   C0079382:friend [Population Group]
   748   C0700327:memory [Finding]
   748   C1706377:Memory [Manufactured Object]

Phrase: "and"

Phrase: "collaborator Gdon Le Dranac"

Phrase: "(Facult de Pharmacie Paris XI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1720296:Xi [Intellectual Product]

Phrase: "Chtenay-Malabry,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "died on February 28th,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011065:Died [Organism Function]
   770   C1546956:Died [Finding]

Phrase: "2000."
Processing 00000000.tx.361: We thank Pamela H. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Pamela H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.362: Cameron (McGill University, Montral, Qubec, Canada) for reviewing the manuscript. 

Phrase: "Cameron"

Phrase: "(McGill University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Montral,"

Phrase: "Qubec,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "for reviewing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewing [Intellectual Product]
  1000   C1704362:Reviewing [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.363: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.364: R.A. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.365: Roth (Stanford University, Stanford, CA), Dr. 

Phrase: "Roth"

Phrase: "(Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA),"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.366: J. 

Phrase: "J."
Processing 00000000.tx.367: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.368: Mort (Shriners Hospital for Crippled Children, Montreal, Qubec, Canada), Dr. 

Phrase: "Mort (Shriners Hospital for Crippled Children,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0020017:Children's hospital [Health Care Related Organization]
   753   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   753   C1510665:Hospital [Qualitative Concept]

Phrase: "Montreal,"

Phrase: "Qubec,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.369: J.-C. 

Phrase: "J.-C."
Processing 00000000.tx.370: Schwartz (U109 INSERM, Center Paul Broca, Paris, France) and Dr. 

Phrase: "Schwartz"

Phrase: "(U109 INSERM,"

Phrase: "Center Paul Broca,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.371: J.-M. 

Phrase: "J.-M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.372: Chen (The Babraham Institute, Cambridge, United Kingdom) for kind gifts of anti-IDE, -procathepsin B, -TPP II and -TOP antibodies, respectively.  

Phrase: "Chen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "("

Phrase: "The Babraham Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Cambridge,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")"

Phrase: "for kind gifts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1136188:Gifts [Entity]
   777 E C0423899:Gifted [Finding]

Phrase: "of anti-IDE, -"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "procathepsin B, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072033:procathepsin B [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "TPP II"

Phrase: "and -"

Phrase: "TOP antibodies,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "respectively."
Processing 00000000.tx.373: Footnotes  * This work was supported by grants from the Institut National de la Sant et de la Recherche Mdicale and the Fondation pour la Recherche Mdicale (Grant 10000320-01, to F.A.). 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Institut National de la Sant et de la Recherche Mdicale"

Phrase: "and"

Phrase: "the Fondation"

Phrase: "pour"

Phrase: "la Recherche Mdicale"

Phrase: "(Grant 10000320-01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018173:Grant [Quantitative Concept]
   827   C1548284:Grant [Idea or Concept]

Phrase: "to F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A."

Phrase: ")."
Processing 00000000.tx.374: Received June 16, 2000.  

Phrase: "Received June 16,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2000."
Processing 00000000.tx.375: References Top Abstract Introduction Materials and Methods Results Discussion References  Baass PC, Di Guglielmo GM, Authier F, Posner BI, Bergeron JJM 1995 Compartmentalized signal transduction by receptor tyrosine kinases. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Baass PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Di Guglielmo GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1995 Compartmentalized signal transduction by receptor tyrosine kinases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037083:Signal Transduction [Cell Function]
   739   C1160185:transduction [Organism Function]
   739   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.376: Trends Cell Biol 5:465470[CrossRef] Authier F, Posner BI, Bergeron JJM 1994 Hepatic endosomes are a major physiological locus of insulin and glucagon degradation in vivo. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "465470"

Phrase: "[CrossRef"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1994 Hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0034850:Endosomes [Cell Component]

Phrase: "are"

Phrase: "a major physiological locus of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "glucagon degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.377: In: Ciechanover A, Schwartz AL (eds) Cellular Proteolytic Systems. 

Phrase: "In"

Phrase: ":"

Phrase: "Ciechanover A,"

Phrase: "Schwartz AL (eds) Cellular Proteolytic Systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   766   C0449913:System [Functional Concept]
   766   C1553451:System [Manufactured Object]
   766   C1704459:System [Medical Device]
   716 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.378: Wiley-Liss, New York, vol 15:89113 Authier F, Posner BI, Bergeron JJM 1996 Endosomal proteolysis of internalized proteins. 

Phrase: "Wiley-Liss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1508741:LISS [Laboratory Procedure]
   861   C2247545:LIS [Molecular Function]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "vol 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]

Phrase: ":"

Phrase: "89113 Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1996 Endosomal proteolysis of internalized proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597304:Proteolysis [Molecular Function]
Processing 00000000.tx.379: FEBS Lett 389:5560[CrossRef][Medline] Berg T, Gjen T, Bakke O 1995 Physiological functions of endosomal proteolysis. 

Phrase: "FEBS Lett 389"

Phrase: ":"

Phrase: "5560"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Berg T,"

Phrase: "Gjen T,"

Phrase: "Bakke O 1995 Physiological functions of endosomal proteolysis."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0542341:Functions [Functional Concept]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.380: Biochem J 307:313326[Medline] Authier F, Rachubinski RA, Posner BI, Bergeron JJM 1994 Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. 

Phrase: "Biochem J 307"

Phrase: ":"

Phrase: "313326"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Rachubinski RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1994 Endosomal proteolysis of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597304:Proteolysis [Molecular Function]

Phrase: "by an acidic thiol metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "unrelated to insulin degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445356:Unrelated [Finding]
   760   C1704623:Unrelated [Qualitative Concept]
Processing 00000000.tx.381: J Biol Chem 269:30103016[Abstract/Free FullText] Faure R, Baquiran G, Bergeron JJM, Posner BI 1992 The dephosphorylation of insulin and epidermal growth factor receptors. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "30103016"

Phrase: "[Abstract/Free FullText"

Phrase: "] Faure R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Baquiran G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bergeron JJM,"

Phrase: "Posner BI 1992"

Phrase: "The dephosphorylation of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1158884:Dephosphorylation [Molecular Function]
   770   C3160734:Dephosphorylation [Molecular Function]

Phrase: "and"

Phrase: "epidermal growth factor receptors."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0034802:Receptors, Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
Processing 00000000.tx.382: J Biol Chem 267:1121511221[Abstract/Free FullText] Authier F, Di Guglielmo GM, Danielsen GM, Bergeron JJM 1998 Uptake and metabolic fate of [HisA8,HisB4,GluB10,HisB27]insulin in rat liver in vivo. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1121511221"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Di Guglielmo GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Danielsen GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Bergeron JJM 1998 Uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "metabolic fate of [HisA8,"

Phrase: "HisB4,"

Phrase: "GluB10,"

Phrase: "HisB27"

Phrase: "]insulin in rat liver"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.383: Biochem J 332:421430[Medline] Drejer K 1992 The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. 

Phrase: "Biochem J 332"

Phrase: ":"

Phrase: "421430"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Drejer K 1992"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "The bioactivity of insulin analogues"

Phrase: "from in vitro receptor binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597358:Receptor Binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "to in vivo glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.384: Diabetes Metab Rev 8:259286[Medline] Nakagawa SH, Tager HS 1986 Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. 

Phrase: "Diabetes Metab Rev 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "259286"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nakagawa SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Tager HS 1986 Role of the phenylalanine B25 side chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "in directing insulin interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "with its receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.385: Steric and conformational effects. 

Phrase: "Steric"

Phrase: "and"

Phrase: "conformational effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.386: J Biol Chem 261:73327341[Abstract/Free FullText] Nakagawa SH, Tager HS 1987 Role of the COOH-terminal B-chain domain in insulin-receptor interaction. 

Phrase: "J Biol Chem 261"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "73327341"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakagawa SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Tager HS 1987 Role of the COOH-terminal B-chain domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "in insulin-receptor interaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704675:Interaction [Functional Concept]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]
Processing 00000000.tx.387: Identification of perturbations involving the insulin mainchain. 

Phrase: "Identification of perturbations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the insulin mainchain."
Processing 00000000.tx.388: J Biol Chem 262:1205412058[Abstract/Free FullText] Drejer K, Kruse V, Larsen UD, Hougaard P, Bjrn S, Gammeltoft S 1991 Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma HepG2 cells. 

Phrase: "J Biol Chem 262"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1205412058"

Phrase: "[Abstract/Free FullText"

Phrase: "] Drejer K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kruse V,"

Phrase: "Larsen UD,"

Phrase: "Hougaard P,"

Phrase: "Bjrn S,"

Phrase: "Gammeltoft S 1991 Receptor binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "tyrosine kinase activation by insulin analogues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "with extreme affinities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "studied in human hepatoma HepG2 cells."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C2717940:HepG2 Cells [Cell]
   783   C0427861:Human cells [Laboratory or Test Result]
   767   C0178693:human study [Research Activity]
   767   C0677626:hepatoma cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0023903:Hepatoma [Neoplastic Process]
   753   C0086418:Human [Human]
   753   C2239176:Hepatoma [Neoplastic Process]
   753   C3282337:Cells [Cell]
   719   C0557651:Study [Manufactured Object]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719   C2603343:Study [Research Activity]
Processing 00000000.tx.389: Diabetes 40:14881495[Abstract] Tager H, Thomas N, Assoian R, Rubenstein A, Saekow M, Olefsky J, Kaiser ET 1980 Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. 

Phrase: "Diabetes 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "14881495"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tager H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Thomas N,"

Phrase: "Assoian R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rubenstein A,"

Phrase: "Saekow M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Olefsky J,"

Phrase: "Kaiser ET 1980 Semisynthesis"

Phrase: "and"

Phrase: "biological activity of porcine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005532:Biological [Biomedical Occupation or Discipline]
   770   C0205177:Activity [Functional Concept]
   770   C0205460:biological [Qualitative Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "[LeuB24"

Phrase: "]insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "LeuB25"

Phrase: "]insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.390: Proc Natl Acad Sci USA 77:31813185[Abstract] Kobayashi M, Ohgaku S, Iwasaki M, Maegawa H, Watanabe N, Shigeta Y, Inouye K 1983 Receptor binding and biological activity of supernormal insulin, [D-PheB24]-insulin. 

Phrase: "Proc Natl Acad Sci USA 77"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "31813185"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kobayashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohgaku S,"

Phrase: "Iwasaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Maegawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Watanabe N,"

Phrase: "Shigeta Y,"

Phrase: "Inouye K 1983 Receptor binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "biological activity of supernormal insulin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C1145751:insulin activity [Molecular Function]
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205177:Activity [Functional Concept]
   760   C0205460:biological [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "["

Phrase: "D-"

Phrase: "PheB24"

Phrase: "]-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.391: In: Sakamoto N, Alberti KGMM (eds) Current and Future Therapies with Insulin. 

Phrase: "In"

Phrase: ":"

Phrase: "Sakamoto N,"

Phrase: "Alberti KGMM"

Phrase: "(eds) Current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521116:Current [Temporal Concept]
   861   C1705970:Current [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "Future Therapies with Insulin."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0087111:therapies [Therapeutic or Preventive Procedure]
   737 E C0039798:therapy [Functional Concept]
   737 E C1363945:Therapy [Finding]
Processing 00000000.tx.392: Excerpta Medica, Amsterdam, pp 136141 Pullen RA, Lindsay DG, Wood SP, Tickle IJ, Blundell TL, Wollmer A, Krail G, Brandenburg G, Zahn H, Gliemann J, Gammeltoft S 1976 Receptor-binding region of insulin. 

Phrase: "Excerpta Medica,"

Phrase: "Amsterdam,"

Phrase: "pp 136141 Pullen RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538806:Ra [Spatial Concept]

Phrase: "Lindsay DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Wood SP,"

Phrase: "Tickle IJ,"

Phrase: "Blundell TL,"

Phrase: "Wollmer A,"

Phrase: "Krail G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Brandenburg G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Zahn H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gliemann J,"

Phrase: "Gammeltoft S 1976 Receptor-binding region of insulin."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   793   C1149501:insulin receptor binding [Molecular Function]
   770   C0597358:Receptor Binding [Molecular Function]
   767   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   767   C1334133:INSULIN RECEPTOR [Gene or Genome]
   767   C1623517:insulin binding [Molecular Function]
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
Processing 00000000.tx.393: Nature (Lond) 259:369373[Medline] Schwartz GP, Burke GT, Katsoyannis PG 1987 A superactive insulin: [B10-aspartic acid]insulin (human). 

Phrase: "Nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "(Lond) 259"

Phrase: ":"

Phrase: "369373"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schwartz GP,"

Phrase: "Burke"

Phrase: "GT,"

Phrase: "Katsoyannis PG 1987"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1266240:PG [Laboratory Procedure]

Phrase: "A superactive insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "[B10-aspartic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0004015:Aspartic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "]insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: ")."
Processing 00000000.tx.394: Proc Natl Acad Sci USA 84:64086411[Abstract] Simon J, Freychet P, Rosselin G, de Meyts P 1977 Enhanced binding affinity of chicken insulin in rat liver membranes and human lymphocytes: relationship to the kinetic properties of the hormone-receptor interaction. 

Phrase: "Proc Natl Acad Sci USA 84"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "64086411"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Simon J,"

Phrase: "Freychet P,"

Phrase: "Rosselin G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "de Meyts P 1977 Enhanced binding affinity of chicken insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "in rat liver membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
   734   C1882726:Rat Liver [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "human lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]

Phrase: ":"

Phrase: "relationship to the kinetic properties of the hormone-receptor interaction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C2698891:Property of Relationship [Conceptual Entity]
   739   C0439849:Relationship [Qualitative Concept]
   739   C1705630:Relationship [Idea or Concept]
   739   C1706279:Relationship [Idea or Concept]
   739   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.395: Endocrinology 100:115121[Abstract] Hansen BF, Danielsen GM, Drejer K, Srensen AR, Wiberg FC, Klein HH, Lundemose AG 1996 Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. 

Phrase: "Endocrinology 100"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "115121"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hansen BF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006409:BF [Geographic Area]
   861   C1824728:BF [Gene or Genome]

Phrase: "Danielsen GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Drejer K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Srensen AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "Wiberg FC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2983605:FC [Activity]

Phrase: "Klein HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Lundemose AG 1996 Sustained signalling from the insulin receptor"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C3537152:signalling [Biologic Function]
   708 E C1710082:Signal [Phenomenon or Process]

Phrase: "after stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with insulin analogues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C2825028:Insulin Analogue [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0243071:Analogue [Chemical Viewed Structurally]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "increased mitogenic potency."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.396: Biochem J 315:271279[Medline] Authier F, Janicot M, Lederer F, Desbuquois B 1990 Fate of injected glucagon taken up by rat liver in vivo. 

Phrase: "Biochem J 315"

Phrase: ":"

Phrase: "271279"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Janicot M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lederer F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B 1990 Fate of injected glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1539479:FATE [Gene or Genome]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.397: Biochem J 272:703712[Medline] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. 

Phrase: "Biochem J 272"

Phrase: ":"

Phrase: "703712"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lowry OH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "Rosebrough NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Farr AL,"

Phrase: "Randall RJ 1951 Protein measurement with the Folin phenol reagent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0202202:Protein measurement [Laboratory Procedure]
   757   C0202446:Phenol measurement [Laboratory Procedure]
   739   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.398: J Biol Chem 193:265275[Free FullText] Shii K, Roth RA 1986 Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. 

Phrase: "J Biol Chem 193"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "265275"

Phrase: "[Free FullText"

Phrase: "] Shii K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roth RA 1986 Inhibition of insulin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0677626:hepatoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "after microinjection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025991:Microinjection [Therapeutic or Preventive Procedure]

Phrase: "of monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to a specific cytosolic protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
Processing 00000000.tx.399: Proc Natl Acad Sci USA 83:41474151[Abstract] Rowan AD, Mason P, Mach L, Mort JS 1992 Rat procathepsin B. 

Phrase: "Proc Natl Acad Sci USA 83"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "41474151"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rowan AD,"

Phrase: "Mason P,"

Phrase: "Mach L,"

Phrase: "Mort JS 1992 Rat procathepsin B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0072033:procathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.400: J Biol Chem 267:1599315999[Abstract/Free FullText] Authier F, Mort JS, Bell AW, Posner BI, Bergeron JJM 1995 Proteolysis of glucagon within hepatic endosomes by membrane-associated cathepsins B and D. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1599315999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mort JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Bell AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1995 Proteolysis of glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "within hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "by membrane-associated cathepsins B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0699919:Cathepsins B [Amino Acid, Peptide, or Protein,Enzyme]
   844 E C1332804:CATHEPSIN B [Gene or Genome]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.401: J Biol Chem 270:1579815807[Abstract/Free FullText] Hughes CE, Caterson B, White RJ, Roughley PJ, Mort JS 1992 Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. 

Phrase: "J Biol Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1579815807"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hughes CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Caterson B,"

Phrase: "White RJ,"

Phrase: "Roughley PJ,"

Phrase: "Mort JS 1992 Monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0746619:monoclonal [Finding]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizing"

Phrase: "protease-generated neoepitopes from cartilage proteoglycan degradation."
Processing 00000000.tx.402: Application to studies of human link protein cleavage by stromelysin. 

Phrase: "Application to studies of human link protein cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0185125:Application [Health Care Activity]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C3539080:APPLICATION [Quantitative Concept]

Phrase: "by stromelysin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0164371:Stromelysin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.403: J Biol Chem 267:1601116014[Abstract/Free FullText] Rose C, Vargas F, Facchinetti P, Bourgeat P, Bambal RB, Bishop PB, Chan SMT, Moore ANJ, Ganellin CR, Schwartz J-C 1996 Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1601116014"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Rose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "C,"

Phrase: "Vargas F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Facchinetti P,"

Phrase: "Bourgeat P,"

Phrase: "Bambal RB,"

Phrase: "Bishop PB,"

Phrase: "Chan SMT,"

Phrase: "Moore ANJ,"

Phrase: "Ganellin CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Schwartz J-C 1996 Characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "inhibition of a cholecystokinin-inactivating serine peptidase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]
Processing 00000000.tx.404: Nature (Lond) 380:403409[CrossRef][Medline] Chen J-M, Changco A, Brown MA, Brown MA, Barrett AJ 1995 Immunolocalization of thimet oligopeptidase in chicken embryonic fibroblasts. 

Phrase: "Nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "(Lond) 380"

Phrase: ":"

Phrase: "403409"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen J-M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Changco A,"

Phrase: "Brown MA,"

Phrase: "Brown MA,"

Phrase: "Barrett AJ 1995 Immunolocalization of thimet oligopeptidase"

Phrase: "in chicken embryonic fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.405: Exp Cell Res 216:8085[CrossRef][Medline] Authier F, Desbuquois B 1991 Degradation of glucagon in isolated liver endosomes. 

Phrase: "Exp Cell Res 216"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1417055:EXP [Gene or Genome]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "8085"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B 1991 Degradation of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "in isolated liver endosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034850:Endosomes [Cell Component]
Processing 00000000.tx.406: Biochem J 280:211218[Medline] Authier F, Desbuquois B, de Galle B 1992 Ligand-mediated internalization of glucagon receptors in intact rat liver. 

Phrase: "Biochem J 280"

Phrase: ":"

Phrase: "211218"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B,"

Phrase: "de Galle B 1992 Ligand-mediated internalization of glucagon receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0599281:receptor internalization [Phenomenon or Process]
   739   C0871786:internalization [Mental Process]

Phrase: "in intact rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.407: Endocrinology 131:447457[Abstract] Authier F, Mtioui M, Bell AW, Mort JS 1999 Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B. 

Phrase: "Endocrinology 131"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "447457"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mtioui M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bell AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Mort JS 1999 Negative regulation of epidermal growth factor signaling"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C1160192:negative regulation of growth [Organism Function]
   799   C3158357:negative regulation of signaling [Biologic Function]
   777   C1160191:regulation of growth [Organism Function]
           growth regulation
   777   C2756011:regulation of signaling [Biologic Function]
   739   C0205160:Negative [Qualitative Concept]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]
   739   C1513916:Negative [Finding]
   739   C2825415:Negative [Conceptual Entity]
   739   C2825491:Negative [Qualitative Concept]

Phrase: "by selective proteolytic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "in the endosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosome [Cell Component]

Phrase: "mediated by cathepsin B."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332804:CATHEPSIN B [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.408: J Biol Chem 274:3372333731[Abstract/Free FullText] Chauvet G, Tahiri K, Authier F, Desbuquois B 1998 Endosome-lysosome transfer of insulin and glucagon in a liver cell-free system. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3372333731"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chauvet G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Tahiri K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B 1998 Endosome-lysosome transfer of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0040671:Transfer [Mental Process]
   744   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "glucagon in a liver cell-free system."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0030280:Glucagon Cell [Cell]
   748   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   748   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.409: Eur J Biochem 254:527537[Abstract] Authier F, Chauvet G 1999 In vitro endosome-lysosome transfer of dephosphorylated EGF receptor and Shc in rat liver. 

Phrase: "Eur J Biochem 254"

Phrase: ":"

Phrase: "527537"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Chauvet G 1999 In vitro endosome-lysosome transfer of dephosphorylated EGF receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0040671:Transfer [Mental Process]
   736   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "Shc in rat liver."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1312062:SHC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1705297:SHC [Gene or Genome]
Processing 00000000.tx.410: FEBS Lett 461:2531[CrossRef][Medline] Hamel FG, Mahoney MJ, Duckworth WC 1991 Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification. 

Phrase: "FEBS Lett 461"

Phrase: ":"

Phrase: "2531"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Mahoney MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Duckworth WC 1991 Degradation of intraendosomal insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "by insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "without acidification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522821:acidification [Cell Function]
  1000   C2987513:Acidification [Phenomenon or Process]
Processing 00000000.tx.411: Diabetes 40:436443[Abstract] Clot J-P, Janicot M, Fouque F, Desbuquois B, Haumont P-Y, Lederer F 1990 Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies. 

Phrase: "Diabetes 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "436443"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

Phrase: "Clot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
  1000   C0302148:Clot [Acquired Abnormality]

Phrase: "J-P,"

Phrase: "Janicot M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fouque F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B,"

Phrase: "Haumont P-Y,"

Phrase: "Lederer F 1990 Characterization of insulin degradation products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "generated in liver endosomes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034850:Endosomes [Cell Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   770   C3146294:Generated [Activity]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: ":"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro studies."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.412: Mol Cell Endocrinol 72:175185[CrossRef][Medline] Seabright PJ, Smith GD 1996 The characterization of endosomal insulin degradation intermediates and their sequence of production. 

Phrase: "Mol Cell Endocrinol 72"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "175185"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seabright PJ,"

Phrase: "Smith GD 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: "The characterization of endosomal insulin degradation intermediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "their sequence of production."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.413: Biochem J 320:947956[Medline] Ryan MP, Peavy DE, Frank BH, Duckworth WC 1984 The degradation of monoiodotyrosyl insulin isomers by insulin protease. 

Phrase: "Biochem J 320"

Phrase: ":"

Phrase: "947956"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ryan MP,"

Phrase: "Peavy DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Frank BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Duckworth WC 1984"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013123:WC [Organism Function]
   827   C2825512:WC [Quantitative Concept]

Phrase: "The degradation of monoiodotyrosyl insulin isomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "by insulin protease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021669:Insulin Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]
Processing 00000000.tx.414: Endocrinology 115:591599[Abstract] Shii K, Yokono K, Baba S, Roth RA 1986 Purification and characterization of insulin-degrading enzyme from human erythrocytes. 

Phrase: "Endocrinology 115"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "591599"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shii K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yokono K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Baba S,"

Phrase: "Roth RA 1986 Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243114:purification [Functional Concept]
   812   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of insulin-degrading enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "from human erythrocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]
Processing 00000000.tx.415: Diabetes 35:675683[Abstract] Bergeron JJM, Cruz J, Khan MN, Posner BI 1985 Uptake of insulin and other ligands into receptor-rich endocytic components of target cells: the endosomal apparatus. 

Phrase: "Diabetes 35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "675683"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bergeron JJM,"

Phrase: "Cruz J,"

Phrase: "Khan MN,"

Phrase: "Posner BI 1985 Uptake of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "other ligands into receptor-rich endocytic components of target cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C1621296:receptor ligand [Molecular Function]
   739   C0023688:Ligands [Chemical]

Phrase: ":"

Phrase: "the endosomal apparatus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]
   789   C0034850:Endosome [Cell Component]
Processing 00000000.tx.416: Annu Rev Physiol 47:383403[CrossRef][Medline] Doherty JJ, Kay DG, Lai WH, Posner BI, Bergeron JJM 1990 Selective degradation of insulin within rat liver endosomes. 

Phrase: "Annu Rev Physiol 47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "383403"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Doherty JJ,"

Phrase: "Kay DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Lai WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1990 Selective degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "within rat liver endosomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034850:Endosomes [Cell Component]
   734   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
Processing 00000000.tx.417: J Cell Biol 110:3542[Abstract] Hersh LB, Morihara K 1986 Comparison of the subsite specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin. 

Phrase: "J Cell Biol 110"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "3542"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hersh LB,"

Phrase: "Morihara K 1986 Comparison of the subsite specificity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707455:Comparison [Activity]

Phrase: "of the mammalian neutral endopeptidase 24.11"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C0025250:Neutral Endopeptidase 24.11 [Amino Acid, Peptide, or Protein,Enzyme]
           Endopeptidase-24.11
           Neutral Endopeptidase
   840   C1366499:neutral endopeptidase [Gene or Genome]
   804   C0024660:Mammalian [Mammal]
   804   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1882074:Neutral [Qualitative Concept]
   804   C2825492:Neutral [Phenomenon or Process]

Phrase: "(enkephalinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Enkephalinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:ENKEPHALINASE [Gene or Genome]

Phrase: ")"

Phrase: "to the bacterial neutral endopeptidase thermolysin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0039815:Thermolysin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.418: J Biol Chem 261:64336437[Abstract/Free FullText] Surmacz CA, Wert JJ, Ward WF, Mortimore GE 1988 Uptake and intracellular fate of [14C]sucrose-insulin in perfused rat livers. 

Phrase: "J Biol Chem 261"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "64336437"

Phrase: "[Abstract/Free FullText"

Phrase: "] Surmacz CA,"

Phrase: "Wert JJ,"

Phrase: "Ward WF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043021:WF [Geographic Area]

Phrase: "Mortimore GE 1988 Uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "intracellular fate of [14C"

Phrase: "]sucrose-insulin in perfused rat livers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.419: Am J Physiol 255:C70C75 Renfrew CA, Hubbard AL 1991 Degradation of epidermal growth factor receptor in rat liver. 

Phrase: "Am"

Phrase: "J Physiol 255"

Phrase: ":"

Phrase: "C70C75 Renfrew CA,"

Phrase: "Hubbard AL 1991 Degradation of epidermal growth factor receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1819635:receptor degradation [Molecular Function]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: "in rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.420: J Biol Chem 266:2126521273[Abstract/Free FullText] Ebner R, Derynck R 1991 Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. 

Phrase: "J Biol Chem 266"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2126521273"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ebner R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Derynck R 1991 Epidermal growth factor"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   876   C0034471:R factor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   876   C0602449:R-factor [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1323367:epidermal growth factor [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0014520:Epidermal [Tissue]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0221920:Epidermal [Spatial Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "transforming growth factor-alpha"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0040688:Transforming Growth Factor alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527195:Transforming Growth Factor-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0439095:Alpha [Intellectual Product]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: ":"

Phrase: "differential intracellular routing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0013153:ROUTE [Functional Concept]
   793   C0449444:Route [Spatial Concept]
   793   C1879941:ROUTE [Intellectual Product]

Phrase: "and"

Phrase: "processing of ligand-receptor complexes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]
Processing 00000000.tx.421: Cell Regul 2:599612[Medline] Mullock BM, Branch WJ, van Schaik M, Gilbert LK, Luzio JP 1989 Reconstitution of an endosome-lysosome interaction in a cell-free system. 

Phrase: "Cell Regul 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "599612"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mullock BM,"

Phrase: "Branch WJ,"

Phrase: "van Schaik M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Gilbert LK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038088:LK [Geographic Area]
   861   C2681928:LK [Gene or Genome]

Phrase: "Luzio JP 1989 Reconstitution of an endosome-lysosome interaction"

Phrase: "in a cell-free system."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0007625:Cell-Free System [Cell Component]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.422: J Cell Biol 108:20932099[Abstract] Di Guglielmo GM, Baass PC, Ou W-J, Posner BI, Bergeron JJM 1994 Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. 

Phrase: "J Cell Biol 108"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "20932099"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Di Guglielmo GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Baass PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Ou W-J,"

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1994 Compartmentalization of SHC,"

Phrase: "GRB2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0170953:GRB-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333707:GRB2 [Gene or Genome]

Phrase: "and"

Phrase: "mSOS,"

Phrase: "and"

Phrase: "hyperphosphorylation of Raf-1"

Phrase: "by EGF"

Phrase: "but"

Phrase: "not insulin in liver parenchyma."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.423: EMBO J 13:42694277[Abstract] Futter CE, Felder S, Schlessinger J, Ullrich A, Hopkins CR 1993 Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor. 

Phrase: "EMBO J 13"

Phrase: ":"

Phrase: "42694277"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Futter CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Felder S,"

Phrase: "Schlessinger J,"

Phrase: "Ullrich A,"

Phrase: "Hopkins CR 1993 Annexin I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0103403:Annexin I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C1412417:ANNEXIN I [Gene or Genome]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "phosphorylated in the multivesicular body"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0230825:Multivesicular body [Cell Component]
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "during the processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "of the epidermal growth factor receptor."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
Processing 00000000.tx.424: J Cell Biol 120:7783[Abstract]

Phrase: "J Cell Biol 120"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "7783"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

